<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v46-2022-02-17.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.6 2022-02-17" file="US20230000081A1-20230105.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20221220" date-publ="20230105"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20230000081</doc-number><kind>A1</kind><date>20230105</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>17281210</doc-number><date>20190927</date></document-id></application-reference><us-application-series-code>17</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>56</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>P</subclass><main-group>3</main-group><subgroup>00</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>02</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>36</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>54</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>34</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>30</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>653</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>40</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>80</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>47</main-group><subgroup>14</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>36</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>35</main-group><subgroup>02</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>01</class><subclass>N</subclass><main-group>47</main-group><subgroup>12</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>56</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>47</main-group><subgroup>12</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>02</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>36</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>54</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>34</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>30</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>653</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>40</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>43</main-group><subgroup>80</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>47</main-group><subgroup>14</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>37</main-group><subgroup>36</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>01</class><subclass>N</subclass><main-group>35</main-group><subgroup>02</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20210801</date></cpc-version-indicator><section>A</section><class>01</class><subclass>P</subclass><main-group>3</main-group><subgroup>00</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><invention-title id="d2e43">SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>62737907</doc-number><date>20180927</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>62737914</doc-number><date>20180927</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>62829512</doc-number><date>20190404</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>62829525</doc-number><date>20190404</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>0903608 B.C. Ltd.</orgname><address><city>Vancouver</city><country>CA</country></address></addressbook><residence><country>CA</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>MANHAS</last-name><first-name>Karan</first-name><address><city>Vancouver</city><country>CA</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>ROZEK</last-name><first-name>Annett</first-name><address><city>Port Moody</city><country>CA</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>HE</last-name><first-name>Yuehua</first-name><address><city>Surrey</city><country>CA</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>LAMBRINOUDIS</last-name><first-name>Costantinos</first-name><address><city>Vancouver</city><country>CA</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>BUI</last-name><first-name>Le Linh</first-name><address><city>Vancouver</city><country>CA</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>SHOKATIAN</last-name><first-name>Sadegh</first-name><address><city>Vancouver</city><country>CA</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/CA2019/051386</doc-number><date>20190927</date></document-id><us-371c12-date><date>20210329</date></us-371c12-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Compositions and methods for increasing the efficacy of pesticidal compositions are described herein, including synergistic pesticidal compositions comprising: benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxiconazole, propiconazole, difenoconazole, fludioxonil, mancozeb, tebuconazole, valifenalate, in combination with a C4-C10 saturated or unsaturated aliphatic acid and methods for delivery of pesticidal active ingredients. Some pesticidal compositions and methods as described are directed to compositions and methods for increasing the efficacy of fungicides. Some pesticidal compositions and methods as described are directed to compositions and methods for increasing the efficacy of nematicides. Some pesticidal compositions and methods as described are directed to compositions and methods for increasing the efficacy of insecticides. Methods for enhancing the activity pesticidal active ingredients in pesticidal compositions in use are also described.</p></abstract><drawings id="DRAWINGS"><figure id="Fig-EMI-D00000" num="00000"><img id="EMI-D00000" he="149.78mm" wi="145.97mm" file="US20230000081A1-20230105-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00001" num="00001"><img id="EMI-D00001" he="169.25mm" wi="148.00mm" file="US20230000081A1-20230105-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00002" num="00002"><img id="EMI-D00002" he="153.42mm" wi="162.48mm" file="US20230000081A1-20230105-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00003" num="00003"><img id="EMI-D00003" he="137.16mm" wi="165.35mm" file="US20230000081A1-20230105-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00004" num="00004"><img id="EMI-D00004" he="168.91mm" wi="163.41mm" file="US20230000081A1-20230105-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00005" num="00005"><img id="EMI-D00005" he="155.87mm" wi="156.46mm" file="US20230000081A1-20230105-D00005.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure></drawings><description id="description"><?cross-reference-to-related-applications description="Cross Reference To Related Applications" end="lead"?><heading id="h-0001" level="1">REFERENCE TO RELATED APPLICATIONS</heading><p id="p-0002" num="0001">This application claims priority to, and the benefit of, US provisional patent application Nos. 62/737,907 filed 27 Sep. 2018; 62/737,914 filed 27 Sep. 2018; 62/829,512 filed 4 Apr. 2019; and 62/829,525 filed 4 Apr. 2019, all entitled SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS, all of which are incorporated by reference herein in their entireties.</p><?cross-reference-to-related-applications description="Cross Reference To Related Applications" end="tail"?><?summary-of-invention description="Summary of Invention" end="lead"?><heading id="h-0002" level="1">TECHNICAL FIELD</heading><p id="p-0003" num="0002">An embodiment of the present invention is related to compositions and methods for increasing the efficacy of pesticidal compositions. More particularly, some embodiments are related to synergistic pesticidal compositions and methods for delivery of pesticidal active ingredients. Some embodiments of the present invention are directed to compositions and methods for increasing the efficacy of fungicides.</p><p id="p-0004" num="0003">Some embodiments of the present invention are directed to compositions and methods for increasing the efficacy of nematicides. Some embodiments of the present invention are directed to compositions and methods for increasing the efficacy of insecticides. Further embodiments of the present invention are directed to methods for enhancing the activity pesticidal active ingredients in pesticidal compositions.</p><heading id="h-0003" level="1">BACKGROUND</heading><p id="p-0005" num="0004">Pesticides, including fungicides, herbicides, nematicides and insecticides, are important compositions for use in domestic, agricultural, industrial and commercial settings, such as to provide for control of unwanted pests and/or pathogens. Providing for effective pest control is of high importance in many such settings, since pests and/or other pathogens if not controlled can cause loss and or destruction of crops or other plants, or harm to animals, humans or other beneficial or desired organisms. There remains a need for environmentally safe and effective pesticides, including fungicides, nematicides and insecticides, or compounds that enhance the efficacy of pesticides, including fungicides, nematicides and insecticides, and for methods of enhancing the efficacy of pesticides including fungicides, nematicides and insecticides, so that pesticides can be used in a more environmentally safe and effective manner. In agricultural settings, for example, a variety of plant pests, such as insects, worms, nematodes, fungi, and plant pathogens such as viruses and bacteria, are known to cause significant damage to seeds and ornamental and crop plants. Chemical pesticides have generally been used, but many of these are expensive and potentially toxic to humans, animals, and/or the environment and may persist long after they are applied. Therefore it is typically beneficial to farmers, consumers and the surrounding environment to use the least amount of chemical pesticides as possible, while continuing to control pest growth in order to maximize crop yield. In a growing number of cases, chemical pesticide use has also resulted in growing resistance to certain chemical pesticides by pest organisms, leading to reduced effectiveness, requiring greater doses of pesticidal chemicals, or even failure of certain types of pesticides as viable control agents. As a result, many chemical pesticides are being phased out or otherwise restricted from use.</p><p id="p-0006" num="0005">Natural or biologically-derived pesticidal compounds have been proposed for use in place of some chemical pesticides, in order to attempt to reduce the toxicity, health and environmental risks associated with chemical pesticide use. However, some natural or biologically-derived pesticides have proven less efficacious or consistent in their performance in comparison with competing chemical pesticides, which has limited their adoption as control agents in pesticide markets.</p><p id="p-0007" num="0006">Therefore, there remains a need to provide improved pesticides and pesticidal compositions to allow for effective, economical and environmentally and ecologically safe control of insect, plant, fungal, nematode, mollusk, mite, viral and bacterial pests. In particular, there remains a need to provide for pesticidal compositions that desirably minimize the amount of pesticidal agents or pesticidal active ingredients required to obtain desired or acceptable levels of control of pests in use.</p><p id="p-0008" num="0007">Accordingly, there remains a need to provide synergistic pesticidal compositions that desirably minimize the use of pesticidal agents or pesticidal active ingredients through synergistic efficacy, to provide for desired pest control performance in use. However, large-scale experimental drug combination studies in non-agricultural fields have found that synergistic combinations of drug pairs are extremely complex and rare, with only a 4-10% probability of finding synergistic drug pairs [Yin et al., PLOS 9:e93960 (2014); Cokol et al., Mol. Systems Biol. 7:544 (2011)]. In fact, a systematic screening of about 120,000 two-component drug combinations based on reference-listed drugs found fewer than 10% synergistic pairs, as well as only 5% synergistic two-component pairs for fluconazole, a triazole fungicidal compound related to certain azole agricultural fungicide compounds [Borisy et al., Proc. Natl Acad. Sci. 100:7977-7982 (2003)].</p><p id="p-0009" num="0008">The foregoing examples of the related art and limitations related thereto are intended to be illustrative and not exclusive. Other limitations of the related art will become apparent to those of skill in the art upon consideration of the present disclosure.</p><heading id="h-0004" level="1">BRIEF SUMMARY</heading><p id="p-0010" num="0009">In one embodiment according to the present disclosure, a synergistic pesticidal composition is provided, comprising a pesticidal active ingredient; and a C4-C10 unsaturated aliphatic acid (including an unsaturated C6, C7, C8, C9 or C10 aliphatic acid) or an agriculturally compatible salt thereof, wherein the C4-C10 unsaturated aliphatic acid comprises at least one unsaturated C&#x2014;C bond and wherein a ratio of the concentrations by weight of said pesticidal active ingredient and said C4-C10 unsaturated aliphatic acid or an agriculturally compatible salt thereof is between about 1:15,000 and 15,000:1, and more particularly between about 1:5000 and 5000:1, and further more particularly between about 1:2000 and 2000:1. In another embodiment, a synergistic pesticidal composition is provided, comprising a pesticidal active ingredient; and a C4-C10 saturated aliphatic acid (including a saturated C4, C5, C6, C7, C8, C9 or C10 aliphatic acid) or an agriculturally compatible salt thereof, wherein a ratio of the concentrations by weight of said pesticidal active ingredient and said C4-C10 saturated aliphatic acid or an agriculturally compatible salt thereof is between about 1:15,000 and 15,000:1, and more particularly between about 1:5000 and 5000:1, and further particularly between about 1:2000 and 2000:1. In yet another embodiment, a synergistic pesticidal composition is provided, comprising a pesticidal active ingredient; and a C11 unsaturated or saturated aliphatic acid or an agriculturally compatible salt thereof, wherein a ratio of the concentrations by weight of said pesticidal active ingredient and said C11 unsaturated or saturated aliphatic acid or an agriculturally compatible salt thereof is between about 1:15,000 and 15,000:1, and more particularly between about 1:2000 and 2000:1. In yet a further embodiment, a synergistic pesticidal composition is provided, comprising a pesticidal active ingredient; and a C12 unsaturated or saturated aliphatic acid or an agriculturally compatible salt thereof, wherein a ratio of the concentrations by weight of said pesticidal active ingredient and said C12 unsaturated or saturated aliphatic acid or an agriculturally compatible salt thereof is between about 1:15,000 and 15,000:1, more particularly between about 1:5000 and 5000:1, and further particularly between about 1:2000 and 2000:1. In a further embodiment, a method of synergistically enhancing the pesticidal activity of at least one pesticidal active ingredient adapted to control at least one target pest organism is provided, comprising: providing at least one pesticidal active ingredient active for said at least one target pest organism; adding a synergistically effective concentration of at least one C4-C10 unsaturated aliphatic acid comprising at least one unsaturated C&#x2014;C bond, or an agriculturally acceptable salt thereof, to said pesticidal active ingredient to provide a synergistic pesticidal composition; and applying said synergistic pesticidal composition in a pesticidally effective concentration to control said at least one target pest organism. In another embodiment, instead of a C4-C10 unsaturated aliphatic acid, a C4-C10 saturated aliphatic acid or agriculturally compatible salts thereof may be provided to provide the synergistic pesticidal composition. In yet another embodiment, a C11 unsaturated or saturated aliphatic acid or agriculturally compatible salts thereof may be provided to provide the synergistic pesticidal composition. In yet a further embodiment, a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salts thereof may be provided to provide the synergistic pesticidal composition. In some embodiments, the synergistic pesticidal composition may comprise a C4-C10 unsaturated or saturated aliphatic acid or a biologically compatible salt thereof, wherein said salt comprises at least one of an agriculturally, aquatic life, or mammal-compatible salt, for example. In other embodiments, a C11 unsaturated or saturated aliphatic acid or biologically compatible salt thereof, or a C12 unsaturated or saturated aliphatic acid or biologically compatible salt may be provided.</p><p id="p-0011" num="0010">In another embodiment according to the present disclosure, a pesticidal composition is provided, comprising: one or more pesticidal agents; and one or more unsaturated C4-C10 aliphatic acids or agriculturally compatible salts thereof having at least one unsaturated C&#x2014;C bond. In some other embodiments, a pesticidal composition comprising one or more pesticidal agents at one or more saturated C4-C10 aliphatic acids or agriculturally compatible salts thereof are provided. In some embodiments, the one or more saturated or unsaturated C4-C10 aliphatic acids produce a synergistic effect on the pesticidal activity of the pesticidal composition in comparison to the pesticidal activity of the pesticidal agent alone and are present in a respective synergistically active concentration ratio between about 1:15000 and 15000:1, more particularly between about 1:5000 and 5000:1, and further particularly between about 1:2000 and 2000:1. In some such embodiments, a C11 unsaturated or saturated aliphatic acid or agriculturally compatible salts thereof may be provided. In some further such embodiments, a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salts thereof may be provided. In a further embodiment, a method of synergistically enhancing the pesticidal activity of at least one pesticidal active ingredient adapted to control at least one target pest organism is provided, comprising: providing at least one pesticidal active ingredient active for said at least one target pest organism; adding a synergistically effective concentration of at least one unsaturated or saturated C4-C10 aliphatic acid or an agriculturally acceptable salt thereof to provide a synergistic pesticidal composition; mixing said synergistic pesticidal composition with at least one formulation component comprising a surfactant to form a synergistic pesticidal concentrate; diluting said synergistic pesticidal concentrate with water to form a synergistic pesticidal emulsion; and applying said synergistic pesticidal emulsion at a pesticidally effective concentration and rate to control said at least one target pest organism. In some such embodiments, a C11 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof may be provided. In some further such embodiments, a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof may be provided.</p><p id="p-0012" num="0011">In some embodiments, the synergistic pesticidal composition may comprise a ratio of the concentrations by weight of said pesticidal active ingredient and said at least one saturated or unsaturated C4-C10 aliphatic acid or agriculturally compatible salts thereof is between about at least one of: 1:20,000 and 20,000:1, 1:15000 and 15000:1, 1:10,000 and 10,000:1, 1:5000 and 5000:1, 1:2500 and 2500:1, 1:2000 and 2000:1, 1:1500 and 1500:1, 1:1000 and 1000, 1:750 and 750:1, 1:500 and 500:1, 1:400 and 400:1, 1:300 and 300:1, 1:250 and 250:1, 1:200 and 200:1, 1:150 and 150:1, 1:100 and 100:1, 1:90 and 90:1, 1:80 and 80:1, 1:70 and 70:1, 1:60 and 60:1, 1:50 and 50:1, 1:40 and 40:1, 1:30 and 30:1, 1:25 and 25:1, 1:20 and 20:1, 1:15 and 15:1, 1:10 and 10:1, 1:9 and 9:1. 1:8 and 8:1, 1:7 and 7:1, 1:6 and 6:1, 1:5 and 5:1, 1:4 and 4:1, 1:3 and 3:1, 1:2 and 2:1, 1:1.5 and 1.5:1, and 1.25 and 1.25:1. In a particular such embodiment, the concentration ratios of the pesticidal active ingredient and said at least one C4-C10 saturated or unsaturated aliphatic acid or an agriculturally compatible salt thereof in the synergistic pesticidal composition are advantageously chosen so as to produce a synergistic effect against at least one target pest or pathogen. In some embodiments, the concentration ratios of the pesticidal active ingredient(s) and at least one C11 unsaturated or saturated aliphatic acid or agriculturally compatible salts thereof in the synergistic pesticidal composition may be advantageously chosen so as to produce a synergistic effect against at least one target pest or pathogen. In some further embodiments, the concentration ratios of the pesticidal active ingredient(s) and at least one C11 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof in the synergistic pesticidal composition may be advantageously chosen so as to produce a synergistic effect against at least one target pest or pathogen. In some embodiments, the synergistic pesticidal composition comprises a pesticidal active ingredient, and a C4-C10 unsaturated aliphatic acid which comprises at least one of: a trans-unsaturated C&#x2014;C bond and a cis-unsaturated C&#x2014;C bond. In a further such embodiment, the C4-C10 unsaturated aliphatic acid comprises at least one of: a trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, and trans-9 unsaturated bond. In yet another embodiment, a synergistic pesticidal composition is provided comprising a pesticidal active ingredient and a C4-C10 unsaturated aliphatic acid comprising at least one of: a cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, and cis-9 unsaturated bond. In some such embodiments, the pesticidal composition comprises a C11 unsaturated aliphatic acid or agriculturally compatible salt thereof, comprising at least one of: a trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, trans-9, trans-10, a cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, cis-9, and cis-10 unsaturated bond. In some further such embodiments, the pesticidal composition comprises a C12 unsaturated aliphatic acid or agriculturally compatible salt thereof, comprising at least one of: a trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, trans-9, trans-10, a cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, cis-9, and cis-10 unsaturated bond. In some embodiments, the synergistic pesticidal composition may comprise at least one C4-C10 saturated aliphatic acid, such as one or more of hexanoic, heptanoic, octanoic, nonanoic and decanoic acid, for example. In some further embodiments, the synergistic pesticidal composition may additionally comprise at least one second C4-C10 saturated or unsaturated aliphatic acid. In some further embodiments, the pesticidal composition may additionally comprise at least one second C11 or C12 unsaturated or saturated aliphatic acid, or agriculturally compatible salt thereof.</p><p id="p-0013" num="0012">In some embodiments, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid, such as may be present in, or extracted, fractionated or derived from a natural plant or animal material, for example. In one such embodiment, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in a plant extract or fraction thereof. In another such embodiment, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in an animal extract or product, or fraction thereof. In one such embodiment, the at least one C4-C10 saturated or unsaturated alphatic acid may comprise a naturally occurring aliphatic acid comprised in a plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts therefrom. In another such embodiment, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid comprised in an animal extract or product, such as one or more of cow's milk, goat's milk, beef tallow, and/or cow or goat butter, or fractions or extracts thereof for example. In a particular embodiment, at least one C4-C10 saturated aliphatic acid may be provided in an extract or fraction of one or more plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts therefrom. In some further embodiments, the pesticidal composition may comprise at least one C11 or C12 saturated or unsaturated aliphatic acid provided in an extract or fraction of one or more plant or animal materials.</p><p id="p-0014" num="0013">In some embodiments, the synergistic pesticidal composition exhibits a synergistic inhibition of growth of at least one target pest organism. In some embodiments, the synergistic pesticidal composition comprises a pesticidally effective concentration of the pesticidal active ingredient, and the one or more C4-C10 saturated or unsaturated aliphatic acid. In some further embodiments, the synergistic pesticidal composition comprises a pesticidal active ingredient, and a synergistic concentration of the one or more C4-C10 saturated or unsaturated aliphatic acid. In some embodiments, the synergistic pesticidal composition has a FIC Index (fractional inhibitory concentration index value) of less than 1 according to a growth inhibition assay for inhibition of growth of at least one target pest or pathogen organism. In some embodiments, the synergistic pesticidal composition has a FIC Index value of less than 0.75. In a further embodiment, the synergistic pesticidal composition has a FIC Index value of 0.5 or less. In some embodiments, the synergistic pesticidal composition has a synergistic efficacy factor, or Synergy Factor (comparing synergistic efficacy relative to expected additive (non-synergistic) efficacy according to the Colby Formula, or Loewe's Formula, or other accepted synergy determination method) of: at least 1.01, and more particularly at least 1.1, and further more particularly at least 1.5, and yet further more particularly at least 2, and more particularly at least 5, and yet more particularly at least 10, for example. In some such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C11 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof. In some further such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof.</p><p id="p-0015" num="0014">In some embodiments, the pesticidal active ingredient may comprise at least one of a chemical pesticide and a naturally-derived pesticidal oil or extract. In a further aspect, the pesticidal active ingredient may comprise at least one of: a fungicide, nematicide, insecticide, acaricide, herbicide, and bactericide. In any such embodiments, the synergistic pesticidal composition may comprise one or more C4-C10 saturated or unsaturated aliphatic acid having at least one carboxylic group, and which may be linear or branched. In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a linear monocarboxylic acid. In some embodiments, the C4-C10 unsaturated aliphatic acid may comprise one or more of cis and trans isomers. In an embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may be unsubstituted or substituted. In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a substituent, such as a hydroxy, amino, carbonyl, aldehyde, acetyl, phosphate, or methyl substituent, for example. In one such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise at least one of a 2-, 3-, 4-, 8-, or 10-substituted aliphatic acid. In one such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a hydroxy aliphatic acid. In one particular such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a 2-hydroxy, 3-hydroxy, or 4-hydroxy aliphatic acid. In one embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise an amino aliphatic acid. In one particular such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a 3-amino aliphatic acid. In a further embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise a methyl and/or ethyl substituted aliphatic acid. In a particular such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise at least one of a 2-methyl, 3-methyl, 4-methyl, 2-ethyl, or 2,2-diethyl substituted aliphatic acid, for example. In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise an unsaturated aliphatic acid which may be mono-unsaturated or polyunsaturated, i.e. containing one, two or more unsaturated carbon-carbon (C&#x2014;C) bonds respectively. In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise an unsaturated aliphatic acid with at least one of: a trans-unsaturated C&#x2014;C bond, a cis-unsaturated C&#x2014;C bond, and a plurality of conjugated unsaturated C&#x2014;C bonds. In some such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C11 unsaturated or saturated aliphatic acid. In some further such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C12 unsaturated or saturated aliphatic acid.</p><p id="p-0016" num="0015">In some further embodiments, the one or more C4-C10 (including C4, C5, C6, C7, C8, C9 or C10) saturated or unsaturated aliphatic acid may comprise at least one of: a trans-hexenoic acid, a cis-hexenoic acid, a hexa-dienoic acid, a hexynoic acid, a trans-heptenoic acid, a cis-heptenoic acid, a hepta-dienoic acid, a heptynoic acid, a trans-octenoic acid, a cis-octenoic acid, an octa-dienoic acid, an octynoic acid, a trans-nonenoic acid, a cis-nonenoic acid, a nona-dienoic acid, a nonynoic acid, a trans-decenoic acid, a cis-decenoic acid, a deca-dienoic acid, and a decynoic acid. In another embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may comprise at least one of: a trans-hexenoic acid, a cis-hexenoic acid, a hexa-dienoic acid other than 2,4-hexadienoic acid, a hexynoic acid, a trans-heptenoic acid, a cis-heptenoic acid, a hepta-dienoic acid, a heptynoic acid, a trans-octenoic acid, a cis-octenoic acid, an octa-dienoic acid, an octynoic acid, a trans-nonenoic acid, a cis-nonenoic acid, a nona-dienoic acid, a nonynoic acid, a trans-decenoic acid, a cis-decenoic acid, a deca-dienoic acid, and a decynoic acid. In some embodiments, the one or more unsaturated aliphatic acid may comprise at least one of a C11 or C12 unsaturated aliphatic acid, such as a cis-undecenoic, trans-undecanoic, cis-dodecenoic, trans-dodecenoic, undeca-dienoic, dodeca-dienoic, undecynoic, or dodecynoic acid, for example.</p><p id="p-0017" num="0016">In some further embodiments, the one or more C4-C10 (including C4, C5, C6, C7, C8, C9 or C10) saturated or unsaturated aliphatic acid may comprise at least one of: hexanoic, heptanoic, octanoic, nonanoic and decanoic acid. In some embodiments, the one or more saturated or unsaturated aliphatic acid may comprise at least one of undecanoic or dodecanoic acid.</p><p id="p-0018" num="0017">In some embodiments, the synergistic pesticidal composition may comprise one or more agriculturally compatible or acceptable salts of a one or more C4-C10 saturated or unsaturated aliphatic acid. In one such embodiment, such agriculturally compatible or acceptable salts may comprise one or more of potassium, sodium, calcium, aluminum, other suitable metal salts, ammonium, and other agriculturally acceptable salts of one or more C4-C10 saturated or unsaturated aliphatic acids, for example. In another embodiment, the synergistic pesticidal composition may comprise one or more C4-C10 saturated or unsaturated aliphatic acid or a biologically compatible salt thereof, wherein said salt comprises at least one of an agriculturally, aquatic life, or mammal-compatible salt, for example. In some embodiments, the pesticidal composition may comprise one or more agriculturally compatible or acceptable salts of one or one or more C11 or C12 saturated or unsaturated aliphatic acid.</p><p id="p-0019" num="0018">However, in some other embodiments, the synergistic pesticidal composition may comprise a pesticidal active ingredient and a one or more C4-C10 saturated or unsaturated aliphatic acid, wherein the C4-C10 unsaturated aliphatic acid comprises at least one unsaturated C&#x2014;C bond and wherein a ratio of the concentrations of said pesticidal active ingredient and said C4-C10 unsaturated aliphatic acid is between about 1:15000 and 15000:1, more particularly between about 1:5000 and 5000:1, and further particularly between about 1:2000 and 2000:1. In one such embodiment, the one or more C4-C10 saturated or unsaturated aliphatic acid may exclude agriculturally acceptable salts or other salt forms of the one or more C4-C10 saturated or unsaturated aliphatic acids. In a particular such embodiment, the synergistic pesticidal composition may exclude such salts for desired applications for which the acid forms of the one or more C4-C10 saturated or unsaturated aliphatic acids may be preferred. In one such application, it is known that accumulation of an undesirably high concentration of salts in some soils can be detrimental to the productivity or fertility of the soil, such as in particular salt sensitive soil applications, for example. Accordingly, in some embodiments, specifically excluding salt forms of the one or more C4-C10 saturated or unsaturated aliphatic acids may be particularly desirable. In some such embodiments, the pesticidal composition may comprise one or more C11 or C12 saturated or unsaturated aliphatic acid. In another embodiment, the synergistic pesticidal composition may comprise a pesticidal active ingredient and at least one C4-C10 saturated aliphatic acid, such as at least one of hexanoic, heptanoic, octanoic, nonanoic and decanoic acid, for example. In an alternative embodiment, the synergistic pesticidal composition may comprise a pesticidal active ingredient and at least one C4-C10 unsaturated aliphatic acid but explicitly excluding 2,4-hexadienoic acid. In some such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C11 unsaturated or saturated aliphatic acid. In some further such embodiments, the one or more saturated or unsaturated aliphatic acid may comprise a C12 unsaturated or saturated aliphatic acid.</p><p id="p-0020" num="0019">In some embodiments of the present disclosure, a synergistic pesticidal composition may comprise at least one C4-C10 saturated or unsaturated aliphatic acid and at least one pesticidal active ingredient selected from the list comprising:<ul id="ul0001" list-style="none">    <li id="ul0001-0001" num="0000">    <ul id="ul0002" list-style="none">        <li id="ul0002-0001" num="0020">A) Respiration inhibitors selected from:        <ul id="ul0003" list-style="none">            <li id="ul0003-0001" num="0021">inhibitors of complex III at Q<sub>o </sub>site: azoxystrobin (II-1), coumethoxy-strobin, coumoxystrobin, dimoxystrobin (II-2), enestroburin, fenamin-strobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin (II-3), kresoxim-methyl (II-4), metominostrobin, orysastrobin (II-5), picoxystrobin (II-6), pyraclostrobin (II-7), pyrame-tostrobin, pyraoxystrobin, trifloxystrobin (II-8), 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneamino-oxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;</li>            <li id="ul0003-0002" num="0022">Inhibitors of complex III at Q<sub>i </sub>site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)-amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbony-loxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpro-panoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol5-ylmethoxy)-4-methoxy-pyridine-2-carbon-yl]amino]-6-methyl-4,9-dioxol,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenyl-methyl)-1,5-dioxonan-7-yl 2-methylpropanoate;</li>            <li id="ul0003-0003" num="0023">Inhibitors of complex II: benodanil, benzovindiflupyr (II-9), bixafen (II-10), boscalid (II-11), carboxin, fenfuram, fluopyram (II-12), flutolanil, fluxapyroxad (II-13), furametpyr, isofetamid, isopyrazam (II-14), mepronil, oxycarboxin, penflufen (II-15), penthiopyrad (II-16), sedaxane (II-17), tecloftalam, thifluzamide, N-(4&#x2032;-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluorome-thyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide;</li>            <li id="ul0003-0004" num="0024">Other respiration inhibitors: diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluorometh-ylpyridin-2-yloxy)-phenyl]-ethyl}-amine; binapacryl, dinobuton, dinocap, fluazinam (II-18); ferimzone; fentin salts such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin (II-19); and silthiofam;</li>        </ul>        </li>        <li id="ul0002-0002" num="0025">B) Sterol biosynthesis inhibitors (SBI fungicides) selected from:        <ul id="ul0004" list-style="none">            <li id="ul0004-0001" num="0026">C14 demethylase inhibitors (DMI fungicides): azaconazole, bitertanol, bromuconazole, cyproconazole (II-20), difenoconazole (II-21), diniconazole, diniconazole-M, epoxiconazole (II-22), fenbuconazole, fluquinconazole (II-23), flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole (II-24), myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole (II-25), prothioconazole (II-26), simeconazole, tebuconazole (II-27), tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole; imazalil, pefurazoate, prochloraz, triflumizol; fenarimol, nuarimol, pyrifenox, triforine, [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;</li>            <li id="ul0004-0002" num="0027">Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorphacetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;</li>            <li id="ul0004-0003" num="0028">Inhibitors of 3-keto reductase: fenhexamid;</li>        </ul>        </li>        <li id="ul0002-0003" num="0029">C) Nucleic acid synthesis inhibitors selected from:        <ul id="ul0005" list-style="none">            <li id="ul0005-0001" num="0030">phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam) (II-38), ofurace, oxadixyl;</li>            <li id="ul0005-0002" num="0031">others nucleic acid inhibitors: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;</li>        </ul>        </li>        <li id="ul0002-0004" num="0032">D) Inhibitors of cell division and cytoskeleton selected from:        <ul id="ul0006" list-style="none">            <li id="ul0006-0001" num="0033">tubulin inhibitors: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl (II-39); 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine</li>            <li id="ul0006-0002" num="0034">other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone (II-40), pyriofenone;</li>        </ul>        </li>        <li id="ul0002-0005" num="0035">E) Inhibitors of amino acid and protein synthesis selected from:        <ul id="ul0007" list-style="none">            <li id="ul0007-0001" num="0036">methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim, Pyrimethanil (II-41);</li>            <li id="ul0007-0002" num="0037">protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;</li>        </ul>        </li>        <li id="ul0002-0006" num="0038">F) Signal transduction inhibitors selected from:        <ul id="ul0008" list-style="none">            <li id="ul0008-0001" num="0039">MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;</li>            <li id="ul0008-0002" num="0040">G protein inhibitors: quinoxyfen;</li>        </ul>        </li>        <li id="ul0002-0007" num="0041">G) Lipid and membrane synthesis inhibitors selected from:        <ul id="ul0009" list-style="none">            <li id="ul0009-0001" num="0042">Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; propamocarb, propamocarb-hydrochloride;</li>            <li id="ul0009-0002" num="0043">lipid peroxidation inhibitors: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;</li>            <li id="ul0009-0003" num="0044">phospholipid biosynthesis and cell wall deposition: dimethomorph (II-42), flumorph, mandipropamid (II-43), pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;</li>            <li id="ul0009-0004" num="0045">acid amide hydrolase inhibitors: oxathiapiprolin;</li>        </ul>        </li>        <li id="ul0002-0008" num="0046">H) Inhibitors with Multi Site Action selected from:        <ul id="ul0010" list-style="none">            <li id="ul0010-0001" num="0047">inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride (II-44), basic copper sulfate, sulfur;</li>            <li id="ul0010-0002" num="0048">thio- and dithiocarbamates: ferbam, mancozeb (II-45), maneb, metam, metiram (II-46), propineb, thiram, zineb, ziram;</li>            <li id="ul0010-0003" num="0049">organochlorine compounds: anilazine, Chlorothalonil (II-47), captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorophenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;</li>            <li id="ul0010-0004" num="0050">guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1H,5H-[1,4]dithii-no[2,3-c:5,6-c&#x2032;]dipyrrole-1,3,5,7(2H,6H)-tetraone (II-48);</li>        </ul>        </li>        <li id="ul0002-0009" num="0051">I) Cell wall synthesis inhibitors selected from:        <ul id="ul0011" list-style="none">            <li id="ul0011-0001" num="0052">inhibitors of glucan synthesis: validamycin, polyoxin B;</li>            <li id="ul0011-0002" num="0053">melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;</li>        </ul>        </li>        <li id="ul0002-0010" num="0054">J) Plant defence inducers selected from:        <ul id="ul0012" list-style="none">            <li id="ul0012-0001" num="0055">acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; fosetyl, fosetyl-aluminum, phosphorous acid and its salts (II-49);</li>        </ul>        </li>        <li id="ul0002-0011" num="0056">K) Unknown mode of action selected from: bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, tolprocarb, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yl-oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]-ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclo-propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N&#x2032;-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxyacetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-meth-ylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phe-nyl)-isoxazol-5-yl]-2-prop2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, tertbutyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]-amino]oxymethyl]-2-pyridyl]carbamate, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-dif-luoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-qui-nolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline; Fenpicoxamid, florylpicoxamid;</li>        <li id="ul0002-0012" num="0057">L) Antifungal biopesticides selected from: <i>Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pumilus </i>(II-50), <i>Bacillus subtilis </i>(II-51), <i>Bacillus subtilis </i>var. <i>amyloliquefaciens </i>(II-52), <i>Candida oleophila </i>I-82, <i>Candida saitoana, Clonostachys rosea </i>f. <i>catenulata</i>, also named <i>Gliocladium catenulatum, Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Metschnikowia fructicola, Microdochium dimerum, Phlebiopsis gigantea, Pseudozyma flocculosa, Pythium oligandrum </i>DV74, <i>Reynoutria sachlinensis, Talaromyces flavus </i>VI 17b, <i>Trichoderma </i>asperellum SKT-1<i>, T. atroviride </i>LC52, <i>T. harzianum </i>T-22, <i>T. harzianum </i>TH 35, <i>T. harzianum </i>T-39; <i>T. harzianum </i>and <i>T. viride, T. harzianum </i>ICC012 and <i>T. viride </i>ICC080; <i>T. polysporum </i>and <i>T. harzianum; T. stromaticum, T. virens </i>GL-21, <i>T. viride, T. viride </i>TV1<i>, Ulocladium oudemansii </i>HRU3;</li>        <li id="ul0002-0013" num="0058">M) Growth regulators selected from: abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassino-lide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride) (II-54), naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium, II-55), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid, trinex-apac-ethyl and uniconazole;</li>        <li id="ul0002-0014" num="0059">N) Herbicides selected from:        <ul id="ul0013" list-style="none">            <li id="ul0013-0001" num="0060">acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, flufenacet, mefenacet, me-tolachlor, metazachlor, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;</li>            <li id="ul0013-0002" num="0061">amino acid derivatives: bilanafos, glyphosate, glufosinate, sulfosate;</li>            <li id="ul0013-0003" num="0062">aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuryl;</li>            <li id="ul0013-0004" num="0063">Bipyridyls: diquat, paraquat;</li>            <li id="ul0013-0005" num="0064">(thio)carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;</li>            <li id="ul0013-0006" num="0065">cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;</li>            <li id="ul0013-0007" num="0066">dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin;            <ul id="ul0014" list-style="none">                <li id="ul0014-0001" num="0067">diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen; &#x2014;hydroxybenzonitriles: bomoxynil, dichlobenil, ioxynil;</li>                <li id="ul0014-0002" num="0068">imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;</li>            </ul>            </li>            <li id="ul0013-0008" num="0069">phenoxy acetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;</li>            <li id="ul0013-0009" num="0070">pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazon, pyridate;</li>            <li id="ul0013-0010" num="0071">pyridines: aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, picolinafen, thiazopyr;</li>            <li id="ul0013-0011" num="0072">sulfonyl ureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuronethyl, chlorsulfuron, cinosul-furon, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metazosulfuron, metsulfuron-methyl, nico-sulfuron, oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosul-furon, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;</li>            <li id="ul0013-0012" num="0073">triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazinone, metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;</li>            <li id="ul0013-0013" num="0074">ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, methabenzthiazuron, tebuthiuron;</li>            <li id="ul0013-0014" num="0075">other acetolactate synthase inhibitors: bispyribac-sodium, cloransulammethyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribam-benz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, py-roxsulam;</li>            <li id="ul0013-0015" num="0076">other herbicides: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl, chlorthal, cinmethylin, clomazone, cumyluron, cyprosulfa-mide, dicamba, difenzoquat, diflufenzopyr, <i>Drechslera monoceras</i>, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac, mesotrione, methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyri-din-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chlorophenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester;</li>        </ul>        </li>        <li id="ul0002-0015" num="0077">O) Insecticides selected from:        <ul id="ul0015" list-style="none">            <li id="ul0015-0001" num="0078">organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phos-phamidon, phorate, phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;</li>            <li id="ul0015-0002" num="0079">carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenox-ycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;</li>            <li id="ul0015-0003" num="0080">pyrethroids: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zetacypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin;</li>            <li id="ul0015-0004" num="0081">insect growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyramazin, dif-lubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;</li>            <li id="ul0015-0005" num="0082">nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran, flupyradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-2-chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinane;</li>            <li id="ul0015-0006" num="0083">nicotinic acetylcholine receptor disruptors or allosteric modulators (IRAC Goup 5): spinosyn (including but not limited to spinosyns A, D, B, C, E, F, G, H, J, and other spinosyn isolates from <i>Saccharopolyspora spinosa </i>culture), spinosad (comprising primarily spinsyns A and D), and derivatives or substituents thereof (including but not limited to tetracyclic and pentacyclic spinosyn derivatives, aziridine spinosyn derivatives, C-5,6 and/or C-13,14 substituted spinosyn derivatives); spinetoram (including but not limited to XDE-175-J, XDE-175-L or other O-ethyl substituted spinosyn derivatives); butenyl-spinosyn and derivatives or substituents thereof (such as isolates from <i>Saccharopolyspora pogona </i>culture);</li>            <li id="ul0015-0007" num="0084">bioinsecticides including but not limited to <i>Bacillus thuriengiensis, Burkholderia </i>spp, <i>Beauveria bassiana, Metarhizium anisoptiae, Paecilomyces fumosoroseus</i>, and baculoviruses (including but not limited to granuloviruses and nucleopolyhedroviruses);</li>            <li id="ul0015-0008" num="0085">GABA antagonist compounds: endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1-(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1H-pyrazole-3-carbothioic acid amide;</li>            <li id="ul0015-0009" num="0086">mitochondrial electron transport inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;</li>            <li id="ul0015-0010" num="0087">METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon;</li>            <li id="ul0015-0011" num="0088">Uncouplers: chlorfenapyr;</li>            <li id="ul0015-0012" num="0089">oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;</li>            <li id="ul0015-0013" num="0090">moulting disruptor compounds: cryomazine;</li>            <li id="ul0015-0014" num="0091">mixed function oxidase inhibitors: piperonyl butoxide;</li>            <li id="ul0015-0015" num="0092">sodium channel blockers: indoxacarb, metaflumizone;</li>            <li id="ul0015-0016" num="0093">ryanodine receptor inhibitors: chlorantraniliprole, cyantraniliprole, fluben-diamide, N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyra-zole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-car-boxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanyli-dene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide; N-[4,6-di-bromo-2-[(di-2-propyl-lambda-4-sulfanyl-idene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;</li>            <li id="ul0015-0017" num="0094">others: benclothiaz, bifenazate, cartap, flonicamid, pyridalyl, pymetrozine, sulfur, thiocyclam, cyenopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron, pyrifluquinazon, 1,1&#x2032;-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]-methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl] cyclopropaneacetic acid ester; fluensulfone, fluoroalkenyl thioethers; and</li>        </ul>        </li>        <li id="ul0002-0016" num="0095">P) ribonucleic acid (RNA) and associated compounds including double-stranded RNA (dsRNA), microRNA (miRNA) and small interfering RNA (siRNA); bacteriophages.</li>    </ul>    </li></ul></p><p id="p-0021" num="0096">In some such embodiments, the synergistic pesticidal composition may comprise one or more pesticidal active ingredient, such as selected from the list above, and one or more C11 unsaturated or saturated aliphatic acid or agriculturally acceptable salt thereof. In some further such embodiments, the synergistic pesticidal composition may comprise one or more pesticidal active ingredient, such as selected from the list above, and one or more C12 unsaturated or saturated aliphatic acid or agriculturally acceptable salt thereof.</p><p id="p-0022" num="0097">In some embodiments, synergistic pesticidal compositions may be provided, where the pesticidal active ingredient comprises at least one pesticidal natural oil selected from: neem oil, karanja oil, clove oil, clove leaf oil, peppermint oil, spearmint oil, mint oil, cinnamon oil, thyme oil, oregano oil, rosemary oil, geranium oil, lime oil, lavender oil, anise oil, lemongrass oil, tea tree oil, apricot kernel oil, bergamot oil, carrot seed oil, cedar leaf oil, citronella oil, clove bud oil, coriander oil, coconut oil, <i>eucalyptus </i>oil, evening primrose oil, fennel oil, ginger oil, grapefruit oil, nootkatone(+), grapeseed oil, lavender oil, marjoram oil, pine oil, scotch pine oil, and/or garlic oil and/or components, derivatives and/or extracts of one or more pesticidal natural oil, or a combination thereof. In some further embodiments, synergistic pesticidal compositions may be provided which comprise additional active components other than the principal one or more pesticidal active ingredients, wherein such additional active components may comprise one or more additional efficacies and/or synergistic effects on the pesticidal efficacy of the composition, such as but not limited to adjuvants, synergists, agonists, activators, or combinations thereof, for example. In one such embodiment, such additional active components may optionally comprise naturally occurring compounds or extracts or derivatives thereof. In other embodiments, the pesticidal active ingredient may comprise at least one organic, certified organic, US Department of Agriculture (&#x201c;USDA&#x201d;) National Organic Program compliant (&#x201c;NOP-compliant&#x201d;) such as may be included in the US Environmental Protection Agency FIFRA 25b, list of ingredients published dated December 2015 by the US EPA entitled &#x201c;Active Ingredients Eligible for Minimum Risk Pesticide Products&#x201d;, the US EPA FIFRA 4a list published August 2004 entitled &#x201c;List 4A&#x2014;Minimal Risk Inert Ingredients&#x201d; or the US EPA FIFRA 4b list published August 2004 entitled &#x201c;List 4B&#x2014;Other ingredients for which EPA has sufficient information&#x201d;, for example, Organic Materials Review Institute listed (&#x201c;OMRI-listed&#x201d;) or natural pesticidal active ingredient, for example.</p><p id="p-0023" num="0098">In some embodiments, the pesticidal active ingredient may comprise at least one of: neem oil, karanja oil and extracts or derivatives thereof. In further exemplary such embodiments, the pesticidal active ingredient may comprise at least one extract or active component of neem oil or karanja oil, such as but not limited to: azadirachtin, azadiradione, azadirone, nimbin, nimbidin, salannin, deacetylsalannin, salannol, maliantriol, gedunin, karanjin, pongamol, or derivatives thereof, for example.</p><?summary-of-invention description="Summary of Invention" end="tail"?><?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?><description-of-drawings><heading id="h-0005" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p-0024" num="0099">Exemplary embodiments are illustrated in referenced figures of the drawings. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than restrictive.</p><p id="p-0025" num="0100"><figref idref="DRAWINGS">FIG. <b>1</b></figref> illustrates general carbonyl alkene structures (1), (2) and (3) associated with an exemplary C4-C10 unsaturated aliphatic acid, or agriculturally acceptable salt thereof, according to an embodiment of the present disclosure.</p><p id="p-0026" num="0101"><figref idref="DRAWINGS">FIG. <b>2</b></figref> illustrates an exemplary 96 well microtiter plate showing a color transition of a resazurin dye between colors indicating absence and presence of growth of a representative pest or pathogen, in accordance with a synergistic growth inhibition assay according to an embodiment of the present disclosure.</p><p id="p-0027" num="0102"><figref idref="DRAWINGS">FIGS. <b>3</b>-<b>5</b></figref> illustrate the observed survival rate (percent of original insects still surviving) for <i>Trichoplusia ni </i>(cabbage looper caterpillar) over time for in-vitro testing on a modified McMorran artificial diet to which treatments of Pylon&#xae; insecticide (containing chlorfenapyr as the pesticidal active ingredient) and exemplary unsaturated aliphatic acids (and salts) alone are shown in comparison with the corresponding survival rates for treatments with a synergistic pesticidal composition combining Pylon&#xae; insecticide with each of the exemplary unsaturated aliphatic acids (and salts) at three concentrations (shown in <figref idref="DRAWINGS">FIGS. <b>3</b>, <b>4</b></figref>, and <b>5</b> respectively), according to an embodiment of the present invention.</p></description-of-drawings><?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?><?detailed-description description="Detailed Description" end="lead"?><heading id="h-0006" level="1">DETAILED DESCRIPTION OF SEVERAL EMBODIMENTS</heading><p id="p-0028" num="0103">Throughout the following description specific details are set forth in order to provide a more thorough understanding to persons skilled in the art. However, well known elements may not have been shown or described in detail to avoid unnecessarily obscuring the disclosure. Accordingly, the description and drawings are to be regarded in an illustrative, rather than a restrictive, sense.</p><heading id="h-0007" level="1">Definitions</heading><p id="p-0029" num="0104">Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the invention, suitable methods and materials are described herein.</p><p id="p-0030" num="0105">All applications, publications, patents and other references, citations cited herein are incorporated by reference in their entirety. In case of conflict, the specification, including definitions, will control.</p><p id="p-0031" num="0106">As used herein, the singular forms &#x201c;a&#x201d;, &#x201c;and,&#x201d; and &#x201c;the&#x201d; include plural referents unless the context clearly indicates otherwise.</p><p id="p-0032" num="0107">As used herein, all numerical values or numerical ranges include integers within such ranges and fractions of the values or the integers within ranges unless the context clearly indicates otherwise. Thus, for example, reference to a range of 90-100%, includes 91%, 92%, 93%, 94%, 95%, 95%, 97%, etc., as well as 91.1%, 91.2%, 91.3%, 91.4%, 91.5%, etc., 92.1%, 92.2%, 92.3%, 92.4%, 92.5%, etc., and so forth.</p><p id="p-0033" num="0108">As used herein, &#x201c;plant&#x201d; embraces individual plants or plant varieties of any type of plants, in particular agricultural, silvicultural and ornamental plants.</p><p id="p-0034" num="0109">As used herein, the terms &#x201c;pest&#x201d; or &#x201c;pests&#x201d; or grammatical equivalents thereof, are understood to refer to organisms, e.g., including pathogens, that negatively affect a host or other organism&#x2014;such as a plant or an animal&#x2014;by colonizing, damaging, attacking, competing with them for nutrients, infesting or infecting them, as well as undesired organisms that infest human structures, dwellings, living spaces or foodstuffs. Pests include but are not limited to fungi, weeds, nematodes, acari, and arthropods, including insects, arachnids and cockroaches. It is understood that the terms &#x201c;pest&#x201d; or &#x201c;pests&#x201d; or grammatical equivalents thereof can refer to organisms that have negative effects by infesting plants and seeds, and commodities such as stored grain.</p><p id="p-0035" num="0110">As used herein, the terms &#x201c;pesticide&#x201d; or &#x201c;pesticidal&#x201d; or grammatical equivalents thereof, are understood to refer to any composition or substance that can be used in the control of any agricultural, natural environmental, human or other animal pathogenic, and domestic/household pests. The terms &#x201c;control&#x201d; or &#x201c;controlling&#x201d; are meant to include, but are not limited to, any killing, inhibiting, growth regulating, or pestistatic (inhibiting or otherwise interfering with the normal life cycle of the pest) activities of a composition against a given pest. These terms include for example sterilizing activities which prevent the production or normal development of seeds, ova, sperm or spores, cause death of seeds, sperm, ova or spores, or otherwise cause severe injury to the genetic material. Further activities intended to be encompassed within the scope of the terms &#x201c;control&#x201d; or &#x201c;controlling&#x201d; include preventing larvae from developing into mature progeny, modulating the emergence of pests from eggs including preventing eclosion, degrading the egg material, suffocation, interfering with mycelial growth, reducing gut motility, inhibiting the formation of chitin, disrupting mating or sexual communication, preventing feeding (antifeedant) activity, and interfering with location of hosts, mates or nutrient-sources. The term &#x201c;pesticide&#x201d; includes fungicides, herbicides, nematicides, insecticides and the like. The term &#x201c;pesticide&#x201d; encompasses, but is not limited to, naturally occurring compounds as well as so-called &#x201c;synthetic chemical pesticides&#x201d; having structures or formulations that are not naturally occurring, where pesticides may be obtained by various means including, but not limited to, extraction from biological sources, chemical synthesis of the compound, and chemical modification of naturally occurring compounds obtained from biological sources.</p><p id="p-0036" num="0111">As used herein, the terms &#x201c;insecticidal&#x201d; and &#x201c;acaridical&#x201d; or &#x201c;aphicidal&#x201d; or grammatical equivalents thereof, are understood to refer to substances having pesticidal activity against organisms encompassed by the taxonomical classification of root term and also to refer to substances having pesticidal activity against organisms encompassed by colloquial uses of the root term, where those colloquial uses may not strictly follow taxonomical classifications. The term &#x201c;insecticidal&#x201d; is understood to refer to substances having pesticidal activity against organisms generally known as insects of the phylum Arthropoda, class Insecta. Further as provided herein, the term is also understood to refer to substances having pesticidal activity against other organisms that are colloquially referred to as &#x201c;insects&#x201d; or &#x201c;bugs&#x201d; encompassed by the phylum Arthropoda, although the organisms may be classified in a taxonomic class different from the class Insecta. According to this understanding, the term &#x201c;insecticidal&#x201d; can be used to refer to substances having activity against arachnids (class Arachnida), in particular mites (subclass Acari/Acarina), in view of the colloquial use of the term &#x201c;insect.&#x201d; The term &#x201c;acaridical&#x201d; is understood to refer to substances having pesticidal activity against mites (Acari/Acarina) of the phylum Arthropoda, class Arachnida, subclass Acari/Acarina. The term &#x201c;aphicidal&#x201d; is understood to refer to substances having pesticidal activity against aphids (Aphididae) of the phylum Arthopoda, class Insecta, family Aphididae. It is understood that all these terms are encompassed by the term &#x201c;pesticidal&#x201d; or &#x201c;pesticide&#x201d; or grammatical equivalents. It is understood that these terms are not necessarily mutually exclusive, such that substances known as &#x201c;insecticides&#x201d; can have pesticidal activity against organisms of any family of the class Insecta, including aphids, and organisms that are encompassed by other colloquial uses of the term &#x201c;insect&#x201d; or &#x201c;bug&#x201d; including arachnids and mites. It is understood that &#x201c;insecticides&#x201d; can also be known as acaricides if they have pesticidal activity against mites, or aphicides if they have pesticidal activity against aphids.</p><p id="p-0037" num="0112">As used herein, the terms &#x201c;control&#x201d; or &#x201c;controlling&#x201d; or grammatical equivalents thereof, are understood to encompass any pesticidal (killing) activities or pestistatic (inhibiting, repelling, deterring, and generally interfering with pest functions to prevent the damage to the host plant) activities of a pesticidal composition against a given pest. Thus, the terms &#x201c;control&#x201d; or &#x201c;controlling&#x201d; or grammatical equivalents thereof, not only include killing, but also include such activities as repelling, deterring, inhibiting or killing egg development or hatching, inhibiting maturation or development, and chemisterilization of larvae or adults. Repellant or deterrent activities may be the result of compounds that are poisonous, mildly toxic, or non-poisonous to pests, or may act as pheromones in the environment.</p><p id="p-0038" num="0113">As used herein, the term &#x201c;pesticidally effective amount&#x201d; generally means the amount of the inventive mixtures or of compositions comprising the mixtures needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target pest organism. The pesticidally effective amount can vary for the various mixtures/compositions used in the invention. A pesticidally effective amount of the mixtures/compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mod+e of application, and the like. As used herein, where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value within that stated range is encompassed within embodiments of the invention. The upper and lower limits of these smaller ranges may independently define a smaller range of values, and it is to be understood that these smaller ranges are intended to be encompassed within embodiments of the invention, subject to any specifically excluded limit in the stated range.</p><p id="p-0039" num="0114">In one embodiment according to the present disclosure, a synergistic pesticidal composition comprises a C4-C10 unsaturated aliphatic acid (or agriculturally acceptable salt thereof), the and at least one pesticidal active ingredient. In some embodiments, the effective dose of the pesticidal active ingredient when used in combination with the one or more C4-C10 saturated or unsaturated aliphatic acid is lower than the effective dose of the pesticidal active ingredient when used alone (i.e. a smaller amount of pesticidal active can still control pests when used in a synergistic composition together with the one or more C4-C10 saturated or unsaturated aliphatic acid). In some embodiments, a pesticidal active ingredient that is not effective against a particular species of pest can be made effective against that particular species when used in a synergistic composition together with one or more C4-C10 saturated or unsaturated aliphatic acid. In some such embodiments, the pesticidal composition may comprise a C11 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof. In some further such embodiments, the pesticidal composition may comprise a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof.</p><p id="p-0040" num="0115">Without being bound by any particular theory, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acids according to some embodiments of the present disclosure act as cell permeabilizing agents, and when combined with a suitable pesticidal active ingredient, may desirably facilitate the entry of the pesticidal active ingredient into the cells of a target pest or pathogen, thereby desirably providing for a synergistic activity of such a synergistic pesticidal composition. All eukaryotic cell membranes, including for example fungal cell membranes and the cell membranes of insects and nematodes are biochemically similar in that they all comprise a lipid bilayer which is comprised of phospholipids, glycolipids and sterols, as well as a large number of proteins (Cooper &#x26; Hausmann 2013). The amphipathic structure of the lipid bilayer and the polarity of membrane proteins restricts passage of extracellular compounds across the membrane and allows compartmentalization of internal organelles from the intracellular environment. Without being bound by theory, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acids according to some embodiments disclosed herein will act as cell permeabilizing agents, and when combined with a suitable pesticidal active ingredient may desirably act to enhance the entry of the active ingredient (such as but not limited to fungicidal, insecticidal, acaricidal, molluscicidal, bactericidal and nematicidal actives) into the cells and/or into the intracellular organelles or intracellular bodies of a target pest or pathogen (such as but not limited to fungi, insects, acari, mollusks, bacteria and nematodes, respectively), for example.</p><p id="p-0041" num="0116">In a further embodiment, without being bound by theory, it is believed that the size and/or polarity of many pesticidal molecules prevents and/or limits the pesticidal active ingredient from crossing the cellular membrane, but that the addition of one or more C4-C10 saturated or unsaturated aliphatic acid in accordance with some embodiments of the present disclosure may desirably compromise or provide for the disturbance of the pest cell membrane's lipid bilayer integrity and protein organization such as to create membrane gaps, and/or increase the membrane fluidity, such as to allow the pesticidal active to more effectively enter the cell and/or intracellular organelles of the pest cells, for example. In some such embodiments, the pesticidal composition may comprise a C11 unsaturated aliphatic acid or agriculturally compatible salt thereof. In some further such embodiments, the pesticidal composition may comprise a C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof.</p><p id="p-0042" num="0117">In another aspect, without being bound to any particular theory, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acids, or agriculturally acceptable salts thereof, (and in some additional embodiments, alternatively a C11 or C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof). In some further such embodiments, the pesticidal composition may comprise a C12 unsaturated aliphatic acid or agriculturally compatible salt thereof according to some embodiments of the present disclosure act as at least one of a potentiator, synergist, adjuvant and/or agonist when combined with a suitable pesticidal active ingredient, thereby desirably providing for a synergistic activity of such a synergistic pesticidal composition against a target pest or pathogen.</p><p id="p-0043" num="0118">In some embodiments according to the present disclosure, a synergistic pesticidal composition accordingly to the present invention comprises one or more C4-C10 saturated or unsaturated aliphatic acid, or agriculturally acceptable salts thereof (and in some additional embodiments, alternatively a C11 or C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof), as an exemplary cell permeabilizing agent, in combination with a pesticide. In some embodiments, the synergistic composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof), as an exemplary cell permeabilizing agent, in combination with a fungicide. In some embodiments, the synergistic composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof), as an exemplary cell permeabilizing agent, in combination with a nematicide. In some embodiments, the synergistic composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof), as an exemplary cell permeabilizing agent, in combination with an insecticide.</p><p id="p-0044" num="0119">In one such embodiment, without being bound to a particular theory, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acid (and in some additional embodiments, alternatively a C11 or C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof) may act as a cellular membrane delivery agent, so as to improve the entry of and/or bioavailability or systemic distribution of a pesticidal active ingredient within a target pest cell and/or within a pest intracellular organelle, such by facilitating the pesticidal active ingredient in passing into the mitochondria of the pest cells, for example. In some other embodiments, without being bound by a particular theory, the one or more C4-C10 saturated or unsaturated aliphatic acid may further provide for synergistic interaction with one or more additional compounds provided as part of the pesticidal composition, such as an additional one or more C4-C10 saturated aliphatic acid, or one or more C4-C10 unsaturated aliphatic acid, or one or more additional active ingredients or adjuvants, so as to provide for synergistic enhancement of a pesticidal effect provided by the at least one pesticidal active ingredient, for example.</p><p id="p-0045" num="0120">In another aspect, without being bound to any particular theory, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) according to some embodiments of the present disclosure act as at least one of a potentiator, synergist, adjuvant and/or agonist when combined with a suitable pesticidal ingredient, thereby desirably providing for a synergistic activity of such a synergistic pesticidal composition against a target pest or pathogen. In some additional embodiments, such synergistic pesticidal composition may alternatively comprise a C11 or C12 unsaturated or saturated aliphatic acid or agriculturally compatible salt thereof.</p><p id="p-0046" num="0121">Without being bound by any particular theory, in some embodiments of the present invention, it is believed that the one or more C4-C10 saturated or unsaturated aliphatic acids act to compromise or alter the integrity of the lipid bilayer and protein organization of cellular membranes in target pest organisms. Further, it is also believed that in some embodiments one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action that is dependent upon interaction with one or more components of the cellular membrane of a target pest. In some such embodiments, one or more C4-C10 saturated or unsaturated aliphatic acids may be particularly adapted for combining to form a synergistic pesticidal composition, demonstrating synergistic efficacy, with pesticidal actives which have a mode of action dependent on interaction with a cellular membrane protein. In one such embodiment, the cellular membrane protein may comprise one or more cytochrome complexes, such as a cytochrome bel complex or a cytochrome p450 complex, for example. Accordingly, in one aspect, synergistic pesticidal compositions according to some embodiments of the present invention may desirably be selected to comprise one or more C4-C10 saturated or unsaturated aliphatic acids, and one or more pesticidal active having a pesticidal mode of action that is dependent upon interaction with one or more components of the cellular membrane of a target pest, such as a cellular membrane protein, for example. In one aspect, one or more C11 or C12 saturated or unsaturated aliphatic acids is provided in combination with one or more pesticidal active having a pesticidal mode of action that is dependent upon interaction with one or more components of the cellular membrane of a target pest, such as a cellular membrane protein, for example. In a particular embodiment, one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action interacting with (such as by inhibiting one or more receptor sites) the cellular membrane cytochrome be 1 complex (also known as the cytochrome complex III), such as fungicidal actives collectively referred to as Group 11 actives by the Fungicide Resistance Action Committee (FRAC), including e.g. azoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, fenamidone, or pyribencar. In one such embodiment, a synergistic pesticidal composition may be selected comprising one or more C4-C10 saturated or unsaturated aliphatic acid and a pesticidal active having a pesticidal mode of action interacting with the cellular cytochrome bel complex, such as a strobilurin pesticidal active. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.</p><p id="p-0047" num="0122">In another particular embodiment, one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action interacting with (such as by inhibiting one or more receptor sites) the cellular membrane cytochrome p450 complex, such as to inhibit sterol biosynthesis, as is the case with exemplary fungicidal actives collectively referred to as FRAC Group 3 actives, including e.g. triforine, pyrifenox, pyrisoxazole, fenarimol, nuarimol, imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, or prothioconazole. In one such embodiment, a synergistic pesticidal composition may be selected comprising one or more C4-C10 saturated or unsaturated aliphatic acid and a pesticidal active having a pesticidal mode of action interacting with the cellular cytochrome p450 complex, such as an azole or triazole pesticidal active, for example. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.</p><p id="p-0048" num="0123">In another particular embodiment, one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action interacting with (such as by inhibiting one or more receptor sites) the cellular membrane, such as to uncouple oxidative phosphorylation, as is the case with exemplary insecticidal actives collectively referred to as Group 13 actives by the Insecticide Resistance Action Committee (IRAC), including e.g. quinoxyfen or proquinazid. In one such embodiment, a synergistic pesticidal composition may be selected comprising one or more C4-C10 saturated or unsaturated aliphatic acid and a pesticidal active having a pesticidal mode of action interacting with the cellular membrane, such as a pyrrole insecticidal active, an example of which is chlorfenapyr. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.</p><p id="p-0049" num="0124">In another particular embodiment, one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action interacting with (such as by disrupting and/or allosterically modulating one or more receptor sites) the cellular membrane, such as to disrupt one or more nicotinic acetylcholine receptor sites (such as Site 1), as is the case with exemplary insecticidal actives collectively referred to as Group 5 actives by the Insecticide Resistance Action Committee (IRAC). Such IRAC Group 5 actives include, for example: spinosyn (including but not limited to spinosyns A, D, B, C, E, F, G, H, J, and other spinosyn isolates from <i>Saccharopolyspora spinosa </i>culture), spinosad (comprising primarily spinsyns A and D), and derivatives or substituents thereof (including but not limited to tetracyclic and pentacyclic spinosyn derivatives, aziridine spinosyn derivatives, C-5,6 and/or C-13,14 substituted spinosyn derivatives); spinetoram (including but not limited to XDE-175-J, XDE-175-L or other O-ethyl substituted spinosyn derivatives); butenyl-spinosyn and derivatives or substituents thereof (such as isolates from <i>Saccharopolyspora pogona </i>culture). In one such embodiment, a synergistic pesticidal composition may be selected comprising one or more C4-C10 saturated or unsaturated aliphatic acid and a pesticidal active having a pesticidal mode of action interacting with the cellular membrane, such as a spinosyn or spinosyn derivative insecticidal active, examples of which may include Spinosad and spinetoram. In alternative such embodiments, the synergistic pesticidal composition may comprise one or more C11 or C12 saturated or unsaturated aliphatic acids, substituents, or salts thereof.</p><p id="p-0050" num="0125">Without being bound by any particular theory, in some further embodiments of the present invention, it is believed that one or more C4-C10 saturated or unsaturated aliphatic acids act to compromise or alter the integrity of the lipid bilayer and protein organization of cellular membranes in target pest organisms, and by so doing are effective to increase at least one of the fluidity and permeability of a cellular membrane of a target pest organism, which may desirably increase permeability and/or transport of a pesticidal active through the cellular membrane, for example. Further, it is also believed that in some embodiments one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action that is dependent upon transport across one or more cellular membrane of a target pest, such as to interact with a target site inside a cell or an intracellular organelle of the target pest. In some such embodiments, a synergistic pesticidal composition according to an embodiment of the present invention, demonstrating synergistic efficacy, may comprise one or more C4-C10 saturated or unsaturated aliphatic acid, and one or more pesticidal active having a mode of action dependent on transport across a cellular membrane. Accordingly, in one aspect, synergistic pesticidal compositions according to some embodiments of the present invention may desirably be selected to comprise one or more C4-C10 saturated or unsaturated aliphatic acids, and one or more pesticidal active having a pesticidal mode of action that is dependent upon interaction with a target site within a cell or intracellular organelle of a target pest, such as a cellular membrane protein, for example. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.</p><p id="p-0051" num="0126">In a particular embodiment, one or more C4-C10 saturated or unsaturated aliphatic acids are particularly adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives having a pesticidal mode of action interacting with (such as by inhibiting one or more receptors) at a target site across a cellular membrane of a target pest, such as fungicidal actives collectively referred to as FRAC Group 9 and Group 12 actives, for example, including e.g. cyprodinil, mepanipyrim, pyrimethanil, fenpiclonil or fludioxonil. In one such embodiment, a synergistic pesticidal composition may be selected comprising one or more C4-C10 saturated or unsaturated aliphatic acid and a pesticidal active having a pesticidal mode of action interacting with a target site within a cellular membrane of a target pest, such as one or more of an anilinopyrimidine such as cyprodinil, and a phenylpyrrole such as fludioxonil, for example. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.</p><p id="p-0052" num="0127">Without being bound by any particular theory, in some yet further embodiments of the present invention, it is believed that one or more C4-C10 saturated or unsaturated aliphatic acids act to compromise or alter the integrity of the lipid bilayer and protein organization of cellular membranes in target pest organisms, and by so doing are effective to increase at least one of the fluidity and permeability of a cellular membrane of a target pest organism, which may desirably increase permeability and/or transport of a pesticidal active through the cellular membrane, for example. Further, it is also believed that in some alternative embodiments one or more C4-C10 unsaturated aliphatic acids having unsaturated C&#x2014;C bonds at one or more of the second (2-), third (3-) and terminal ((n&#x2212;1)-) locations in the aliphatic acid carbon chain may be desirably adapted for combination to form synergistic pesticidal compositions according to embodiments of the invention, which demonstrate synergistic efficacy, with pesticidal actives. In some particular such embodiments, one or more C4-C10 aliphatic acids comprising an unsaturated C&#x2014;C bond at one or more of the 2-,3- and (n&#x2212;1)-locations (wherin n is the number of carbons in the unsaturated aliphatic acid) may desirably be adapted for forming synergistic pesticidal compositions in combination with one or more pesticidal active having a pesticidal mode of action that is dependent upon interaction with a cellular membrane component of a target pest, or dependent upon transport across one or more cellular membrane of a target pest (such as to interact with a target site inside a cell or an intracellular organelle of the target pest). In some such embodiments, a synergistic pesticidal composition according to an embodiment of the present invention, demonstrating synergistic efficacy, may comprise one or more C4-C10 unsaturated aliphatic acid having an unsaturated C&#x2014;C bond at one or more of the 2-, 3- and terminal ((n&#x2212;1)-) locations in the aliphatic acid carbon chain, and one or more pesticidal active having a mode of action dependent on interaction with a target pest cellular membrane component, or on transport across a target pest cellular membrane. In alternative such embodiments, the synergistic pesticidal composition comprises one or more C11 or C12 unsaturated aliphatic acids having an unsaturated C&#x2014;C bond at one or more of the 2-, 3- and terminal ((n&#x2212;1)-).</p><p id="p-0053" num="0128">In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) comprises an aliphatic carbonyl alkene. In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) comprises at least one C4-C10 unsaturated aliphatic acid having at least one carboxylic group and at least one unsaturated C&#x2014;C bond. In another embodiment, the C4-C10 unsaturated aliphatic acid (or agriculturally acceptable salt thereof) comprises at least two C4-C10 unsaturated aliphatic acids having at least one carboxylic group and at least one unsaturated C&#x2014;C bond. In yet another embodiment, the C4-C10 unsaturated aliphatic acid (or agriculturally acceptable salt thereof) comprises at least one carboxylic acid group and at least one of a double or triple C&#x2014;C bond. In a further embodiment, a synergistic pesticidal composition is provided comprising at least one pesticidal active ingredient, and at least one C4-C10 unsaturated aliphatic acid (or agriculturally acceptable salt thereof) having at least one carboxylic acid group and at least one unsaturated C&#x2014;C bond, in combination with at least one C4-C10 saturated aliphatic acid (or agriculturally acceptable salt thereof). In yet another embodiment, the C4-C10 saturated or unsaturated aliphatic acid may be provided as a plant extract or oil, or fraction thereof, containing the at least one C4-C10 saturated or unsaturated aliphatic acid, for example, or in further embodiments, containing the one or more C11 or C12 saturated or unsaturated aliphatic acid.</p><p id="p-0054" num="0129">In some embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) comprises an aliphatic carbonyl alkene having one of the general structures (1), (2) or (3), as shown in <figref idref="DRAWINGS">FIG. <b>1</b></figref>. In further embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid may additionally comprise a C11 or C12 saturated or unsaturated aliphatic acid, and may comprise an aliphatic carbonyl alkene having one of the general structures (1), (2) or (3) as shown in <figref idref="DRAWINGS">FIG. <b>1</b></figref>. In some embodiments, the C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid may additionally comprise at least one substituent selected from the list comprising: hydroxy, alkyl and amino substituents. In some exemplary embodiments, the at least one substituent may comprise at least one of: 2-hydroxy, 3-hydroxy, 4-hydroxy, 8-hydroxy, 10-hydroxy, 12-hydroxy, 2-methyl, 3-methyl, 4-methyl, 2-ethyl, 3-ethyl, 4-ethyl, 2,2-diethyl, 2-amino, 3-amino, and 4-amino substituents, for example. In some embodiments, the C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid may comprise an agriculturally acceptable salt form of any of the above-mentioned aliphatic acids. In some embodiments, the composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) and a fungicidal active ingredient. In some embodiments, the effective dose of the fungicidal active ingredient when used in combination with the one or more C4-C10 saturated or unsaturated aliphatic acid is lower than the effective dose of the fungicidal active ingredient when used alone (i.e. a smaller amount of fungicidal active can still control fungi when used in a composition together with the one or more C4-C10 saturated or unsaturated aliphatic acid). In some embodiments, a fungicidal active ingredient that is not effective against a particular species of fungi (such as at a particular concentration that is below a lower limit of efficacy for a particular fungi, or for a particular species of fungi which may be at least partially resistant or tolerant to the particular fungicidal active ingredient when applied alone) can be made effective against that particular species when used in a composition together with one or more C4-C10 saturated or unsaturated aliphatic acid, or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid.</p><p id="p-0055" num="0130">In some embodiments, the composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) and a nematicidal active ingredient. In some embodiments, the effective dose of the nematicidal active ingredient when used in combination with the one or more C4-C10 saturated or unsaturated aliphatic acid is lower than the effective dose of the nematicidal active ingredient when used alone (i.e. a smaller amount of nematicidal active can still control nematodes when used in a composition together with the one or more C4-C10 saturated or unsaturated aliphatic acid). In some embodiments, a nematicidal active ingredient that is not effective against a particular species of nematode (such as at a particular concentration that is below a lower limit of efficacy for a particular nematode, or for a particular species of nematode which may be at least partially resistant or tolerant to the particular nematicidal active ingredient when applied alone) can be made effective against that particular species when used in a composition together with one or more C4-C10 saturated or unsaturated aliphatic acid, or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid.</p><p id="p-0056" num="0131">In some embodiments, the composition comprises one or more C4-C10 saturated or unsaturated aliphatic acid (or agriculturally acceptable salt thereof) and an insecticidal active ingredient. In some embodiments, the effective dose of the insecticidal active ingredient when used in combination with the one or more C4-C10 saturated or unsaturated aliphatic acid is lower than the effective dose of the insecticidal active ingredient when used alone (i.e. a smaller amount of insecticidal active can still control insects, to an exemplary desired degree of control, when used in a composition together with the one or more C4-C10 saturated or unsaturated aliphatic acid). In some embodiments, the aliphatic acid may further comprise one or more C11 or C12 saturated or unsaturated aliphatic acid. In some embodiments, an insecticidal active ingredient that is not effective against a particular species of insect (such as at a particular concentration that is below a lower limit of efficacy for a particular insect, or for a particular species of insect which may be at least partially resistant or tolerant to the particular insecticidal active ingredient when applied alone) can be made effective against that particular species when used in a composition together with one or more C4-C10 saturated or unsaturated aliphatic acid, or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid. In further embodiments, the one or more C4-C10 saturated or unsaturated aliphatic acid (or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid) may desirably provide for a synergistic increased efficacy of at least one of an acaricidal, molluscicidal, bactericidal or virucidal active ingredient such that the composition is pesticidally effective against one or more of an acari, mollusk, bacterial or viral pest, for example.</p><p id="p-0057" num="0132">In some embodiments, a pesticidal composition is provided comprising at least one C4-C10 saturated or unsaturated aliphatic acid (or in some further embodiments at least one C11 or C12 saturated or unsaturated apliphatic acid) and an insecticidal pesticidal active ingredient, comprising at least one nicotinic acetylcholine receptor disruptors. In one such embodiment, the insecticidal active ingredient may comprise at least one or more of: a spinosyn (including but not limited to spinosyns A, D, B, C, E, F, G, H, J, and other spinosyn isolates from <i>Saccharopolyspora spinosa </i>culture), spinosad (comprising primarily spinsyns A and D), and derivatives or substituents thereof (including but not limited to tetracyclic and pentacyclic spinosyn derivatives, aziridine spinosyn derivatives, C-5,6 and/or C-13,14 substituted spinosyn derivatives); a spinetoram (including but not limited to XDE-175-J and XDE-175-L); and a butenyl-spinosyn and derivatives or substituents thereof (such as isolates from <i>Saccharopolyspora pogona </i>culture). In a particular such embodiment, a pesticidal composition is provided, comprising at least one C4-C10 saturated or unsaturated aliphatic acid (or in some further embodiments at least one C11 or C12 saturated or unsaturated apliphatic acid) and at least one of spinosyn A and spinosyn D. In a further such embodiment, the at least one spinosyn comprises spinosad. In some embodiments, the pesticidal composition comprises a synergistic pesticidal composition. In some particular embodiments, the synergistic pesticidal composition desirably provides a synergistic efficacy to control at least one insect pest.</p><p id="p-0058" num="0133">In some further embodiments, a method of reducing a risk of resistance of at least one target pest to at least one pesticidal active ingredient is provided, the method comprising:<ul id="ul0016" list-style="none">    <li id="ul0016-0001" num="0000">    <ul id="ul0017" list-style="none">        <li id="ul0017-0001" num="0134">selecting at least one C4-C10 saturated or unsaturated aliphatic acid, or suitable salt thereof, which when applied to said at least one target pest as a pesticidal composition comprising said at least one pesticidal active ingredient and said at least one C4-C10 saturated or unsaturated aliphatic acid, or suitable salt thereof, is effective to provide a synergistic efficacy against said at least one target pest, relative to the application of said at least one pesticidal active ingredient alone; and applying said at least one pesticidal composition to a locus proximate to said at least one target pest.</li>    </ul>    </li></ul></p><p id="p-0059" num="0135">In some embodiments, the at least one C4-C10 saturated or unsaturated aliphatic acid, or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid, may comprise a naturally occurring aliphatic acid, such as may be present in, or extracted, fractionated or derived from a natural plant or animal material, for example. In one such embodiment, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in a plant extract or fraction thereof. In another such embodiment, the at least one C4-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in an animal extract or product, or fraction thereof. In one such embodiment, the at least one C4-C10 saturated or unsaturated alphatic acid may comprise a naturally occurring aliphatic acid comprised in a plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts therefrom. In another such embodiment, the at least one C4-C10 saturated or unsaturated alphatic acid may comprise a naturally occurring aliphatic acid comprised in an animal extract or product, such as one or more of cow's milk, goat's milk, beef tallow, and/or cow or goat butter, or fractions or extracts thereof for example. In a particular embodiment, at least one C4-C10 saturated or unsaturated aliphatic acid may be provided as a component of one or more natural plant or animal material, or extract or fraction thereof. In a particular such embodiment, at least one C4-C10 saturated aliphatic acid may be provided in an extract or fraction of one or more plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts therefrom.</p><p id="p-0060" num="0136">In some embodiments, an emulsifier or other surfactant may used in preparing pesticidal compositions according to aspects of the present disclosure. Suitable surfactants can be selected by one skilled in the art. Examples of surfactants that can be used in some embodiments of the present disclosure include, but are not limited to sodium lauryl sulfate, saponin, ethoxylated alcohols, ethoxylated fatty esters, alkoxylated glycols, ethoxylated fatty acids, ethoxylated castor oil, glyceryl oleates, carboxylated alcohols, carboxylic acids, ethoxylated alkylphenols, fatty esters, sodium dodecylsulfide, other natural or synthetic surfactants, and combinations thereof. In some embodiments, the surfactant(s) are non-ionic surfactants. In some embodiments, the surfactant(s) are cationic or anionic surfactants. In some embodiments, a surfactant may comprise two or more surface active agents used in combination. The selection of an appropriate surfactant depends upon the relevant applications and conditions of use, and selection of appropriate surfactants are known to those skilled in the art.</p><p id="p-0061" num="0137">In one aspect, a pesticidal composition according to some embodiments of the present disclosure comprises one or more suitable carrier or diluent component. A suitable carrier or diluent component can be selected by one skilled in the art, depending on the particular application desired and the conditions of use of the composition. Commonly used carriers and diluents may include ethanol, isopropanol, isopropyl myristate, other alcohols, water and other inert carriers, such as but not limited to those listed by the EPA as a Minimal Risk Inert Pesticide Ingredients (4A) (the list of ingredients published dated December 2015 by the US EPA FIFRA 4a list published August 2004 entitled &#x201c;List 4A&#x2014;Minimal Risk Inert Ingredients&#x201d;) or, for example, Inert Pesticide Ingredients (4B) (the US EPA FIFRA 4b list published August 2004 entitled &#x201c;List 4B&#x2014;Other ingredients for which EPA has sufficient information&#x201d;) or under EPA regulation 40 CFR 180.950 dated May 24, 2002, each of which is hereby incorporated herein in its entirety for all purposes including for example, citric acid, lactic acid, glycerol, castor oil, benzoic acid, carbonic acid, ethoxylated alcohols, ethoxylated amides, glycerides, benzene, butanol, 1-propanol, hexanol, other alcohols, dimethyl ether, and polyethylene glycol.</p><p id="p-0062" num="0138">In one embodiment according to the present disclosure, a method of enhancing the efficacy of a pesticide is provided. In one aspect, a method of enhancing the efficacy of a fungicide is provided. In another aspect, a method of enhancing the efficacy of a nematicide is provided. In a further aspect, a method of enhancing the efficacy of an insecticide is provided.</p><p id="p-0063" num="0139">In one such embodiment, the method comprises providing a synergistic pesticidal composition comprising a pesticidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid (or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid) and exposing a pest to the resulting synergistic composition. In a particular exemplary embodiment, without being bound by any particular theory, the at least one C4-C10 saturated or unsaturated aliphatic acid may desirably be functional as a cell permeabilizing or cell membrane disturbing agent. In one aspect, the method comprises providing a fungicidal composition comprising a fungicidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid and exposing a fungus to the resulting synergistic composition. In another aspect, the method comprises providing a nematicidal composition comprising a nematicidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid and exposing a nematode to the resulting synergistic composition. In a further aspect, the method comprises providing an insecticidal composition comprising an insecticidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid and exposing an insect to the resulting synergistic composition.</p><p id="p-0064" num="0140">In one embodiment according to the present disclosure, the at least one C4-C10 saturated or unsaturated aliphatic acid (or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid) provided in a pesticidal composition comprises an unsaturated aliphatic carbonyl alkene. In a particular such embodiment, without being bound by any particular theory, the at least one C4-C10 unsaturated aliphatic acid may desirably be functional as a cell permeabilizing or cell membrane disturbing agent. In one such embodiment, the cell permeabilizing agent comprises a carbonyl alkene having the general structure (1), (2) or (3), as shown in <figref idref="DRAWINGS">FIG. <b>1</b></figref>. In a further embodiment, the cell permeabilizing agent comprises at least one unsaturated aliphatic acid comprising at least one carboxylic group and having at least one unsaturated C&#x2014;C bond.</p><p id="p-0065" num="0141">In one exemplary embodiment, a method comprises providing a synergistic pesticidal composition comprising a pesticidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid (or in further embodiments, with one or more C11 or C12 saturated or unsaturated aliphatic acid) which is functional as a cell permeabilizing agent, and exposing a pest to the synergistic pesticidal composition to increase the amount of the pesticidal active ingredient that enters cells of the pest. In some such embodiments, the pesticidal active is a fungicide and the pest is a fungus, and without being bound by a particular theory, the at least one C4-C10 saturated or unsaturated aliphatic acid cell permeabilizing agent allows the fungicide to pass more easily through the fungal cell walls and membranes, and/or intracellular membranes. In some such embodiments, the pesticide is a nematicide and the pest is a nematode, and without being bound by a particular theory, the at least one C4-C10 saturated or unsaturated aliphatic acid cell permeabilizing agent allows the nematicide to pass more easily through the nematode cell and intracellular membranes. In some such embodiments, the pesticide is an insecticide, and without being bound by a particular theory, the at least one C4-C10 saturated or unsaturated aliphatic acid cell permeabilizing agent allows the insecticide to pass more easily through insect cuticle, chitin membrane, or cell or intracellular membranes.</p><p id="p-0066" num="0142">In some embodiments, in addition to the actual synergistic action with respect to pesticidal activity, certain synergistic pesticidal compositions according to embodiments of the present disclosure can also desirably have further surprising advantageous properties. Examples of such additional advantageous properties may comprise one or more of: more advantageous degradability in the environment; improved toxicological and/or ecotoxicological behaviour such as reduced aquatic toxicity or toxicity to beneficial insects, for example.</p><p id="p-0067" num="0143">In a further aspect, for any of the embodiments described above or below providing for a synergistic pesticidal composition comprising at least one pesticidal active and one or more C4-C10 saturated or unsaturated aliphatic acid or salt thereof, in an alternative embodiment, the synergistic pesticidal composition may alternatively comprise at least one pesticidal active and one or more C11 saturated or unsaturated aliphatic acid or salt thereof. In another aspect, for any of the embodiments described above providing for a synergistic pesticidal composition comprising at least one pesticidal active and one or more C4-C10 saturated or unsaturated aliphatic acid or salt thereof, in an alternative embodiment, the synergistic pesticidal composition may alternatively comprise at least one pesticidal active and one or more C12 saturated or unsaturated aliphatic acid or salt thereof.</p><heading id="h-0008" level="1">EXPERIMENTAL METHODS</heading><p id="p-0068" num="0144">In accordance with an embodiment of the present disclosure, the combination of at least one C4-C10 saturated or unsaturated aliphatic acid (and in some embodiments alternatively at least one C11 or C12 saturated or unsaturated aliphatic acid) and a pesticidal active ingredient produces a synergistic pesticidal composition demonstrating a synergistic pesticidal effect. In some embodiments, the synergistic action between the pesticidal active ingredient, and the at least one C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid components of the pesticidal compositions according to embodiments of the present disclosure was tested using a Synergistic Growth Inhibition Assay, which is derived from and related to a checkerboard assay as is known in the art for testing of combinations of antimicrobial agents. In the Synergistic Growth Inhibition Assay used in accordance with some embodiments of the present disclosure, multiple dilutions of combinations of pesticidal active ingredient and at least one C4-C10 saturated or unsaturated aliphatic acid agents are tested in individual cells for inhibitory activity against a target pest or pathogenic organism. In one such embodiment, the combinations of pesticidal active ingredient and C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents may preferably be tested in decreasing concentrations. In a further such embodiment, the combinations of pesticidal active ingredient and C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents may be tested in increasing concentrations. These multiple combinations of the pesticidal active ingredient and at least one C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents may be prepared in 96-well microtiter plates. In one such embodiment, the Synergistic Growth Inhibition Assay then comprises rows which each contain progressively decreasing concentrations of the pesticidal active ingredient and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents to test for the MIC of the agents in combination at which growth of the target pest or pathogen is inhibited. Thus, each well of the microtiter plate is a unique combination of the two agents, at which inhibitory efficacy of the combination against the target pest or pathogen can be determined.</p><p id="p-0069" num="0145">A method of determining and quantifying synergistic efficacy is by calculation of the &#x201c;Fractional Inhibitory Concentration Index&#x201d; or FIC index, as is known in the art for determining synergy between two antibiotic agents (see for example M. J. Hall et al., &#x201c;The fractional inhibitory concentration (FIC) index as a measure of synergy&#x201d;, J Antimicrob Chem., 11 (5):427-433, 1983, for example). In one embodiment according to the present disclosure, for each row of microtiter cells in the Synergistic Growth Inhibition Assay, the FIC index is calculated from the lowest concentration of the pesticidal active ingredient and one or more C4-C10 saturated or unsaturated aliphatic acid agents necessary to inhibit growth of a target pest or pathogen. The FIC of each component is derived by dividing the concentration of the agent present in that well of the microtiter plate by the minimal inhibitory concentration (MIC) needed of that agent alone to inhibit growth of the target pest or pathogen. The FIC index is then the sum of these values for both agents in that well of the microtiter plate. The FIC index is calculated for each row as follows:</p><p id="p-0070" num="0000"><br/><?in-line-formulae description="In-line Formulae" end="lead"?>FIC<sub>index</sub>=MIC<sub>a</sub>/MIC<sub>A</sub>+MIC<sub>b</sub>/MIC<sub>B </sub><?in-line-formulae description="In-line Formulae" end="tail"?></p><p id="p-0071" num="0146">where MIC<sub>a</sub>, MIC<sub>b </sub>are the minimal inhibitory concentration (MIC) of compounds A and B, respectively, when combined in the mixture of the composition, and MIC<sub>A</sub>, MIC<sub>B </sub>are the MIC of compounds A and B, respectively, when used alone. Fractional inhibitory concentration indices may then used as measure of synergy. When the lowest FIC index obtained in a microtiter plate in this way is less than 1 (FIC<sub>index</sub>&#x3c;1), the combination of the pesticidal active ingredient and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents exhibits synergism, and indicates a synergistic pesticidal composition. When the FIC index is equal to 1, the combination is additive. FIC index values of greater than 4 are considered to exhibit antagonism.</p><p id="p-0072" num="0147">In a particular embodiment, when the FIC index is equal or less than 0.5, the combination of the pesticidal active ingredient and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents exhibits strong synergism. For example, in one embodiment, an FIC index of 0.5 may correspond to a synergistic pesticidal composition comprising a pesticidal agent at &#xbc; of its individual MIC, and one or more (or alternatively C11 or C12) C4-C10 saturated or unsaturated aliphatic acid agent at &#xbc; of its individual MIC.</p><p id="p-0073" num="0148">In some embodiments of the present disclosure, the exemplary Synergistic Growth Inhibition Assay was conducted starting with an initial composition comprising a pesticidal active ingredient agent (compound A) at its individual MIC and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent (compound B) at its individual MIC in the first well of a row on a 96 well microtiter plate. Then, serial dilutions of these initial compositions in successive wells in the row of the microtiter plate were used to assay the pesticidal composition under the same conditions to determine the concentration of the composition combining the two agents corresponding to the microtiter well in which growth inhibition of the target pest or organism ceases. The minimal inhibitory concentrations of each individual pesticidal active ingredient agent (compound A) and each of the one or more C4-C10 saturated or unsaturated aliphatic acid agent (as compound B) were determined in parallel with the compositions combining the two agents.</p><p id="p-0074" num="0149">In some embodiments, <i>Fusarium oxysporum </i>was used as a representative pest organism or pathogen to determine synergy in pesticidal compositions comprising a pesticidal active ingredient agent (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent (compound B). Resazurin dye (also known as Alamar blue dye) was used as an indicator to determine the presence of growth or inhibition of growth of <i>Fusarium oxysporum </i>in the wells of the 96 well microtiter plates used in the exemplary Synergistic Growth Inhibition Assay. In addition to the color change of the resazurin dye in the presence of growth of the <i>Fusarium oxysporum</i>, an optical or visual examination of the microtiter well may also be made to additionally determine the presence of growth or inhibition of growth of the <i>Fusarium oxysporum. </i></p><p id="p-0075" num="0150">In other embodiments, <i>Botrytis cinerea </i>was used as a representative pest organism or pathogen to determine synergy in pesticidal compositions comprising a pesticidal active ingredient (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent (compound B). Similarly to as described above, Resazurin was used as an indicator of growth or inhibition of growth of <i>Botrytis cinerea </i>in the exemplary Synergistic Growth Inhibition Assay. In addition to the color change of the resazurin, an optical or visual examination of the microtiter well may also be made to additionally determine the presence of growth or inhibition of growth of the <i>Botrytis cinerea. </i></p><p id="p-0076" num="0151">In further embodiments, <i>Sclerotinia sclerotiorum </i>was used as a representative pest organism or pathogen to determine synergy in pesticidal compositions comprising a pesticidal active ingredient (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent (compound B). Similarly to as described above, Resazurin was used as an indicator of growth or inhibition of growth of <i>Sclerotinia sclerotiorum </i>in the exemplary Synergistic Growth Inhibition Assay. In addition to the color change of the resazurin, an optical or visual examination of the microtiter well may also be made to additionally determine the presence of growth or inhibition of growth of the <i>Sclerotinia sclerotiorum. </i></p><p id="p-0077" num="0152">Alternatively, other suitable representative pest or pathogen organisms may be used to determine synergy of combinations of pesticidal active ingredient agents and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents in accordance with embodiments of the present disclosure. For example, other representative fungal pathogens may be used, such as but not limited to <i>Leptosphaeria maculans, Sclerotinia </i>spp. and <i>Verticillium </i>spp. In yet other examples, suitable non-fungal representative pests or pathogens may be used, such as insect, acari, nematode, bacterial, viral, mollusc or other pests or pathogens suitable for use in an MIC growth inhibition assay test method. All examples detailed below were tested according to the exemplary Synergistic Growth Inhibition Assay described above, using routine techniques for MIC determination known to those of skill in the art. Stock solutions of the pesticidal active ingredient agents and the one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents were initially prepared in 100% dimethylsulfoxide (&#x201c;DMSO&#x201d;), and diluted to 10% DMSO using sterile potato dextrose broth (PDB) before further serial dilution to obtain the test solution concentrations for use in the microtiter plate wells, with exceptions in particular experimental examples noted in detail below. Accordingly, the maximum concentration of DMSO in the test solutions was limited to 10% DMSO or less, which was separately determined to be non-inhibitory to the growth of the representative fungal pests used in the test.</p><p id="p-0078" num="0153">A culture of the representative fungal pathogen, namely <i>Fusarium oxysporum, Botrytis cinerea</i>, or <i>Sclerotinia sclerotiorum</i>, for example, is grown to exponential phase in potato dextrose broth (PDB). A 20 uL aliquot of homogenized mycelium from the culture is transferred to a well of a 96 well microtiter plate, and incubated for a period between 1 day and 7 days (depending on the pathogen and the particular assay reagents, as noted in the example descriptions below) with 180 uL of the test solution comprising the pesticidal and aliphatic acid agents in combination at a range of dilutions, to allow the mycelium to grow. Following the incubation period, 10 uL of resazurin dye is added to each well and the color in the solution is observed and compared to the color of the test solution at the same concentrations in wells without mycelial culture innoculum to control for effects of the test solution alone. The resazurin dye appears blue for wells with only the initial 20 uL culture where growth has been inhibited, and appears pink for wells where mycelial growth has occurred, as shown in <figref idref="DRAWINGS">FIG. <b>2</b></figref>, where the transition from blue to pink color can be clearly seen in each of the uppermost 4 rows of microtiter wells (labelled as 1-4 in <figref idref="DRAWINGS">FIG. <b>2</b></figref>) as the concentration of the pesticidal and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agents in the test solution decreases from left to right. In addition to the color change of the resazurin dye, growth or absence of growth of the mycelial culture is also observed visually or optically.</p><p id="p-0079" num="0154">In accordance with this assay method, the Minimum Inhibitory Concentration is the lowest concentration at which growth is inhibited, and corresponds to the microtiter well in which the dye color is the same as for the control without culture and without growth, and/or in which a visual and/or optical inspection confirm that growth is inhibited.</p><heading id="h-0009" level="1">EXPERIMENTAL EXAMPLES</heading><heading id="h-0010" level="1">Example 1: Growth Inhibition of <i>Fusarium oxysporum </i>by Pyraclostrobin in Combination with Several Exemplary C4-C10 Unsaturated Aliphatic Acids (or Agriculturally Acceptable Salts Thereof)</heading><p id="p-0080" num="0155">Sample Preparation:</p><p id="p-0081" num="0156">10 mg of pyraclostrobin (available from Santa Cruz Biotechnology of Dallas, Tex. as stock #229020) was dissolved in 10 mL dimethylsulfoxide (DMSO) and the resulting solution was diluted 2-fold in DMSO to give a concentration of 0.5 mg/mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to give a concentration of 0.05 mg/mL in 10% DMSO/90% PDB. The solubility of pyraclostrobin in 10% DMSO/90% PDB was determined to be 0.0154 mg/mL using high performance liquid chromatography (HPLC).</p><p id="p-0082" num="0157">A solution of (2E,4E)-2,4-hexadienoic acid, potassium salt, was prepared by dissolving 2 g of (2E,4E)-2,4-hexadienoic acid, potassium salt, in 20 mL of PDB which was diluted further by serial dilution in PDB. A solution of (2E,4E)-2,4-hexadienoic acid (available from Sigma-Aldrich as stock #W342904) was prepared by dissolving 20 mg of (2E,4E)-2,4-hexadienoic acid in 1 mL DMSO and adding 0.1 mL to 0.9 mL PDB resulting in a 2 mg/mL solution of (2E,4E)-2,4-hexadienoic acid in 10% DMSO/90% PDB which was diluted further by serial dilution in PDB.</p><p id="p-0083" num="0158">A solution of trans-2-hexenoic acid (available from Sigma-Aldrich as stock #W316903) was prepared by dissolving 100 mg trans-2-hexenoic acid in 1 mL DMSO and adding 0.1 mL to 0.9 mL PDB resulting in a 10 mg/mL solution in 10% DMSO/90% PDB which was diluted further by serial dilution in PDB. A solution of trans-3-hexenoic acid (available from Sigma-Aldrich as stock #W317004) was prepared by adding 20 uL trans-3-hexenoic acid to 1980 uL PDB and the resulting solution was serially diluted in PDB. The density of trans-3-hexenoic acid was assumed to be 0.963 g/mL.</p><p id="p-0084" num="0159">Combinations of pyraclostrobin and one or more exemplary C4-C10 saturated or unsaturated aliphatic acids (and agriculturally acceptable salts thereof) were prepared by adding 0.5 mL of 0.0308 mg/mL pyraclostrobin to 0.5 mL of 1.25 mg/mL (2E,4E)-2,4-hexadienoic acid, potassium salt, (combination 1), 0.5 mL of 0.25 mg/mL (2E,4E)-2,4-hexadienoic acid (combination 2), 0.5 mL of 0.625 mg/mL (2E,4E)-2,4-hexadienoic acid (combination 3), 0.5 mL of 1.25 mg/mL of trans-2-hexenoic acid (combination 4), or 0.5 mL of 0.6019 mg/mL trans-3-hexenoic acid (combination 5). Each combination was tested over a range of 2-fold dilutions in the Synergistic Growth Inhibition Assay detailed above, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 1.</p><p id="p-0085" num="0000"><tables id="TABLE-US-00001" num="00001"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 1</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by pyraclostrobin in combination with several</entry></row><row><entry>exemplary unsaturated aliphatic acids (or agriculturally acceptable salts thereof).</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0154</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>acid, potassium salt</entry></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.00385</entry><entry>0.1563</entry><entry>40</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid, potassium salt</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.00385</entry><entry>0.03125</entry><entry>20</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.001925</entry><entry>0.03906</entry><entry>8</entry><entry>0.44</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>Trans-2-hexenoic acid</entry><entry>0.00385</entry><entry>0.1563</entry><entry>40</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.00385</entry><entry>0.07813</entry><entry>20</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0011" level="1">Example 2: Growth Inhibition of <i>Fusarium oxysporum </i>by Fludioxonil in Combination with Several Exemplary Unsaturated Aliphatic Acids (or Agriculturally Acceptable Salts Thereof)</heading><p id="p-0086" num="0160">Sample Preparation:</p><p id="p-0087" num="0161">20 mg of fludioxonil (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China) was dissolved in 10 mL dimethylsulfoxide (DMSO) and the resulting solution was diluted 2-fold in DMSO to give a concentration of 1 mg/mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to give a concentration of 0.1 mg/mL in 10% DMSO/90% PDB. The solubility of fludioxonil in 10% DMSO/90% PDB was determined to be 0.0154 mg/mL using HPLC.</p><p id="p-0088" num="0162">A solution of (2E,4E)-2,4-hexadienoic acid, potassium salt, was prepared by dissolving 2 g of (2E,4E)-2,4-hexadienoic acid, potassium salt, in 20 mL of PDB which was diluted further by serial dilution in PDB. A solution of (2E,4E)-2,4-hexadienoic acid (available from Sigma-Aldrich as #W342904) was prepared by dissolving 20 mg of (2E,4E)-2,4-hexadienoic acid in 1 mL DMSO and adding 0.1 mL to 0.9 mL PDB resulting in a 2 mg/mL solution of (2E,4E)-2,4-hexadienoic acid in 10% DMSO/90% PDB which was diluted further by serial dilution in PDB.</p><p id="p-0089" num="0163">A solution of trans-2-hexenoic acid (available from Sigma-Aldrich as stock #W316903) was prepared by dissolving 100 mg trans-2-hexenoic acid in 1 mL DMSO and adding 0.1 mL to 0.9 mL PDB resulting in a 10 mg/mL solution in 10% DMSO/90% PDB which was diluted further by serial dilution in PDB. A solution of trans-3-hexenoic acid (available from Sigma-Aldrich as stock #W317004) was prepared by adding 20 uL trans-3-hexenoic acid to 1980 uL PDB and the resulting solution was serially diluted in PDB. The density of trans-3-hexenoic acid was assumed to be 0.963 g/mL.</p><p id="p-0090" num="0164">Combinations of compounds A and B as shown below in Table 2 were prepared by adding 0.5 mL of 9.63&#xd7;10&#x2212;4 mg/mL fludioxonil to each of 0.5 mL of 0.625 mg/mL (2E,4E)-2,4-hexadienoic acid, potassium salt, (combination 1), 0.5 mL of 0.25 mg/mL (2E,4E)-2,4-hexadienoic acid (combination 2), 0.5 mL of 0.625 mg/mL of trans-2-hexenoic acid (combination 3), and 0.5 mL of 0.6019 mg/mL trans-3-hexenoic acid (combination 4). Each combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 2.</p><p id="p-0091" num="0000"><tables id="TABLE-US-00002" num="00002"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="329pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 2</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil in combination with several</entry></row><row><entry>exemplary unsaturated aliphatic acids (or agriculturally acceptable salts thereof).</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>4.8125 &#xd7; 10<sup>&#x2212;4</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>acid, potassium salt</entry></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>6.0188 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.03906</entry><entry>649</entry><entry>0.19</entry></row><row><entry/><entry/><entry>acid, potassium salt</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>6.0188 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.01563</entry><entry>260</entry><entry>0.25</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>Trans-2-hexenoic acid</entry><entry>1.2038 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.07813</entry><entry>649</entry><entry>0.5</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>Trans-3-hexenoic acid</entry><entry>1.2038 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.07813</entry><entry>649</entry><entry>0.5</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0012" level="1">Example 3: Growth Inhibition of <i>Fusarium oxysporum </i>by Fludioxonil in Combination with Several Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0092" num="0165">Sample Preparation:</p><p id="p-0093" num="0166">20 mg fludioxonil (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China) was dissolved in 10 mL dimethylsulfoxide (DMSO) and the resulting solution was diluted 2-fold in DMSO to give a concentration of 1 mg/mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to give a concentration of 0.1 mg/mL in 10% DMSO/90% PDB. The solubility of fludioxonil in 10% DMSO/90% PDB was determined to be 0.0154 mg/mL using HPLC.</p><p id="p-0094" num="0167">Stock solutions of several exemplary C4-C10 unsaturated aliphatic acids as Compound B for testing individual MICs were prepared at 25 uL/mL in DMSO by adding 25 uL of each Compound B to 975 uL DMSO, followed by 10-fold dilution in PDB, for each of 3-octenoic acid (available from Sigma-Aldrich as stock #CDS000466), trans-2-octenoic acid (available from Sigma-Aldrich), 9-decenoic acid (available from Sigma-Aldrich as #W366005), 3-decenoic acid (available from Sigma-Aldrich as stock #CDS000299), and trans-2-decenoic acid (available from TCI America as stock #D0098).</p><p id="p-0095" num="0168">For testing in combination with fludioxonil, solutions of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid were prepared at 0.78 uL/mL in DMSO by adding 3.125 uL of each Compound B to 2 mL of DMSO, followed by 2-fold dilution in DMSO to give 0.78 uL/mL. Solutions of 3-decenoic acid and trans-2-decenoic acid were prepared similarly, but applying a further 2-fold dilution in DMSO to give a concentration of 0.39 uL/mL in DMSO.</p><p id="p-0096" num="0169">Each of these resulting stock solutions were then diluted 10-fold in PDB to give solutions of 0.078 uL/mL for each of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid, and to give solutions of 0.039 uL/mL for each of 3-decenoic acid and trans-2-decenoic acid, all in 10% DMSO/90% PDB. Combinations of the exemplary Compound B components with fludioxonil were prepared by adding 0.5 mL of 0.078 uL/mL of each of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid or 0.039 uL/mL of each of 3-decenoic acid and trans-2-decenoic acid, to 0.5 mL of 4.813&#xd7;10<sup>&#x2212;4 </sup>mg/mL fludioxonil obtained from serial dilution of 0.0154 mg/mL of fludioxonil in 10% DMSO/90% PDB, as prepared above, with PDB. The density of 3-octenoic acid was assumed to be 0.938 g/mL. The density of trans-2-octenoic acid was assumed to be 0.955 g/mL. The density of 3-decenoic acid was assumed to be 0.939 g/mL. The density of trans-2-decenoic acid was assumed to be 0.928 g/mL. The density of 9-decenoic acid was assumed to be 0.918 g/mL.</p><p id="p-0097" num="0170">Each combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 3.</p><p id="p-0098" num="0000"><tables id="TABLE-US-00003" num="00003"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 3</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil in combination</entry></row><row><entry>with several exemplary unsaturated aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>2.4063 &#xd7; 10<sup>&#x2212;4</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.1466</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.1492</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.07336</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.03625</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.07172</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>3-Octenoic acid</entry><entry>1.2031 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.01832</entry><entry>152</entry><entry>0.63</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>Trans-2-octenoic acid</entry><entry>1.2031 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.01865</entry><entry>155</entry><entry>0.63</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>3-Decenoic acid</entry><entry>1.2031 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00917</entry><entry>76</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>Trans-2-decenoic acid</entry><entry>1.2031 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00906</entry><entry>75</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>9-Decenoic acid</entry><entry>1.2031 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.01793</entry><entry>149</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0013" level="1">Example 4: Growth Inhibition of <i>Fusarium oxysporum </i>by Thyme Oil in Combination in Combination with Several Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0099" num="0171">Sample Preparation:</p><p id="p-0100" num="0172">12.5 mg of thyme oil (available from Sigma-Aldrich as stock #W306509) was dissolved in 1 g dimethylsulfoxide (DMSO) and the resulting solution was diluted 10-fold in PDB to give a concentration of 1.25 mg/mL 10% DMSO/90% PDB.</p><p id="p-0101" num="0173">Stock solutions of several exemplary C4-C10 unsaturated aliphatic acids as Compound B for testing individual MICs were prepared at 25 &#x3bc;L/mL by adding 25 &#x3bc;L of each of 3-octenoic acid (available from Sigma-Aldrich as stock #CDS000466), trans-2-octenoic acid (available from Sigma-Aldrich as stock #CDS000466), 9-decenoic acid (available from Sigma-Aldrich as stock #W366005), 3-decenoic acid (available from Sigma-Aldrich as stock #CDS000299), and trans-2-decenoic acid (available from TCI America as stock #D0098), to 975 &#x3bc;L DMSO followed by 10-fold dilution in PDB.</p><p id="p-0102" num="0174">Stock solutions of the exemplary C4-C10 unsaturated aliphatic acids as Compound B for testing in combination with thyme oil were prepared by adding 3.125 &#x3bc;L of each of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid, to 2 mL of DMSO followed by 2-fold dilution in DMSO to give a 0.78 L/mL concentration stock solution. Solutions of 3-decenoic acid and trans-2-decenoic acid were prepared similarly, but applying a further 2-fold dilution in DMSO to give a concentration of 0.39 &#x3bc;L/mL. Each of these resulting stock solutions were then diluted 10-fold dilution in PDB to give solutions of 0.078 &#x3bc;L/mL (for each of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid) and 0.039 L/mL (for 3-decenoic acid and trans-2-decenoic acid) in 10% DMSO/90% PDB.</p><p id="p-0103" num="0175">Combinations of the exemplary Compound B components with thyme oil were prepared by adding 0.5 mL of 0.078 i/mL of each of 3-octenoic acid, trans-2-octenoic acid, and 9-decenoic acid or 0.039 &#x3bc;L/mL of each of 3-decenoic acid and trans-2-decenoic acid, to 0.5 mL of 1.25 mg/mL thyme oil in 10% DMSO/90% PDB. The density of 3-octenoic acid was assumed to be 0.938 g/mL. The density of trans-2-octenoic acid was assumed to be 0.955 g/mL. The density of 3-decenoic acid was assumed to be 0.939 g/mL. The density of trans-2-decenoic acid was assumed to be 0.928 g/mL. The density of 9-decenoic acid was assumed to be 0.918 g/mL</p><p id="p-0104" num="0176">Each combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 4.</p><p id="p-0105" num="0000"><tables id="TABLE-US-00004" num="00004"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 4</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by thyme oil in combination</entry></row><row><entry>in combination with several exemplary unsaturated aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Thyme oil</entry><entry/><entry>1.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.14656</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.14922</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.07336</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.03625</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.07172</entry></row><row><entry>1</entry><entry>Thyme oil</entry><entry>3-Octenoic acid</entry><entry>0.3125</entry><entry>0.01832</entry><entry>0.059</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Thyme oil</entry><entry>Trans-2-octenoic acid</entry><entry>0.3125</entry><entry>0.01865</entry><entry>0.060</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Thyme oil</entry><entry>3-Decenoic acid</entry><entry>0.3125</entry><entry>0.00917</entry><entry>0.029</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Thyme oil</entry><entry>Trans-2-decenoic acid</entry><entry>0.3125</entry><entry>0.00906</entry><entry>0.029</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Thyme oil</entry><entry>9-Decenoic acid</entry><entry>0.3125</entry><entry>0.01793</entry><entry>0.057</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0014" level="1">Example 5: Growth Inhibition of <i>Botrytis cinerea </i>by Neem Oil Limonoid Extract (Extracted from Cold-Pressed Neem Oil) and Fortune Aza Technical (Azadirachtin Extract) in Combination with Various Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0106" num="0177">Sample Preparation:</p><p id="p-0107" num="0178">An extract of limonoids was prepared from cold-pressed neem oil using solvent extraction with hexane and methanol to prepare a neem oil limonoid extract. Fortune Aza Technical pesticide containing 14% azadirachtin (extracted from neem seed/kernel source) was obtained from Fortune Biotech Ltd. of Secunderabad, India.</p><p id="p-0108" num="0179">Solutions of neem oil limonoid extract and Fortune Aza Technical were prepared at 5 mg/mL in DMSO followed by ten-fold dilution in PDB to give a concentration of 0.5 mg/mL in 10% DMSO/90% PDB.</p><p id="p-0109" num="0180">Stock solutions of 3-octenoic acid and trans-2-octenoic acid as Compound B for testing of individual MICs were prepared at 25 &#x3bc;L/mL by adding 25 &#x3bc;L of each Compound B to 975 &#x3bc;L DMSO followed by 10-fold dilution in PDB.</p><p id="p-0110" num="0181">For testing in combination with neem oil limonoid extract and Fortune Aza Technical, stock solutions of 3-octenoic acid and trans-2-octenoic acid were prepared at 6.25 L/mL by adding 62.5 &#x3bc;L of the respective compound to 937.5 &#x3bc;L of DMSO followed by 10-fold dilution in PDB (ratio 11.7). Stock solutions of 3-octenoic acid and trans-2-octenoic acid were prepared at 3.125 L/mL for testing in combination by adding 31.25 &#x3bc;L of the respective compound to 968.75 &#x3bc;L of DMSO followed by 10-fold dilution in PDB (ratio 6.0 or 5.9). Stock solutions of 3-octenoic acid and trans-2-octenoic acid at 0.625 L/mL for testing in combination were prepared by adding 6.25 &#x3bc;L of the respective compound to 993.75 &#x3bc;L of DMSO followed by 10-fold dilution in PDB (ratio 1.2). The density of 3-octenoic acid was assumed to be 0.938 g/mL. The density of trans-2-octenoic acid was assumed to be 0.955 g/mL. Combinations were prepared by adding 0.5 mL of 6.25 &#x3bc;L/mL, 3.125 &#x3bc;L/mL, or 0.625 &#x3bc;L/mL 3-octenoic acid ortrans-2-octenoic acid, as prepared above (as Compound B), to 0.5 mL neem oil limonoid extract or Fortune Aza Technical at 0.5 mg/mL in acid DMSO/90% PDB (as Compound A) for testing in the synergistic growth inhibition assay. Each combination was observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Tables 5 and 6.</p><p id="p-0111" num="0000"><tables id="TABLE-US-00005" num="00005"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 5</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by limonoid extract from cold-pressed</entry></row><row><entry>neem oil in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Neem oil</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry>limonoid extract</entry></row><row><entry/><entry/><entry>3-octenoic acid</entry><entry/><entry>0.14656</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.07461</entry></row><row><entry>1</entry><entry>Neem oil</entry><entry>3-octenoic acid</entry><entry>0.0078125</entry><entry>0.09160</entry><entry>11.7</entry><entry>0.66</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>2</entry><entry>Neem oil</entry><entry>3-octenoic acid</entry><entry>0.015625</entry><entry>0.09160</entry><entry>5.9</entry><entry>0.69</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>3</entry><entry>Neem oil</entry><entry>3-octenoic acid</entry><entry>0.0625</entry><entry>0.07656</entry><entry>1.2</entry><entry>0.75</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>4</entry><entry>Neem oil</entry><entry>Trans-2-octenoic acid</entry><entry>0.0078125</entry><entry>0.04663</entry><entry>6.0</entry><entry>0.66</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>5</entry><entry>Neem oil</entry><entry>Trans-2-octenoic acid</entry><entry>0.03125</entry><entry>0.03730</entry><entry>1.2</entry><entry>0.63</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0112" num="0000"><tables id="TABLE-US-00006" num="00006"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 6</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by Fortune Aza Technical</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fortune Aza</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry>Tech.</entry></row><row><entry/><entry/><entry>3-octenoic acid</entry><entry/><entry>0.14656</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.07461</entry></row><row><entry>1</entry><entry>Fortune Aza</entry><entry>3-octenoic acid</entry><entry>0.0078125</entry><entry>0.09160</entry><entry>11.7</entry><entry>0.66</entry></row><row><entry/><entry>Tech.</entry></row><row><entry>2</entry><entry>Fortune Aza</entry><entry>3-octenoic acid</entry><entry>0.015625</entry><entry>0.09160</entry><entry>5.9</entry><entry>0.69</entry></row><row><entry/><entry>Tech.</entry></row><row><entry>3</entry><entry>Fortune Aza</entry><entry>3-octenoic acid</entry><entry>0.0625</entry><entry>0.07656</entry><entry>1.2</entry><entry>0.75</entry></row><row><entry/><entry>Tech.</entry></row><row><entry>4</entry><entry>Fortune Aza</entry><entry>Trans-2-octenoic acid</entry><entry>0.0078125</entry><entry>0.04663</entry><entry>6.0</entry><entry>0.66</entry></row><row><entry/><entry>Tech.</entry></row><row><entry>5</entry><entry>Fortune Aza</entry><entry>Trans-2-octenoic acid</entry><entry>0.03125</entry><entry>0.03730</entry><entry>1.2</entry><entry>0.63</entry></row><row><entry/><entry>Tech.</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0015" level="1">Example 6: Growth Inhibition of <i>Fusarium oxysporum </i>by Fludioxonil in Combination with Various Exemplary Saturated Aliphatic Acids</heading><p id="p-0113" num="0182">Sample Preparation:</p><p id="p-0114" num="0183">20 mg fludioxonil was dissolved in 10 mL dimethylsulfoxide (DMSO) and the resulting solution was diluted 2-fold in DMSO to give a concentration of 1 mg/mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to give a concentration of 0.1 mg/mL in 10% DMSO/90% PDB. The solubility of fludioxonil in 10% DMSO/90% PDB was determined to be 0.0154 mg/mL using high performance liquid chromatography. A solution of 0.000963 mg/mL fludioxonil was prepared by adding 625 &#x3bc;L of 0.0154 mg/mL fludioxonil to 9375 &#x3bc;L of PDB.</p><p id="p-0115" num="0184">For testing individual MICs, stock solutions of hexanoic acid or octanoic acid as Component B were prepared by adding 100 &#x3bc;L hexanoic acid (93 mg) or octanoic acid (91 mg) to 900 &#x3bc;L PDB resulting in concentrations of 9.3 mg/mL and 9.1 mg/mL, respectively. A stock solution of decanoic acid was prepared at 10 mg/mL in DMSO followed by 10-fold dilution in PDB producing a concentration of 1 mg/mL in 10% DMSO/90% PDB. The stock solution of decanoic acid, potassium salt, was prepared by adding 100 mg to 10 mL of PDB resulting in a concentration of 10 mg/mL. A stock solution of dodecanoic acid was prepared at 1 mg/mL in DMSO followed by 10-fold dilution in PDB producing a concentration of 0.1 mg/mL in 10% DMSO/90% PDB.</p><p id="p-0116" num="0185">For testing MICs of combinations, a solution of hexanoic acid at 0.29 mg/mL was prepared by adding 156 &#x3bc;L of the 9.3 mg/mL stock solution to 4844 &#x3bc;L PDB. Similarly, a solution of octanoic acid at 1.14 mg/mL was prepared diluting the 9.1 mg/mL stock solution in PDB. A solution of decanoic acid at 0.5 mg/mL was prepared by 2-fold dilution of the 1 mg/mL stock solution. A solution of decanoic acid, potassium salt, at 0.156 mg/mL was prepared by adding 78 &#x3bc;L of the 10 mg/mL stock solution to 4922 &#x3bc;L PDB. A solution of dodecanoic acid at 0.2 mg/mL was prepared by dissolving 2 mg in 1 mL DMSO followed by 10-fold dilution in PDB at 40&#xb0; C.</p><p id="p-0117" num="0186">Combinations for results shown in Table 7 were prepared by adding 0.5 mL of 0.0154 mg/mL fludioxonil to 0.5 mL of each of the stock solutions. Each combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 7.</p><p id="p-0118" num="0000"><tables id="TABLE-US-00007" num="00007"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 7</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil in combination</entry></row><row><entry>with various exemplary saturated aliphatic acids (and salts thereof).</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>4.8125 &#xd7; 10<sup>&#x2212;4</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.14531</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.56875</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>Decanoic acid,</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>potassium salt</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>Hexanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00114</entry><entry>10</entry><entry>0.26</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>Octanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00444</entry><entry>37</entry><entry>0.26</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>Decanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00195</entry><entry>16</entry><entry>0.26</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>Decanoic acid,</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00061</entry><entry>5</entry><entry>0.26</entry></row><row><entry/><entry/><entry>potassium salt</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>Dodecanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00078</entry><entry>7</entry><entry>0.26</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0119" num="0187">Combinations for results shown in Table 8 were prepared by adding 0.5 mL of 0.000963 mg/mL fludioxonil to 0.5 mL of each of the stock solutions.</p><p id="p-0120" num="0000"><tables id="TABLE-US-00008" num="00008"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 8</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>4.8125 &#xd7; 10<sup>&#x2212;4</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.29</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>1.14</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>Decanoic acid,</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>potassium salt</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>Hexanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.03633</entry><entry>309</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>Octanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.14219</entry><entry>1181</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>Decanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.0625</entry><entry>519</entry><entry>0.5</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>Decanoic acid,</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.01953</entry><entry>162</entry><entry>0.5</entry></row><row><entry/><entry/><entry>potassium salt</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>Dodecanoic acid</entry><entry>1.20375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.025</entry><entry>208</entry><entry>0.5</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0016" level="1">Example 7: Growth Inhibition of <i>Fusarium oxysporum </i>by Limonoid Extract from Cold-Pressed Neem Oil and Fortune Aza Technical (Azadirachtin Extract) in Combination with Various Exemplary Saturated Aliphatic Acids</heading><p id="p-0121" num="0188">Sample Preparation:</p><p id="p-0122" num="0189">An extract of limonoids was prepared from cold-pressed neem oil using solvent extraction with hexane and methanol to prepare a neem oil limonoid extract. Fortune Aza Technical pesticide containing 14% azadirachtin (extracted from neem seed/kernel source) was obtained from Fortune Biotech Ltd. of Secunderabad, India (also referred to as &#x201c;Azatech&#x201d;). Solutions of neem oil limonoid extract and Fortune Aza Technical were prepared at 5 mg/mL in DMSO followed by ten-fold dilution in PDB to give a concentration of 0.5 mg/mL in 10% DMSO/90% PDB. These solutions were used for testing the individual MICs.</p><p id="p-0123" num="0190">For testing the individual MIC of octanoic acid, a solution was prepared by adding 100 uL octanoic acid (91 mg) to 900 uL PDB resulting in concentrations of 9.1 mg/mL. A stock solution of decanoic acid was prepared at 10 mg/mL in DMSO followed by 10-fold dilution in PDB producing a concentration of 1 mg/mL in 10% DMSO/90% PDB.</p><p id="p-0124" num="0191">Combinations with octanoic acid were prepared by dissolving 5 mg neem oil limonoid extract or Fortune Aza Technical in 1 mL of DMSO and adding 6.25 uL octanoic acid (d=0.91 g/mL) followed by 10-fold dilution in PDB. This produced a solution containing 0.5 mg/mL neem oil limonoid extract or Fortune Aza Technical and 0.56875 mg/mL octanoic acid. Combinations with decanoic acid were prepared by dissolving 5 mg neem oil limonoid extract or Fortune Aza Technical in 1 mL of DMSO and adding 2.5 mg of decanoic acid followed by 10-fold dilution in PDB. This produced a solution containing 0.5 mg/mL neem oil limonoid extract or Fortune Aza Technical and 0.25 mg/mL decanoic acid.</p><p id="p-0125" num="0192">Each combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following a 24 hour incubation period, and the FIC Index for each combination calculated, as shown below in Table 9.</p><p id="p-0126" num="0000"><tables id="TABLE-US-00009" num="00009"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 9</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by neem oil limonoid extract or Fortune Aza</entry></row><row><entry>Technical (Azatech) in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Neem oil</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry>limonoid extract</entry></row><row><entry/><entry>Azatech</entry><entry/><entry>0.5</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.56875</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.25</entry></row><row><entry>1</entry><entry>Neem oil</entry><entry>Octanoic acid</entry><entry>0.0625</entry><entry>0.07109</entry><entry>1.14</entry><entry>0.25</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>2</entry><entry>Neem oil</entry><entry>Decanoic acid</entry><entry>0.125</entry><entry>0.0625</entry><entry>0.5</entry><entry>0.5</entry></row><row><entry/><entry>limonoid extract</entry></row><row><entry>3</entry><entry>Fortune</entry><entry>Octanoic acid</entry><entry>0.0625</entry><entry>0.07109</entry><entry>1.14</entry><entry>0.25</entry></row><row><entry/><entry>Aza Tech.</entry></row><row><entry>4</entry><entry>Fortune</entry><entry>Decanoic acid</entry><entry>0.125</entry><entry>0.0625</entry><entry>0.5</entry><entry>0.5</entry></row><row><entry/><entry>Aza Tech.</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0017" level="1">Sample Preparation for Examples 8-34</heading><p id="p-0127" num="0193">For each of experimental Examples 8-34 described below, concentrated stock solutions, and diluted working solutions were prepared for each of the exemplary pesticidal active ingredients as Component A, and each of the exemplary unsaturated and saturated aliphatic acids as Component B, in accordance with the following descriptions:</p><p id="p-0128" num="0194">Compound A Pesticidal Active Ingredients:</p><p id="p-0129" num="0195">Concentrated stock solutions were prepared by dissolving pesticidal active ingredient in 100% dimethylsulfoxide (DMSO), which were then diluted 10-fold in potato dextrose broth (PDB) to give a working stock solution, as described below:</p><p id="p-0130" num="0196">Pyraclostrobin (available from Santa Cruz Biotech, Dallas, Tex., USA, as stock 4 SC-229020): A 0.5 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.05 mg/mL working stock solution, for which an effective solubilized concentration of 0.015 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.015 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0131" num="0197">Azoxystrobin (available from Sigma-Aldrich, St. Louis, Mo., USA, as stock #31697): A 1.75 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.175 mg/mL working stock solution, for which an effective solubilized concentration of 0.15 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.15 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0132" num="0198">Chlorothalonil (available from Chem Service Inc., West Chester, Pa., USA, as stock #N-11454): A 0.5 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.05 mg/mL working stock solution, for which an effective solubilized concentration of 0.002 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.002 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0133" num="0199">Fludioxonil (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China): A 1.05 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.105 mg/mL working stock solution, for which an effective solubilized concentration of 0.021 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.021 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0134" num="0200">Cyprodinil (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China): A 1.37 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.137 mg/mL working stock solution, for which an effective solubilized concentration of 0.009 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.009 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0135" num="0201">Metalaxyl: A 3.32 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.332 mg/mL working stock solution, for which an effective solubilized concentration of 0.316 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.316 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0136" num="0202">Difenoconazole (available from Santa Cruz Biotech, Dallas, Tex., USA, as stock no. SC-204721): A 1.3 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.13 mg/mL working stock solution, for which an effective solubilized concentration of 0.051 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.051 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0137" num="0203">Propiconazole (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China): A 1.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.10 mg/mL working stock solution, for which an effective solubilized concentration of 0.089 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.089 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0138" num="0204">Epoxiconazole (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China): A 2.5 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.25 mg/mL working stock solution, for which an effective solubilized concentration of 0.03 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.025 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0139" num="0205">Tebuconazole (available from Shanghai Terppon Chemical Co. Ltd., of Shanghai, China): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working stock solution, for which an effective solubilized concentration of 0.45 mg/mL was verified using high performance liquid chromatography (HPLC). This 0.45 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in Tables the tables below.</p><p id="p-0140" num="0206">Picoxystrobin (available from Sigma Aldrich, #33658): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working picoxystrobin stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0141" num="0207">Isopyrazam (available from Sigma Aldrich, #32532): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working isopyrazam stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0142" num="0208">Penthiopyrad (available from aksci.com, #X5975): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working penthiopyrad stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0143" num="0209">Oxathiapiprolin (available from carbosynth.com, #FO159014): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working oxathiapiprolin stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0144" num="0210">Prothioconazole (available from Sigma Aldrich, #34232): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working prothioconazole stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0145" num="0211">Trifloxystrobin (available from Sigma Aldrich, #46447): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working trifloxystrobin stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0146" num="0212">Mancozeb (available from Sigma Aldrich, #45553): A 5.0 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg/mL working penthiopyrad stock solution, which was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0147" num="0213">Thyme oil (available from Sigma-Aldrich, St. Louis, Mo., USA as stock #W306509), garlic oil (available from New Directions Aromatics, Missisauga, ON, Canada), lemongrass oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OL123), wintergreen oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OW134), peppermint oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OP1531), spearmint oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #AS132), clove leaf oil (available from New Directions Aromatics, Missisauga, ON, Canada), cinnamon leaf oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OC2131), tea tree oil (available from Newco Natural Technology, Calgary, AB, Canada), geranium oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OW134), peppermint oil (available from Xenex Labs, Coquitlam, BC, Canada as stock #OG1042), rosemary oil (available from Xenex Labs of Coquitlam, BC, Canada as stock #OR131), and oregano oil (available from New Directions Aromatics, Missisauga, ON, Canada): A 100 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 10 mg/mL concentration. This 10 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below. Nootkatone(+) (available from Alfa Aesar, Ward Hill, Mass., USA as stock #A19166): A 10 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 1.0 mg/mL concentration. This 1.0 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in Tables 10-111 below.</p><p id="p-0148" num="0214">Neem oil limonoid extract: An extract of limonoids was prepared from cold-pressed neem oil using solvent extraction with hexane and methanol to prepare a neem oil limonoid extract. A 5 mg/mL stock solution of neem oil limonoid extract in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 0.5 mg/mL concentration. This 0.5 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0149" num="0215">Fortune Aza Technical: Fortune Aza Technical&#x2122; pesticide containing 14% azadirachtin (extracted from neem seed/kernel source) was obtained from Fortune Biotech Ltd. of Secunderabad, India. A 5 mg/mL stock solution of Fortune Aza Technical in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 0.5 mg/mL concentration. This 0.5 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0150" num="0216">Karanja oil flavonoid extract: An extract of flavonoids was prepared from cold-pressed karanja oil by solvent extraction. A 5 mg/mL stock solution of karanja oil flavonoid extract in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 0.5 mg/mL concentration. This 0.5 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0151" num="0217">Salannin: Salannin was extracted and purified from cold-pressed neem oil by solvent extraction. A 1 mg/mL stock solution of salannin in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 0.1 mg/mL concentration. This 0.1 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0152" num="0218">Compound B Unsaturated Aliphatic Acids:</p><p id="p-0153" num="0219">Concentrated stock solutions were prepared by dissolving each exemplary unsaturated aliphatic acid in 100% dimethylsulfoxide (DMSO), which were then diluted 10-fold in potato dextrose broth (PDB) to give a working stock solution, as described below:</p><p id="p-0154" num="0220">Trans-2-hexenoic acid, trans-3-hexenoic acid, cis-3-hexenoic acid, 5-hexenoic acid, 3-heptenoic acid, trans-2-octenoic acid, trans-3-octenoic acid, 3-octenoic acid, 7-octenoic acid, 3-decenoic acid, cis-3-decenoic acid, 9-decenoic acid, trans-2-nonenoic acid, 3-nonenoic acid, (9Z)-octadecenoic acid (oleic acid) (all available from Sigma-Aldrich, St. Louis, Mo., USA), trans-2-decenoic acid (available from TCI America, Portland, Oreg., USA as stock #D0098), cis-2-decenoic acid (available from BOC Sciences, Sirley, N.Y., USA), and trans-2-undecenoic acid (available from Alfa Aesar, Ward Hill, Mass., USA as stock #L-11579): A 50 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 5 mg/mL concentration. This 5 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0155" num="0221">(2E,4E)-2,4-hexadienoic acid (available from Sigma-Aldrich, St. Louis, Mo., USA): A 20 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 2 mg/mL concentration. This 2 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in the tables below.</p><p id="p-0156" num="0222">Compound B Saturated Aliphatic Acids:</p><p id="p-0157" num="0223">Concentrated stock solutions were prepared by dissolving each exemplary saturated aliphatic acid in 100% dimethylsulfoxide (DMSO), which were then diluted 10-fold in potato dextrose broth (PDB) to give a working stock solution, as described below:</p><p id="p-0158" num="0224">Hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid (all available from Sigma-Aldrich, St. Louis, Mo., USA): A 50 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 5 mg/mL concentration. This 5 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in data Tables below.</p><p id="p-0159" num="0225">Decenoic acid (available from Sigma-Aldrich, St. Louis, Mo., USA): A 10 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 1 mg/mL concentration. This 1 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in data Tables below.</p><p id="p-0160" num="0226">Dodecenoic acid (available from Sigma-Aldrich, St. Louis, Mo., USA): A 1 mg/mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution of 0.1 mg/mL concentration. This 0.1 mg/mL effective concentration working stock solution was used for further serial dilution in PDB to the required individual concentrations as specified in data Tables below.</p><p id="p-0161" num="0227">Exemplary Hydroxy-substituted aliphatic acids: 2- and 3-hydroxybutyric acid, 2-hydroxyhexanoic acid, 12-hydroxydodecanoic acid (all available from Sigma-Aldrich, St. Louis, Mo., USA); 3-hydroxydecanoic acid, 3-hydroxyhexanoic acid (both available from Shanghai Terppon Chemical, Shanghai, China); 3-, 8-, 10-hydroxyoctanoic acid (all available from AA Blocks LLC, San Diego, Calif., USA), 2-hydroxyoctanoic acid (available from Alfa Aesar, Ward Hill, Mass., USA): a stock solution was prepared for each by dissolving each acid in 100% DMSO, which was then diluted in PDB to 10% DMSO concentration, before further serial dilution in PDB to the required individual concentrations as specified in the data Tables below.</p><p id="p-0162" num="0228">Exemplary alkyl-substituted aliphatic acids: 2-ethylhexanoic acid, 2-methyloctanoic acid, 3-methylnonanoic acid, 3-methylbutyric acid (all available from Sigma-Aldrich, St. Louis, Mo., USA); 2,2-diethylbutyric acid, 2- and 4-methylhexanoic acid, 2-methyldecanoic acid (all available from AA Blocks LLC, San Diego, Calif., USA); 3-methylhexanoic acid (available from 1 ClickChemistry Inc., Kendall Park, N.J., USA): a stock solution was prepared for each by dissolving each acid in 100% DMSO, which was then diluted in PDB to 10% DMSO concentration, before further serial dilution in PDB to the required individual concentrations as specified in the data Tables below.</p><p id="p-0163" num="0229">Exemplary amino-substituted aliphatic acid: 3-aminobutyric acid (available from AK Scientific Inc., Union City, Calif., USA): a stock solution was prepared by dissolving each acid in 100% DMSO, which was then diluted in PDB to 10% DMSO concentration, before further serial dilution in PDB to the required individual concentrations as specified in the data Tables below.</p><p id="p-0164" num="0230">The working stock solutions for each Compound A and Compound B component were then serially diluted to test the individual MIC of each pesticidal active ingredient (as Compound A), each unsaturated or saturated aliphatic acid (as Compound B), and the combined MIC of each combination of Compound A and Compound B, according to the synergistic growth inhibition assay described above.</p><heading id="h-0018" level="1">Example 8: Growth Inhibition of <i>Fusarium oxysporum </i>by Pyraclostrobin, Azoxystrobin, Chlorothalonil, Fluidioxonil, Cyprodinil, Difenoconazole, and Tebuconazole, in Combination with Various Exemplary Saturated Aliphatic Acids</heading><p id="p-0165" num="0231">Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, fluidioxonil, cyprodinil, difenoconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 10-15 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, and decanoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 10-15 below.</p><p id="p-0166" num="0232">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 10-15 below.</p><p id="p-0167" num="0000"><tables id="TABLE-US-00010" num="00010"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 10</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by pyraclostrobin,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>3-Hydroxybutyric acid</entry><entry/><entry>10</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.25</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>Hexanoic acid</entry><entry>0.00187</entry><entry>0.019531</entry><entry>10</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Heptanoic acid</entry><entry>0.00375</entry><entry>0.039062</entry><entry>10</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Octanoic acid</entry><entry>0.00187</entry><entry>0.039062</entry><entry>21</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>Nonanoic acid</entry><entry>0.00375</entry><entry>0.039062</entry><entry>10</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>Decanoic acid</entry><entry>0.00375</entry><entry>0.015625</entry><entry>4</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Dodecanoic acid</entry><entry>0.00375</entry><entry>0.025</entry><entry>7</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxybutyric acid</entry><entry>0.00375</entry><entry>2.5</entry><entry>667</entry><entry>0.50</entry></row><row><entry>8</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.00187</entry><entry>0.015625</entry><entry>8</entry><entry>0.25</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0168" num="0000"><tables id="TABLE-US-00011" num="00011"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 11</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by azoxystrobin, in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.075</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.07812</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Hexanoic acid</entry><entry>0.01875</entry><entry>0.039062</entry><entry>2</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>Heptanoic acid</entry><entry>0.01875</entry><entry>0.039062</entry><entry>2</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>Octanoic acid</entry><entry>0.01875</entry><entry>0.039062</entry><entry>2</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>Nonanoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>Dodecanoic acid</entry><entry>0.01875</entry><entry>0.025</entry><entry>1.3</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0169" num="0000"><tables id="TABLE-US-00012" num="00012"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 12</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by chlorothalonil,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="63pt" align="left"/><colspec colname="4" colwidth="56pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="63pt" align="left"/><colspec colname="4" colwidth="56pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Chlorothalonil</entry><entry/><entry>0.000125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>1</entry><entry>Chlorothalonil</entry><entry>Heptanoic acid</entry><entry>6.25 &#xd7; 10&#x2212;5</entry><entry>0.039062</entry><entry>625</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Chlorothalonil</entry><entry>Octanoic acid</entry><entry>6.25 &#xd7; 10&#x2212;5</entry><entry>0.039062</entry><entry>625</entry><entry>0.63</entry></row><row><entry>3</entry><entry>Chlorothalonil</entry><entry>Nonanoic acid</entry><entry>6.25 &#xd7; 10&#x2212;5</entry><entry>0.019531</entry><entry>313</entry><entry>0.56</entry></row><row><entry>4</entry><entry>Chlorothalonil</entry><entry>Dodecanoic acid</entry><entry>6.25 &#xd7; 10&#x2212;5</entry><entry>0.025</entry><entry>400</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Chlorothalonil</entry><entry>3-Hydroxydecanoic</entry><entry>1.9531 &#xd7; 10<sup>&#x2212;6</sup>&#x2003;&#x2009;</entry><entry>0.003125</entry><entry>16000</entry><entry>0.19</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0170" num="0000"><tables id="TABLE-US-00013" num="00013"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 13</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil and cyprodinil,</entry></row><row><entry>in combination with an exemplary saturated aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>0.021</entry><entry/><entry/><entry/></row><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.009</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.25</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>Dodecanoic acid</entry><entry>0.00525</entry><entry>0.025</entry><entry>5</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.00131</entry><entry>0.03125</entry><entry>24</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Cyprodinil</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.00225</entry><entry>0.03125</entry><entry>14</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0171" num="0000"><tables id="TABLE-US-00014" num="00014"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="287pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 14</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by difenoconazole,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Difenoconazole</entry><entry>Heptanoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>Octanoic acid</entry><entry>0.01275</entry><entry>0.078125</entry><entry>6</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0172" num="0000"><tables id="TABLE-US-00015" num="00015"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 15A</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by tebuconazole, in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.255</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>Heptanoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>Octanoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>Nonanoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>Decanoic acid</entry><entry>0.05625</entry><entry>0.007812</entry><entry>0.14</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>Dodecanoic acid</entry><entry>0.05625</entry><entry>0.0025</entry><entry>0.4</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0173" num="0000"><tables id="TABLE-US-00016" num="00016"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 15B</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by various synthetic fungicides</entry></row><row><entry>in combination with saturated 3-hydroxy aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>0.021</entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.225</entry></row><row><entry/><entry/><entry>3-Hydroxybuturic acid</entry><entry/><entry>10</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.25</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxybuturic acid</entry><entry>0.001875</entry><entry>2.5</entry><entry>1333</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>3-Hydroxybuturic acid</entry><entry>0.0375</entry><entry>2.5</entry><entry>67</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.0375</entry><entry>0.625</entry><entry>17</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>3-Hydroxybuturic acid</entry><entry>0.00525</entry><entry>2.5</entry><entry>476</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.01275</entry><entry>2.5</entry><entry>196</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.05625</entry><entry>2.5</entry><entry>44</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.05625</entry><entry>0.0625</entry><entry>1.1</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0019" level="1">Example 9: Growth Inhibition of Sclerotinta <i>Sclerotiorum </i>by Pyraclostrobin, Azoxystrobin, Propiconazole, Epiconazole, Tebuconazole, and Difenoconazole, in Combination with Various Exemplary Saturated Aliphatic Acids</heading><p id="p-0174" num="0233">Working solutions of pyraclostrobin, azoxystrobin, propiconazole, epiconazole, tebuconazole, and difenoconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 16-20 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 16-20 below.</p><p id="p-0175" num="0234">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 16-20 below.</p><p id="p-0176" num="0000"><tables id="TABLE-US-00017" num="00017"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 16</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by pyraclostrobin,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>Hexanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.009765</entry><entry>10</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Heptanoic acid</entry><entry>4.688 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.004883</entry><entry>10</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Octanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.004883</entry><entry>5</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>Nonanoic acid</entry><entry>4.688 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.004883</entry><entry>10</entry><entry>0.31</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>Decanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.001953</entry><entry>2</entry><entry>0.14</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Dodecanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.00625</entry><entry>7</entry><entry>0.25</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0177" num="0000"><tables id="TABLE-US-00018" num="00018"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 17</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by azoxystrobin,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Hexanoic acid</entry><entry>0.0375</entry><entry>0.019531</entry><entry>0.52</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>Heptanoic acid</entry><entry>0.0375</entry><entry>0.009766</entry><entry>0.26</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>Octanoic acid</entry><entry>0.01875</entry><entry>0.004883</entry><entry>0.26</entry><entry>0.25</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>Nonanoic acid</entry><entry>0.01875</entry><entry>0.004883</entry><entry>0.26</entry><entry>0.19</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>Decanoic acid</entry><entry>0.0375</entry><entry>0.003906</entry><entry>0.10</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Azoxystrobin</entry><entry>Dodecanoic acid</entry><entry>0.009375</entry><entry>0.003125</entry><entry>0.33</entry><entry>0.13</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0178" num="0000"><tables id="TABLE-US-00019" num="00019"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 18</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by propiconazole,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Propiconazole</entry><entry/><entry>0.089</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Propiconazole</entry><entry>Decanoic acid</entry><entry>0.0445</entry><entry>0.0078125</entry><entry>0.18</entry><entry>0.60</entry></row><row><entry>2</entry><entry>Propiconazole</entry><entry>Dodecanoic acid</entry><entry>0.0223</entry><entry>0.0125</entry><entry>0.56</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0179" num="0000"><tables id="TABLE-US-00020" num="00020"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 19</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by epiconzaole and tebuconazole,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry><entry/><entry/><entry/></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.225</entry></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.0390625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Epoxiconazole</entry><entry>Heptanoic acid</entry><entry>0.0075</entry><entry>0.009765</entry><entry>1.3</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Epoxiconazole</entry><entry>Octanoic acid</entry><entry>0.00375</entry><entry>0.004883</entry><entry>1.3</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Epoxiconazole</entry><entry>Decanoic acid</entry><entry>0.0075</entry><entry>0.003906</entry><entry>0.5</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Epoxiconazole</entry><entry>Dodecanoic acid</entry><entry>0.00375</entry><entry>0.00625</entry><entry>1.7</entry><entry>0.19</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>Hexanoic acid</entry><entry>0.028125</entry><entry>0.009765</entry><entry>0.35</entry><entry>0.25</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>Heptanoic acid</entry><entry>0.028125</entry><entry>0.004883</entry><entry>0.17</entry><entry>0.25</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>Octanoic acid</entry><entry>0.0028125</entry><entry>0.004883</entry><entry>0.17</entry><entry>0.19</entry></row><row><entry>8</entry><entry>Tebuconazole</entry><entry>Nonanoic acid</entry><entry>0.028125</entry><entry>0.004883</entry><entry>0.17</entry><entry>0.19</entry></row><row><entry>9</entry><entry>Tebuconazole</entry><entry>Decanoic acid</entry><entry>0.05625</entry><entry>0.003906</entry><entry>0.07</entry><entry>0.38</entry></row><row><entry>10</entry><entry>Tebuconazole</entry><entry>Dodecanoic acid</entry><entry>0.028125</entry><entry>0.00625</entry><entry>0.22</entry><entry>0.19</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0180" num="0000"><tables id="TABLE-US-00021" num="00021"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 20A</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by difenoconazole,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.01275</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.015615</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.025</entry></row><row><entry>1</entry><entry>Difenoconazole</entry><entry>Nonanoic acid</entry><entry>0.006375</entry><entry>0.009766</entry><entry>1.5</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>Decanoic acid</entry><entry>0.006375</entry><entry>0.003906</entry><entry>0.6</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>Dodecanoic acid</entry><entry>0.003188</entry><entry>0.00625</entry><entry>2.0</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0181" num="0000"><tables id="TABLE-US-00022" num="00022"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 20B</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various fungicides,</entry></row><row><entry>in combination with various exemplary saturated hydroxy aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.00375</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxyst robin</entry><entry/><entry>0.075</entry></row><row><entry/><entry>Chlorothalonil</entry><entry/><entry>3.125 &#xd7; 10<sup>&#x2212;5</sup></entry></row><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.009</entry></row><row><entry/><entry>Metalaxyl</entry><entry/><entry>1.261</entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.0255</entry></row><row><entry/><entry>Propiconazole</entry><entry/><entry>0.089</entry></row><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.05625</entry></row><row><entry/><entry/><entry>3-Hydroxybuturic acid</entry><entry/><entry>5.0</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.0625</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxybuturic acid</entry><entry>0.0009375</entry><entry>1.25</entry><entry>1333</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.0009375</entry><entry>0.625</entry><entry>667</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.0009375</entry><entry>0.015625</entry><entry>17</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.01875</entry><entry>0.625</entry><entry>33</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Chlorothalonil</entry><entry>3-Hydroxyhexanoic acid</entry><entry>7.813 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>1.25</entry><entry>160000</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Cyprodinil</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.00225</entry><entry>1.25</entry><entry>556</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Metalaxyl</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.31525</entry><entry>1.25</entry><entry>4</entry><entry>0.75</entry></row><row><entry>8</entry><entry>Difenoconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.006375</entry><entry>2.5</entry><entry>392</entry><entry>0.75</entry></row><row><entry>9</entry><entry>Difenoconazole</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.006375</entry><entry>1.25</entry><entry>196</entry><entry>0.75</entry></row><row><entry>10</entry><entry>Propiconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.02225</entry><entry>2.5</entry><entry>112</entry><entry>0.75</entry></row><row><entry>11</entry><entry>Propiconazole</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.02225</entry><entry>1.25</entry><entry>56</entry><entry>0.75</entry></row><row><entry>12</entry><entry>Epoxiconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.001875</entry><entry>0.625</entry><entry>333</entry><entry>0.19</entry></row><row><entry>13</entry><entry>Epoxiconazole</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.00375</entry><entry>0.625</entry><entry>167</entry><entry>0.38</entry></row><row><entry>14</entry><entry>Tebuconazole</entry><entry>3-Hydroxybuturic acid</entry><entry>0.014062</entry><entry>1.25</entry><entry>89</entry><entry>0.50</entry></row><row><entry>15</entry><entry>Tebuconazole</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.014062</entry><entry>0.625</entry><entry>44</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0020" level="1">Example 10: Growth Inhibition of <i>Botrytis cinerea </i>by Pyraclostrobin, Azoxystrobin, Cyprodinil, Metalaxyl, Epiconazole, Tebuconazole, Propiconazole, and Difenoconazole, in Combination with Various Exemplary Saturated Aliphatic Acids</heading><p id="p-0182" num="0235">Working solutions of pyraclostrobin, azoxystrobin, cyprodiil, metalaxyl, epiconazole, tebuconazole, propiconazole, and difenoconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 21-26 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 21-26 below. Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 21-26 below.</p><p id="p-0183" num="0000"><tables id="TABLE-US-00023" num="00023"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 21</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by pyraclostrobin, in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0019</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.025</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>Hexanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.009766</entry><entry>10</entry><entry>0.63</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Heptanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.004883</entry><entry>5</entry><entry>0.56</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Octanoic acid</entry><entry>4.688 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.002441</entry><entry>5</entry><entry>0.28</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>Nonanoic acid</entry><entry>4.688 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.002441</entry><entry>5</entry><entry>0.28</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>Decanoic acid</entry><entry>2.344 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.001953</entry><entry>8</entry><entry>0.19</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Dodecanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.003125</entry><entry>3</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0184" num="0000"><tables id="TABLE-US-00024" num="00024"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="287pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 22</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by azoxystrobin, in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.0375</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Hexanoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>Heptanoic acid</entry><entry>0.01875</entry><entry>0.009765</entry><entry>0.5</entry><entry>0.63</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>Octanoic acid</entry><entry>0.01875</entry><entry>0.009765</entry><entry>0.5</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>Nonanoic acid</entry><entry>0.01875</entry><entry>0.009765</entry><entry>0.5</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>Decanoic acid</entry><entry>0.009375</entry><entry>0.078125</entry><entry>0.8</entry><entry>0.35</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0185" num="0000"><tables id="TABLE-US-00025" num="00025"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 23</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by pyraclostrobin, cyprodinil,</entry></row><row><entry>metalaxyl, azoxystrobin, epoxiconazole, and tebuconazole, in combination</entry></row><row><entry>with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="49pt" align="left"/><colspec colname="4" colwidth="42pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.00375</entry><entry/><entry/><entry/></row><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.0045</entry></row><row><entry/><entry>Metalaxyl</entry><entry/><entry>0.316</entry></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.075</entry></row><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry>0.03125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>Decanoic acid</entry><entry>2.344 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.001953</entry><entry>8</entry><entry>0.13</entry></row><row><entry>3</entry><entry>Cyprodinil</entry><entry>Decanoic acid</entry><entry>5.625 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.03125</entry><entry>28</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Metalaxyl</entry><entry>Decanoic acid</entry><entry>0.0395</entry><entry>0.015625</entry><entry>0.4</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>Decanoic acid</entry><entry>0.009375</entry><entry>0.0078125</entry><entry>0.8</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Epoxiconazole</entry><entry>Decanoic acid</entry><entry>0.00375</entry><entry>0.015625</entry><entry>4</entry><entry>0.63</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>Decanoic acid</entry><entry>0.014062</entry><entry>0.0078125</entry><entry>0.6</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0186" num="0000"><tables id="TABLE-US-00026" num="00026"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 24</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by difenoconazole and propiconazole,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry><entry/><entry/><entry/></row><row><entry/><entry>Propiconazole</entry><entry/><entry>0.089</entry></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Difenoconazole</entry><entry>Hexanoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3.1</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>Heptanoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>1.5</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Difenoconazole</entry><entry>Octanoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>1.5</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>Nonanoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>1.5</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>Decanoic acid</entry><entry>0.006275</entry><entry>0.015625</entry><entry>2.5</entry><entry>0.18</entry></row><row><entry>6</entry><entry>Difenoconazole</entry><entry>Dodecanoic acid</entry><entry>0.01275</entry><entry>0.0125</entry><entry>1.0</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Propiconazole</entry><entry>Decanoic acid</entry><entry>0.011125</entry><entry>0.015625</entry><entry>1.4</entry><entry>0.18</entry></row><row><entry>8</entry><entry>Propiconazole</entry><entry>Dodecanoic acid</entry><entry>0.02225</entry><entry>0.0125</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0187" num="0000"><tables id="TABLE-US-00027" num="00027"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 25</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by tebuconazole, in</entry></row><row><entry>combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.015625</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>Hexanoic acid</entry><entry>0.014062</entry><entry>0.009766</entry><entry>0.7</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>Heptanoic acid</entry><entry>0.014062</entry><entry>0.004883</entry><entry>0.3</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>Octanoic acid</entry><entry>0.014062</entry><entry>0.004883</entry><entry>0.3</entry><entry>0.19</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>Nonanoic acid</entry><entry>0.014062</entry><entry>0.004883</entry><entry>0.3</entry><entry>0.19</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>Decanoic acid</entry><entry>0.007031</entry><entry>0.003906</entry><entry>0.6</entry><entry>0.31</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>Dodecanoic acid</entry><entry>0.014062</entry><entry>0.003125</entry><entry>0.2</entry><entry>0.19</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0188" num="0000"><tables id="TABLE-US-00028" num="00028"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 26</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by cyprodinil and metalaxyl,</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.0045</entry><entry/><entry/><entry/></row><row><entry/><entry>Metalaxyl</entry><entry/><entry>0.316</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry>1</entry><entry>Cyprodinil</entry><entry>Decanoic acid</entry><entry>0.001125</entry><entry>0.03125</entry><entry>28</entry><entry>0.65</entry></row><row><entry>2</entry><entry>Metalaxyl</entry><entry>Octanoic acid</entry><entry>0.01975</entry><entry>0.004883</entry><entry>0.25</entry><entry>0.13</entry></row><row><entry>3</entry><entry>Metalaxyl</entry><entry>Decanoic acid</entry><entry>0.0395</entry><entry>0.015625</entry><entry>0.4</entry><entry>0.33</entry></row><row><entry>4</entry><entry>Metalaxyl</entry><entry>Dodecanoic acid</entry><entry>0.079</entry><entry>0.0125</entry><entry>0.16</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0021" level="1">Example 11: Growth Inhibition of <i>Fusarium oxysporum </i>by Pyraclostrobin, Azoxystrobin, Fludioxonil, Cyprodinil, Difenoconazole, Epoxiconazole, and Tebuconazole, in Combination with Various Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0189" num="0236">Working solutions of pyraclostrobin, azoxystrobin, fludioxonil, cyprodinil, difenoconazole, epoxiconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 27-32 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-3-hexenoic acid, 4-hexenoic acid, 5-hexenoic acid, 3-heptenoic acid, trans-2-octenoic acid, trans-3-octenoic acid, 7-octenoic acid, 3-decenoic acid, 9-decenoic acid, trans-2-nonenoic acid, 3-nonenoic acid, trans-2-decenoic acid, and trans-2-undecenoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 27-32 below.</p><p id="p-0190" num="0237">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 27-32 below.</p><p id="p-0191" num="0000"><tables id="TABLE-US-00029" num="00029"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 27</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by pyraclostrobin, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.025</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>4-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.00375</entry><entry>0.0625</entry><entry>17</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.001875</entry><entry>0.078125</entry><entry>42</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>4-Hexenoic acid</entry><entry>0.00375</entry><entry>0.15625</entry><entry>42</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>5-Hexenoic acid</entry><entry>0.00375</entry><entry>0.039062</entry><entry>10</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>3-Heptenoic acid</entry><entry>0.001875</entry><entry>0.078125</entry><entry>42</entry><entry>0.63</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>10</entry><entry>0.19</entry></row><row><entry>7</entry><entry>Pyraclostrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>10</entry><entry>0.25</entry></row><row><entry>8</entry><entry>Pyraclostrobin</entry><entry>7-Octenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>10</entry><entry>0.19</entry></row><row><entry>9</entry><entry>Pyraclostrobin</entry><entry>3-Decenoic acid</entry><entry>0.00375</entry><entry>0.078125</entry><entry>21</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Pyraclostrobin</entry><entry>9-Decenoic acid</entry><entry>0.00375</entry><entry>0.039062</entry><entry>10</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0192" num="0000"><tables id="TABLE-US-00030" num="00030"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 28</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by azoxystrobin, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.0375</entry><entry>0.078125</entry><entry>2</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>3-Heptenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>1</entry><entry>0.25</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.0375</entry><entry>0.039062</entry><entry>1</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>1</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>9-Decenoic acid</entry><entry>0.00375</entry><entry>0.039062</entry><entry>1</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0193" num="0000"><tables id="TABLE-US-00031" num="00031"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 29</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by fludioxonil and cyprodinil,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>0.021</entry><entry/><entry/><entry/></row><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.009</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>3-Heptenoic acid</entry><entry>0.00525</entry><entry>0.03906</entry><entry>7</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>3-Decenoic acid</entry><entry>0.00525</entry><entry>0.03906</entry><entry>7</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Cyprodinil</entry><entry>3-Decenoic acid</entry><entry>0.00225</entry><entry>0.019531</entry><entry>9</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0194" num="0000"><tables id="TABLE-US-00032" num="00032"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 30</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by difenoconazole, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>4-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Difenoconazole</entry><entry>Trans-3-hexenoic acid</entry><entry>0.006375</entry><entry>0.078125</entry><entry>12</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>4-Hexenoic acid</entry><entry>0.01275</entry><entry>0.15625</entry><entry>12</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Difenoconazole</entry><entry>3-Heptenoic acid</entry><entry>0.006375</entry><entry>0.078125</entry><entry>12</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>3-Octenoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>1.5</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Difenoconazole</entry><entry>Trans-3-octenoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Difenoconazole</entry><entry>7-Octenoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.50</entry></row><row><entry>8</entry><entry>Difenoconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.38</entry></row><row><entry>9</entry><entry>Difenoconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>1.5</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Difenoconazole</entry><entry>9-Decenoic acid</entry><entry>0.01275</entry><entry>0.039062</entry><entry>3</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0195" num="0000"><tables id="TABLE-US-00033" num="00033"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 31</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by epoxiconazole, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Epoxiconazole</entry><entry>Trans-3-hexenoic acid</entry><entry>0.0075</entry><entry>0.078125</entry><entry>10</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Epoxiconazole</entry><entry>3-Heptenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Epoxiconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Epoxiconazole</entry><entry>3-Octenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Epoxiconazole</entry><entry>3-Decenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0196" num="0000"><tables id="TABLE-US-00034" num="00034"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 32</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by tebuconazole, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.225</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>3-Octenoic acid</entry><entry>0.05625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>Trans-3-octenoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>7-Octenoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.028125</entry><entry>0.019531</entry><entry>0.7</entry><entry>0.19</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>3-Nonenoic acid</entry><entry>0.05625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.05625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>8</entry><entry>Tebuconazole</entry><entry>9-Decenoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.75</entry></row><row><entry>9</entry><entry>Tebuconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.05625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0022" level="1">Example 12: Growth Inhibition of <i>Sclerotinia sclerotiorum </i>by Pyraclostrobin, Azoxystrobin, Chlorothalonil, Fludioxonil, Difenoconazole, Propiconazole, Epoxiconazole, and Tebuconazole, in Combination with Various Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0197" num="0238">Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, difenoconazole, propiconazole, epoxiconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 33-42 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 5-hexenoic acid, 3-heptenoic acid, trans-2-octenoic acid, trans-3-octenoic acid, 3-octenoic acid, 7-octenoic acid, 3-decenoic acid, cis-3-hexenoic acid, 9-decenoic acid, trans-2-nonenoic acid, 3-nonenoic acid, (9Z)-octadecenoic acid, trans-2-decenoic acid, cis-2-decenoic acid, and trans-2-undecenoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 33-42 below.</p><p id="p-0198" num="0239">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 33-42 below.</p><p id="p-0199" num="0000"><tables id="TABLE-US-00035" num="00035"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="329pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 33</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by pyraclostrobin,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="91pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="91pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>(9Z)-octadecenoic acid</entry><entry/><entry>5.0</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic acid</entry><entry>0.001875</entry><entry>0.015625</entry><entry>8</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Trans-2-hexenoic acid</entry><entry>0.000937</entry><entry>0.009765</entry><entry>10</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.000937</entry><entry>0.019531</entry><entry>21</entry><entry>0.25</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>5-Hexenoic acid</entry><entry>0.000937</entry><entry>0.019531</entry><entry>21</entry><entry>0.25</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>3-Heptenoic acid</entry><entry>0.000937</entry><entry>0.009766</entry><entry>10</entry><entry>0.25</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.19</entry></row><row><entry>7</entry><entry>Pyraclostrobin</entry><entry>3-Octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.13</entry></row><row><entry>8</entry><entry>Pyraclostrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.19</entry></row><row><entry>9</entry><entry>Pyraclostrobin</entry><entry>7-Octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.19</entry></row><row><entry>10</entry><entry>Pyraclostrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>11</entry><entry>Pyraclostrobin</entry><entry>3-Nonenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>12</entry><entry>Pyraclostrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.000937</entry><entry>0.002441</entry><entry>3</entry><entry>0.25</entry></row><row><entry>13</entry><entry>Pyraclostrobin</entry><entry>3-Decenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.09</entry></row><row><entry>14</entry><entry>Pyraclostrobin</entry><entry>9-Decenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.19</entry></row><row><entry>15</entry><entry>Pyraclostrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>16</entry><entry>Pyraclostrobin</entry><entry>(9Z)-octadecenoic acid</entry><entry>0.00375</entry><entry>2.5</entry><entry>667</entry><entry>1.00</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0200" num="0000"><tables id="TABLE-US-00036" num="00036"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 34</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by pyraclostrobin,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.00375</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Cis-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Cis-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.001875</entry><entry>0.039062</entry><entry>21</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Cis-3-hexenoic acid</entry><entry>0.001875</entry><entry>0.039062</entry><entry>21</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.0009375</entry><entry>0.002441</entry><entry>3</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>Cis-2-decenoic acid</entry><entry>0.0009375</entry><entry>0.002441</entry><entry>3</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0201" num="0000"><tables id="TABLE-US-00037" num="00037"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 35</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by azoxystrobin,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.009766</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.0375</entry><entry>0.039062</entry><entry>1</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>5-Hexenoic acid</entry><entry>0.0375</entry><entry>0.039062</entry><entry>1</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>3-Heptenoic acid</entry><entry>0.0375</entry><entry>0.019531</entry><entry>0.5</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>3-Octenoic acid</entry><entry>0.0375</entry><entry>0.019531</entry><entry>0.5</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.01875</entry><entry>0.009766</entry><entry>0.5</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Azoxystrobin</entry><entry>3-Nonenoic acid</entry><entry>0.0375</entry><entry>0.019531</entry><entry>0.5</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Azoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.0375</entry><entry>0.004882</entry><entry>0.1</entry><entry>0.75</entry></row><row><entry>8</entry><entry>Azoxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.01875</entry><entry>0.009766</entry><entry>0.5</entry><entry>0.38</entry></row><row><entry>9</entry><entry>Azoxystrobin</entry><entry>9-Decenoic acid</entry><entry>0.01875</entry><entry>0.009766</entry><entry>0.5</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0202" num="0000"><tables id="TABLE-US-00038" num="00038"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 36</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by chlorothalonil,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Chlorothalonil</entry><entry/><entry>3.125 &#xd7; 10<sup>&#x2212;5</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Chlorothalonil</entry><entry>Trans-2-nonenoic acid</entry><entry>3.906 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>0.009766</entry><entry>2500</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Chlorothalonil</entry><entry>3-Nonenoic acid</entry><entry>7.813 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>0.019531</entry><entry>2500</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Chlorothalonil</entry><entry>9-Decenoic acid</entry><entry>7.813 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>0.019531</entry><entry>2500</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0203" num="0000"><tables id="TABLE-US-00039" num="00039"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 37</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by fludioxonil,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Fludioxonil</entry><entry/><entry>0.000164</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Fludioxonil</entry><entry>Trans-2-octenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.019531</entry><entry>238</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>3-Octenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.019531</entry><entry>238</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>Trans-2-nonenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.009766</entry><entry>119</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>3-Nonenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.009766</entry><entry>119</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>Trans-2-decenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.009766</entry><entry>119</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Fludioxonil</entry><entry>9-Decenoic acid</entry><entry>8.203 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.019531</entry><entry>238</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0204" num="0000"><tables id="TABLE-US-00040" num="00040"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 38</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by difenoconazole,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.0255</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>3-decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Difenoconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.006375</entry><entry>0.019531</entry><entry>3.1</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.006375</entry><entry>0.009766</entry><entry>1.5</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Difenoconazole</entry><entry>3-Nonenoic acid</entry><entry>0.006375</entry><entry>0.009766</entry><entry>1.5</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.006375</entry><entry>0.009766</entry><entry>1.5</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>3-Decenoic acid</entry><entry>0.006375</entry><entry>0.019531</entry><entry>3.1</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Difenoconazole</entry><entry>9-Decenoic acid</entry><entry>0.006375</entry><entry>0.019531</entry><entry>3.1</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Difenoconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.006375</entry><entry>0.009766</entry><entry>1.5</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0205" num="0000"><tables id="TABLE-US-00041" num="00041"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 39</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by propiconazole,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Propiconazole</entry><entry/><entry>0.089</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Propiconazole</entry><entry>3-Heptenoic acid</entry><entry>0.02225</entry><entry>0.019531</entry><entry>0.9</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Propiconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.02225</entry><entry>0.009766</entry><entry>0.4</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Propiconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.02225</entry><entry>0.009766</entry><entry>0.4</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Propiconazole</entry><entry>9-Decenoic acid</entry><entry>0.02225</entry><entry>0.009766</entry><entry>0.9</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Propiconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.02225</entry><entry>0.009766</entry><entry>0.4</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0206" num="0000"><tables id="TABLE-US-00042" num="00042"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 40</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by epoxiconazole,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Epoxiconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.0075</entry><entry>0.009766</entry><entry>1.3</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Epoxiconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.0075</entry><entry>0.009766</entry><entry>1.3</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Epoxiconazole</entry><entry>3-Decenoic acid</entry><entry>0.0075</entry><entry>0.019531</entry><entry>2.6</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Epoxiconazole</entry><entry>9-Decenoic acid</entry><entry>0.0075</entry><entry>0.019531</entry><entry>2.6</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0207" num="0000"><tables id="TABLE-US-00043" num="00043"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 41</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by tebuconazole,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>Trans-3-hexenoic acid</entry><entry>0.05625</entry><entry>0.039062</entry><entry>0.7</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>3-Heptenoic acid</entry><entry>0.05625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.028125</entry><entry>0.004882</entry><entry>0.2</entry><entry>0.38</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>3-Nonenoic acid</entry><entry>0.05625</entry><entry>0.009766</entry><entry>0.2</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>3-Decenoic acid</entry><entry>0.028125</entry><entry>0.009766</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>9-Decenoic acid</entry><entry>0.028125</entry><entry>0.009766</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.05625</entry><entry>0.009766</entry><entry>0.2</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0208" num="0000"><tables id="TABLE-US-00044" num="00044"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 42</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by tebuconazole,</entry></row><row><entry>in combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-octanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>Trans-3-octanoic acid</entry><entry>0.028125</entry><entry>0.019531</entry><entry>0.7</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.028125</entry><entry>0.004882</entry><entry>0.2</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0023" level="1">Example 13: Growth Inhibition of <i>Botrytis cinerea </i>by Pyraclostrobin, Azoxystrobin, Chlorothalonil, Cyprodinil, Metalaxyl, Epoxiconazole, and Tebuconazole, in Combination with Various Exemplary Unsaturated Aliphatic Acids</heading><p id="p-0209" num="0240">Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxiconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 43-50 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 5-hexenoic acid, 3-heptenoic acid, trans-2-octenoic acid, trans-3-octenoic acid, 3-octenoic acid, 7-octenoic acid, 3-decenoic acid, 9-decenoic acid, trans-2-nonenoic acid, 3-nonenoic acid, (9Z)-octadecenoic acid, trans-2-decenoic acid, and trans-2-undecenoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 43-50 below.</p><p id="p-0210" num="0241">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 43-50 below.</p><p id="p-0211" num="0000"><tables id="TABLE-US-00045" num="00045"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 43</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by pyraclostrobin, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.001875</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.0625</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>4-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.000469</entry><entry>0.007812</entry><entry>17</entry><entry>0.38</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Trans-2-hexenoic acid</entry><entry>0.000937</entry><entry>0.009766</entry><entry>10</entry><entry>0.63</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.000469</entry><entry>0.009766</entry><entry>21</entry><entry>0.31</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>4-Hexenoic acid</entry><entry>0.000937</entry><entry>0.019531</entry><entry>21</entry><entry>0.56</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>5-Hexenoic acid</entry><entry>0.000469</entry><entry>0.009766</entry><entry>21</entry><entry>0.31</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>3-Heptenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>7</entry><entry>Pyraclostrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.19</entry></row><row><entry>8</entry><entry>Pyraclostrobin</entry><entry>3-Octenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.16</entry></row><row><entry>9</entry><entry>Pyraclostrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>10</entry><entry>Pyraclostrobin</entry><entry>7-Octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>11</entry><entry>Pyraclostrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>12</entry><entry>Pyraclostrobin</entry><entry>3-Nonenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>13</entry><entry>Pyraclostrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.50</entry></row><row><entry>14</entry><entry>Pyraclostrobin</entry><entry>3-Decenoic acid</entry><entry>0.000234</entry><entry>0.004882</entry><entry>21</entry><entry>0.19</entry></row><row><entry>15</entry><entry>Pyraclostrobin</entry><entry>9-Decenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.14</entry></row><row><entry>16</entry><entry>Pyraclostrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.000937</entry><entry>0.009766</entry><entry>10</entry><entry>0.56</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0212" num="0000"><tables id="TABLE-US-00046" num="00046"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 44</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by pyraclostrobin, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.001875</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>(2E,4E)-2,4-hexadienoic</entry><entry/><entry>0.0625</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>(2E,4E)-2,4-hexadienoic</entry><entry>0.000234</entry><entry>0.003906</entry><entry>17</entry><entry>0.19</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>Trans-2-hexenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.000469</entry><entry>0.009766</entry><entry>21</entry><entry>0.31</entry></row><row><entry>4</entry><entry>Pyraclostrobin</entry><entry>5-Hexenoic acid</entry><entry>0.000469</entry><entry>0.009766</entry><entry>21</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Pyraclostrobin</entry><entry>3-Heptenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.19</entry></row><row><entry>6</entry><entry>Pyraclostrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.19</entry></row><row><entry>7</entry><entry>Pyraclostrobin</entry><entry>3-Octenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>8</entry><entry>Pyraclostrobin</entry><entry>7-Octenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.19</entry></row><row><entry>9</entry><entry>Pyraclostrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.19</entry></row><row><entry>10</entry><entry>Pyraclostrobin</entry><entry>3-Nonenoic acid</entry><entry>0.000469</entry><entry>0.004882</entry><entry>10</entry><entry>0.31</entry></row><row><entry>11</entry><entry>Pyraclostrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.16</entry></row><row><entry>12</entry><entry>Pyraclostrobin</entry><entry>3-Decenoic acid</entry><entry>0.000234</entry><entry>0.004882</entry><entry>21</entry><entry>0.19</entry></row><row><entry>13</entry><entry>Pyraclostrobin</entry><entry>9-Decenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.16</entry></row><row><entry>14</entry><entry>Pyraclostrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.000234</entry><entry>0.002441</entry><entry>10</entry><entry>0.16</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0213" num="0000"><tables id="TABLE-US-00047" num="00047"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 45</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by azoxystrobin, in combination</entry></row><row><entry>with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.075</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>4-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>Trans-2-hexenoic acid</entry><entry>0.0375</entry><entry>0.039062</entry><entry>1</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.0375</entry><entry>0.078125</entry><entry>2</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>4-Hexenoic acid</entry><entry>0.0375</entry><entry>0.078125</entry><entry>2</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>5-Hexenoic acid</entry><entry>0.0375</entry><entry>0.078125</entry><entry>2</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Azoxystrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.009375</entry><entry>0.009766</entry><entry>1</entry><entry>0.25</entry></row><row><entry>7</entry><entry>Azoxystrobin</entry><entry>3-Octenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.50</entry></row><row><entry>8</entry><entry>Azoxystrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.38</entry></row><row><entry>9</entry><entry>Azoxystrobin</entry><entry>7-Octenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.38</entry></row><row><entry>10</entry><entry>Azoxystrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.75</entry></row><row><entry>11</entry><entry>Azoxystrobin</entry><entry>3-Nonenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.50</entry></row><row><entry>12</entry><entry>Azoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.009375</entry><entry>0.009766</entry><entry>1</entry><entry>0.38</entry></row><row><entry>13</entry><entry>Azoxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.009375</entry><entry>0.019531</entry><entry>2</entry><entry>0.38</entry></row><row><entry>14</entry><entry>Azoxystrobin</entry><entry>9-Decenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.50</entry></row><row><entry>15</entry><entry>Azoxystrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.01875</entry><entry>0.019531</entry><entry>1</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0214" num="0000"><tables id="TABLE-US-00048" num="00048"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 46</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by chlorothalonil, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Chlorothalonil</entry><entry/><entry>1.758 &#xd7; 10<sup>&#x2212;5</sup></entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Chlorothalonil</entry><entry>Trans-2-nonenoic acid</entry><entry>4.395 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>0.004882</entry><entry>1111</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Chlorothalonil</entry><entry>9-Decenoic acid</entry><entry>4.395 &#xd7; 10<sup>&#x2212;6</sup></entry><entry>0.019531</entry><entry>4444</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0215" num="0000"><tables id="TABLE-US-00049" num="00049"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 47</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by cyprodinil, in combination</entry></row><row><entry>with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.0045</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Cyprodinil</entry><entry>3-Heptenoic acid</entry><entry>0.001125</entry><entry>0.039062</entry><entry>35</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Cyprodinil</entry><entry>Trans-2-octenoic acid</entry><entry>0.001125</entry><entry>0.039062</entry><entry>35</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Cyprodinil</entry><entry>3-Octenoic acid</entry><entry>0.001125</entry><entry>0.039062</entry><entry>35</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Cyprodinil</entry><entry>7-Octenoic acid</entry><entry>0.000562</entry><entry>0.019531</entry><entry>35</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Cyprodinil</entry><entry>Trans-2-nonenoic acid</entry><entry>0.001125</entry><entry>0.039062</entry><entry>35</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Cyprodinil</entry><entry>3-Nonenoic acid</entry><entry>0.001125</entry><entry>0.039062</entry><entry>35</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Cyprodinil</entry><entry>3-Decenoic acid</entry><entry>0.000562</entry><entry>0.039062</entry><entry>69</entry><entry>0.63</entry></row><row><entry>8</entry><entry>Cyprodinil</entry><entry>9-Decenoic acid</entry><entry>0.000562</entry><entry>0.019531</entry><entry>35</entry><entry>0.38</entry></row><row><entry>9</entry><entry>Cyprodinil</entry><entry>Trans-2-undecenoic acid</entry><entry>0.000562</entry><entry>0.019531</entry><entry>35</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0216" num="0000"><tables id="TABLE-US-00050" num="00050"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 48</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by metalaxyl, in combination</entry></row><row><entry>with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Metalaxyl</entry><entry/><entry>0.316</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Metalaxyl</entry><entry>3-Nonenoic acid</entry><entry>0.079</entry><entry>0.039062</entry><entry>0.5</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Metalaxyl</entry><entry>9-Decenoic acid</entry><entry>0.079</entry><entry>0.039062</entry><entry>0.5</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Metalaxyl</entry><entry>Trans-2-undecenoic acid</entry><entry>0.079</entry><entry>0.039062</entry><entry>0.5</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0217" num="0000"><tables id="TABLE-US-00051" num="00051"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 49</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by epoxiconazole, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>(9Z)-octadecenoic acid</entry><entry/><entry>5.0</entry></row><row><entry>1</entry><entry>Epoxiconazole</entry><entry>3-Heptenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Epoxiconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Epoxiconazole</entry><entry>3-Octenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Epoxiconazole</entry><entry>Trans-3-octenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Epoxiconazole</entry><entry>Trans-2-nonenoic acid</entry><entry>0.00375</entry><entry>0.019531</entry><entry>5</entry><entry>0.25</entry></row><row><entry>6</entry><entry>Epoxiconazole</entry><entry>3-Nonenoic acid</entry><entry>0.00375</entry><entry>0.019531</entry><entry>5</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Epoxiconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.00375</entry><entry>0.019531</entry><entry>5</entry><entry>0.38</entry></row><row><entry>8</entry><entry>Epoxiconazole</entry><entry>3-Decenoic acid</entry><entry>0.001875</entry><entry>0.019531</entry><entry>10</entry><entry>0.31</entry></row><row><entry>9</entry><entry>Epoxiconazole</entry><entry>9-Decenoic acid</entry><entry>0.00375</entry><entry>0.019531</entry><entry>5</entry><entry>0.25</entry></row><row><entry>10</entry><entry>Epoxiconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.0075</entry><entry>0.039062</entry><entry>5</entry><entry>0.75</entry></row><row><entry>11</entry><entry>Epoxiconazole</entry><entry>(9Z)-octadecenoic acid</entry><entry>0.015</entry><entry>2.5</entry><entry>167</entry><entry>1.00</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0218" num="0000"><tables id="TABLE-US-00052" num="00052"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 50</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by tebuconazole, in combination</entry></row><row><entry>with various exemplary unsaturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>(9Z)-octadecenoic acid</entry><entry/><entry>5.0</entry></row><row><entry>1</entry><entry>Tebuconazole</entry><entry>5-Hexenoic acid</entry><entry>0.028125</entry><entry>0.039062</entry><entry>1.4</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Tebuconazole</entry><entry>Trans-2-octenoic acid</entry><entry>0.014062</entry><entry>0.009766</entry><entry>0.7</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>Trans-2-decenoic acid</entry><entry>0.028125</entry><entry>0.019531</entry><entry>0.7</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>3-Decenoic acid</entry><entry>0.028125</entry><entry>0.019531</entry><entry>0.7</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>9-Decenoic acid</entry><entry>0.014062</entry><entry>0.019531</entry><entry>1.4</entry><entry>0.63</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>Trans-2-undecenoic acid</entry><entry>0.028125</entry><entry>0.019531</entry><entry>0.7</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>(9Z)-octadecenoic acid</entry><entry>0.015</entry><entry>2.5</entry><entry>44</entry><entry>1.00</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0024" level="1">Example 15: Growth Inhibition of <i>Botrytis cinerea </i>by Pyraclostrobin, Azoxystrobin, Cyprodinil, Difenoconazole, Epoxiconazole and Tebuconazole, in Combination with Various Exemplary Hydroxy-Substituted Saturated Aliphatic Acids</heading><p id="p-0219" num="0242">Working solutions of pyraclostrobin, azoxystrobin, cyprodinil, difenoconazole, epoxiconazole and tebuconazole, were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Table 51 below. Working solutions of 3-hydroxybutyric acid, 3-hydroxyhexanoic acid and 3-hydroxydecanoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Table 51 below.</p><p id="p-0220" num="0243">Each individual compound and combination was tested over a range of 2-fold dilutions in the growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Table 51 below.</p><p id="p-0221" num="0000"><tables id="TABLE-US-00053" num="00053"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 51</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various synthetic fungicides</entry></row><row><entry>in combination with various exemplary saturated aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Cyprodinil</entry><entry/><entry>0.009</entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.0255</entry></row><row><entry/><entry>Epoxiconazole</entry><entry/><entry>0.03</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>3-hydroxybutyric acid</entry><entry/><entry>10</entry></row><row><entry/><entry/><entry>3-hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-hydroxydecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-hydroxybutyric acid</entry><entry>0.00375</entry><entry>2.5</entry><entry>667</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>3-hydroxybutyric acid</entry><entry>0.0375</entry><entry>5</entry><entry>133</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Cyprodinil</entry><entry>3-hydroxybutyric acid</entry><entry>0.00225</entry><entry>5</entry><entry>2222</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Cyprodinil</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.00225</entry><entry>1.25</entry><entry>556</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Cyprodinil</entry><entry>3-hydroxydecanoic acid</entry><entry>0.00225</entry><entry>0.0625</entry><entry>28</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Difenoconazole</entry><entry>3-hydroxybutyric acid</entry><entry>0.01275</entry><entry>2.5</entry><entry>196</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Difenoconazole</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.01275</entry><entry>0.625</entry><entry>49</entry><entry>0.75</entry></row><row><entry>8</entry><entry>Difenoconazole</entry><entry>3-hydroxydecanoic acid</entry><entry>0.01275</entry><entry>0.03125</entry><entry>2</entry><entry>0.75</entry></row><row><entry>9</entry><entry>Epoxiconazole</entry><entry>3-hydroxybutyric acid</entry><entry>0.0075</entry><entry>2.5</entry><entry>333</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Tebuconazole</entry><entry>3-hydroxybutyric acid</entry><entry>0.01406</entry><entry>1.25</entry><entry>89</entry><entry>0.25</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0025" level="1">Example 16: Growth Inhibition of <i>Fusarium oxysporum </i>by Pyraclostrobin, Azoxystrobin, Fludioxonil, and Tebuconazole, in Combination with Various Exemplary Hydroxy-Substituted Aliphatic Acids</heading><p id="p-0222" num="0244">Working solutions of pyraclostrobin, azoxystrobin, fludioxonil, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 52-54 below. Working solutions of 2-hydroxybutyric acid, 2-hydroxyhexanoic acid, 2-hydroxyoctanoic acid, 3-hydroxyoctanoic acid, 8-hydroxyoctanoic acid, and 10-hydroxydecanoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 52-54 below.</p><p id="p-0223" num="0245">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 52-54 below.</p><p id="p-0224" num="0000"><tables id="TABLE-US-00054" num="00054"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 52</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by various synthetic fungicides</entry></row><row><entry>in combination with exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>5</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.0075</entry><entry>0.3125</entry><entry>42</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.0075</entry><entry>1.25</entry><entry>167</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.075</entry><entry>0.3125</entry><entry>4</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.075</entry><entry>1.25</entry><entry>17</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.05625</entry><entry>0.625</entry><entry>11</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0225" num="0000"><tables id="TABLE-US-00055" num="00055"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 53</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by pyraclostrobin in</entry></row><row><entry>combination with an exemplary hydroxy-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>10-Hydroxydecanoic</entry><entry/><entry>1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>10-Hydroxydecanoic</entry><entry>0.00375</entry><entry>0.25</entry><entry>67</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0226" num="0000"><tables id="TABLE-US-00056" num="00056"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 54</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Fusarium oxysporum </i>by various synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>0.021</entry></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.225</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>2-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.00375</entry><entry>1.25</entry><entry>333</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.00375</entry><entry>0.625</entry><entry>167</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>2-Hydroxybutyric acid</entry><entry>0.00525</entry><entry>1.25</entry><entry>238</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.00525</entry><entry>0.625</entry><entry>119</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.00525</entry><entry>0.15625</entry><entry>30</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Azoxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.0375</entry><entry>1.25</entry><entry>33</entry><entry>0.50</entry></row><row><entry>7</entry><entry>Azoxystrobin</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.0375</entry><entry>0.625</entry><entry>17</entry><entry>0.50</entry></row><row><entry>8</entry><entry>Tebuconazole</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.05625</entry><entry>0.625</entry><entry>11</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0026" level="1">Example 17: Growth Inhibition of <i>Sclerotinia sclerotiorum </i>by Pyraclostrobin, Azoxystrobin, Fludioxonil, Difenoconazole, and Tebuconazole, in Combination with Various Exemplary Hydroxy-Substituted Aliphatic Acids</heading><p id="p-0227" num="0246">Working solutions of pyraclostrobin, azoxystrobin, fludioxonil, difenoconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 55-57 below. Working solutions of 2-hydroxybutyric acid, 2-hydroxyhexanoic acid, 2-hydroxyoctanoic acid, 3-hydroxyoctanoic acid, 8-hydroxyoctanoic acid, 10-hydroxydecanoic acid, and 12-hydroxydodecanoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 55-57 below.</p><p id="p-0228" num="0247">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 55-57 below.</p><p id="p-0229" num="0000"><tables id="TABLE-US-00057" num="00057"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="329pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 55</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by by various synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.28125 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.05625</entry></row><row><entry/><entry/><entry>3-hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>8-hydroxyoctanoic acid</entry><entry/><entry>5</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.001875</entry><entry>0.15625</entry><entry>83</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>&#x2003;9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.3125</entry><entry>333</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>0.15625</entry><entry>4</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>0.625</entry><entry>17</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>8-hydroxyoctanoic acid</entry><entry>8.20315 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>1.25</entry><entry>15238</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.028125</entry><entry>0.15625</entry><entry>6</entry><entry>0.75</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.028125</entry><entry>0.625</entry><entry>22</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0230" num="0000"><tables id="TABLE-US-00058" num="00058"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="329pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 56</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.28125 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.0255</entry></row><row><entry/><entry/><entry>10-hydroxydecanoic acid</entry><entry/><entry>0.5</entry></row><row><entry/><entry/><entry>12-hydroxydodecanoic</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>10-hydroxydecanoic acid</entry><entry>0.001875</entry><entry>0.125</entry><entry>67</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>12-hydroxydodecanoic</entry><entry>0.001875</entry><entry>0.025</entry><entry>13</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>10-hydroxydecanoic acid</entry><entry>0.0375</entry><entry>0.125</entry><entry>3</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>10-hydroxydecanoic acid</entry><entry>8.20315 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.25</entry><entry>3048</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>12-hydroxydodecanoic</entry><entry>0.006375</entry><entry>0.025</entry><entry>4</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0231" num="0000"><tables id="TABLE-US-00059" num="00059"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 57</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.281 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.0255</entry></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Hydroxyoctanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.001875</entry><entry>1.25</entry><entry>667</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.001875</entry><entry>0.625</entry><entry>333</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Pyraclostrobin</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.001875</entry><entry>0.15625</entry><entry>83</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Fludioxonil</entry><entry>2-Hydroxybutyric acid</entry><entry>4.101 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>1.25</entry><entry>30476</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Fludioxonil</entry><entry>2-Hydroxyhexanoic acid</entry><entry>4.101 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.625</entry><entry>15238</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Fludioxonil</entry><entry>2-Hydroxyoctanoic acid</entry><entry>4.101 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.15625</entry><entry>3810</entry><entry>0.63</entry></row><row><entry>7</entry><entry>Difenoconazole</entry><entry>2-Hydroxybutyric acid</entry><entry>0.006375</entry><entry>1.25</entry><entry>196</entry><entry>0.75</entry></row><row><entry>8</entry><entry>Difenoconazole</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.006375</entry><entry>0.625</entry><entry>98</entry><entry>0.50</entry></row><row><entry>9</entry><entry>Azoxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.0375</entry><entry>1.25</entry><entry>33</entry><entry>0.75</entry></row><row><entry>10</entry><entry>Azoxystrobin</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.0375</entry><entry>0.625</entry><entry>17</entry><entry>0.50</entry></row><row><entry>11</entry><entry>Azoxystrobin</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>0.15625</entry><entry>4</entry><entry>0.75</entry></row><row><entry>12</entry><entry>Tebuconazole</entry><entry>2-Hydroxybutyric acid</entry><entry>0.01406</entry><entry>0.625</entry><entry>44</entry><entry>0.38</entry></row><row><entry>13</entry><entry>Tebuconazole</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.028125</entry><entry>0.625</entry><entry>22</entry><entry>0.50</entry></row><row><entry>14</entry><entry>Tebuconazole</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.028125</entry><entry>0.15625</entry><entry>6</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0027" level="1">Example 18: Growth Inhibition of <i>Botryrtis cinerea </i>by Various Exemplary Synthetic Fungicides, in Combination with Various Exemplary Hydroxy-Substituted Saturated Aliphatic Acids</heading><p id="p-0232" num="0248">Working solutions of pyraclostrobin, azoxystrobin, fludioxonil, tebuconazole, and difenoconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 58-61 below. Working solutions of 2-hydroxybutyric, 2-hydroxyhexanoic, 2-hydroxyoctanoic, 10-hydroxydecanoic, 12-hydroxydodecanoic, 3-hydroxyoctanoic, 8-hydroxyoctanoic acids, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 58-61 below.</p><p id="p-0233" num="0249">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 2 days, and the FIC Index for each combination calculated, as shown in Tables 58-61 below.</p><p id="p-0234" num="0000"><tables id="TABLE-US-00060" num="00060"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 58</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>3-hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>8-hydroxyoctanoic acid</entry><entry/><entry>2.5</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.00375</entry><entry>0.15625</entry><entry>42</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Pyraclostrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.00375</entry><entry>0.625</entry><entry>167</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>0.3125</entry><entry>8</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>1.25</entry><entry>33</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.006375</entry><entry>0.3125</entry><entry>49</entry><entry>0.25</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.003516</entry><entry>0.01953</entry><entry>6</entry><entry>0.06</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.001758</entry><entry>0.03906</entry><entry>22</entry><entry>0.03</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0235" num="0000"><tables id="TABLE-US-00061" num="00061"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 59</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>1.641 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>10-Hydroxydecanoic</entry><entry/><entry>0.5</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.05</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>12-Hydroxydodecanoic</entry><entry>0.00375</entry><entry>0.025</entry><entry>7</entry><entry>0.75</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>3-Hydroxyoctanoic acid</entry><entry>4.103 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.019531</entry><entry>476</entry><entry>0.28</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>8-Hydroxyoctanoic acid</entry><entry>4.103 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.078125</entry><entry>1904</entry><entry>0.28</entry></row><row><entry>4</entry><entry>Tebuconazole</entry><entry>10-Hydroxydecanoic</entry><entry>0.003516</entry><entry>0.015625</entry><entry>4</entry><entry>0.06</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0236" num="0000"><tables id="TABLE-US-00062" num="00062"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 60</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="84pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Comp</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="84pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>12-Hydroxydodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry>1</entry><entry>Azoxystrobin</entry><entry>12-Hydroxydodecanoic acid</entry><entry>0.0375</entry><entry>0.05</entry><entry>1.33</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0237" num="0000"><tables id="TABLE-US-00063" num="00063"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 61</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary hydroxy-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Comp</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="42pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry/><entry>2-hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>2-hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.00375</entry><entry>0.15625</entry><entry>42</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>2-hydroxybutyric acid</entry><entry>0.0375</entry><entry>2.5</entry><entry>67</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Azoxystrobin</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.0375</entry><entry>1.25</entry><entry>33</entry><entry>0.75</entry></row><row><entry>4</entry><entry>Azoxystrobin</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.0375</entry><entry>0.3125</entry><entry>8</entry><entry>0.75</entry></row><row><entry>5</entry><entry>Difenoconazole</entry><entry>2-hydroxybutyric acid</entry><entry>0.01275</entry><entry>1.25</entry><entry>98</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0028" level="1">Example 19: Growth Inhibition of Sclerotinta <i>Sclerotiorum </i>by Pyraclostrobin, Azoxystrobin, Fludioxonil, and Tebuconazole, in Combination with Various Exemplary Alkyl-Substituted Aliphatic Acids</heading><p id="p-0238" num="0250">Working solutions ofpyraclostrobin, azoxystrobin, fludioxonil, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 62-66 below. Working solutions of2,2-diethylbutanoic acid, 3-methylbutyric acid, 2-ethylhexanoic acid, 3-methylhexanoic acid, 4-methylhexanoc acid, and 2-methyloctanoic acid, (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 62-66 below.</p><p id="p-0239" num="0251">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 62-66 below.</p><p id="p-0240" num="0000"><tables id="TABLE-US-00064" num="00064"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 62</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary alkyl-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="offset" colwidth="42pt" align="left"/><colspec colname="1" colwidth="49pt" align="left"/><colspec colname="2" colwidth="77pt" align="left"/><colspec colname="3" colwidth="42pt" align="char" char="."/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="56pt" align="char" char="."/><colspec colname="6" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.281 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>2,2-Diethylbutanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry>Pyraclostrobin</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.001875</entry><entry>0.0625</entry><entry>33</entry><entry>0.50</entry></row><row><entry/><entry>Pyraclostrobin</entry><entry>3-Methylbutyric acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.078125</entry><entry>83</entry><entry>0.25</entry></row><row><entry/><entry>Fludioxonil</entry><entry>2,2-Diethylbutanoic acid</entry><entry>4.101 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.0625</entry><entry>1524</entry><entry>0.38</entry></row><row><entry/><entry>Fludioxonil</entry><entry>3-Methylbutyric acid</entry><entry>4.101 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.15625</entry><entry>3810</entry><entry>0.38</entry></row><row><entry/><entry>Azoxystrobin</entry><entry>3-Methylbutyric acid</entry><entry>0.0375</entry><entry>0.15625</entry><entry>4</entry><entry>0.50</entry></row><row><entry/><entry>Tebuconazole</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.028125</entry><entry>0.0625</entry><entry>2</entry><entry>0.50</entry></row><row><entry/><entry>Tebuconazole</entry><entry>3-Methylbutyric acid</entry><entry>0.028125</entry><entry>0.15625</entry><entry>6</entry><entry>0.50</entry></row><row><entry/><entry namest="offset" nameend="6" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0241" num="0000"><tables id="TABLE-US-00065" num="00065"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 63</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various exemplary synthetic</entry></row><row><entry>fungicides in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075&#x2002;</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15&#x2003;&#x2002;</entry></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.28125 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.01275</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.05625</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.625</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>2.34375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.009766</entry><entry>42</entry><entry>0.05</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.01875</entry><entry>0.039062</entry><entry>2</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>2-Ethylhexanoic acid</entry><entry>4.10158 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.078125</entry><entry>1905</entry><entry>0.25</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>2-Ethylhexanoic acid</entry><entry>&#x2002;0.006375</entry><entry>0.078125</entry><entry>12</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Tebuconazole</entry><entry>2-Ethylhexanoic acid</entry><entry>&#x2002;0.028125</entry><entry>0.078125</entry><entry>3</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0242" num="0000"><tables id="TABLE-US-00066" num="00066"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="329pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 64</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various exemplary synthetic</entry></row><row><entry>fungicides in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="56pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="56pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15&#x2003;</entry></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.2813 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-Methyloctanoic acid</entry><entry>&#x2002;9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.009766</entry><entry>10</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>2-Methyloctanoic acid</entry><entry>0.0375</entry><entry>0.019531</entry><entry>0.5</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Fludioxonil</entry><entry>2-Methyloctanoic acid</entry><entry>4.10158 &#xd7; 10<sup>&#x2212;5</sup>&#x2002;</entry><entry>0.019531</entry><entry>476</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0243" num="0000"><tables id="TABLE-US-00067" num="00067"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 65</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by various exemplary synthetic</entry></row><row><entry>fungicides in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0075</entry><entry/><entry/><entry/></row><row><entry/><entry>Fludioxonil</entry><entry/><entry>3.28125 &#xd7; 10<sup>&#x2212;4</sup></entry></row><row><entry/><entry/><entry>3-Methylhexanoic acid</entry><entry/><entry>0.125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Methylhexanoic acid</entry><entry>&#x2003;9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.015625</entry><entry>17</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Fludioxonil</entry><entry>3-Methylhexanoic acid</entry><entry>8.20315 &#xd7; 10<sup>&#x2212;5</sup></entry><entry>0.0625</entry><entry>762</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0244" num="0000"><tables id="TABLE-US-00068" num="00068"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 66</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by pyraclostrobin</entry></row><row><entry>in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="42pt" align="center"/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.00375</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>4-Methylhexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>4-Methylhexanoic acid</entry><entry>9.375 &#xd7; 10<sup>&#x2212;4</sup></entry><entry>0.009766</entry><entry>10</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0029" level="1">Example 20: Growth Inhibition of <i>Botrytis cinerea </i>by Pyraclostrobin, Azoxystrobin, Difenoconazole, and Tebuconazole, in Combination with Various Exemplary Alkyl-Substituted Aliphatic Acids</heading><p id="p-0245" num="0252">Working solutions of pyraclostrobin, azoxystrobin, difenoconazole, and tebuconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 67-70 below. Working solutions of 2,2-diethylbutanoic acid, 3-methylbutyric acid, 2-ethylhexanoic acid, 3-methylhexanoic acid, 4-methylhexanoic acid, and 2-methyloctanoic acid, and 2-methyldecanoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 67-70 below.</p><p id="p-0246" num="0253">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 67-70 below.</p><p id="p-0247" num="0000"><tables id="TABLE-US-00069" num="00069"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 67</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary alkyl-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Comp</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="42pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.0015</entry><entry/><entry/><entry/></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>2,2-Diethylbutanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>4-Methylhexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>4-Methylhexanoic acid</entry><entry>0.00375</entry><entry>0.03906</entry><entry>10</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.01275</entry><entry>0.0625</entry><entry>5</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Difenoconazole</entry><entry>4-Methylhexanoic acid</entry><entry>0.01275</entry><entry>0.03906</entry><entry>3</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Difenoconazole</entry><entry>2-Methyloctanoic acid</entry><entry>0.01275</entry><entry>0.019531</entry><entry>2</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Azoxystrobin</entry><entry>4-Methylhexanoic acid</entry><entry>0.01875</entry><entry>0.039062</entry><entry>2</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Tebuconazole</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.001758</entry><entry>0.003906</entry><entry>2</entry><entry>0.03</entry></row><row><entry>7</entry><entry>Tebuconazole</entry><entry>4-Methylhexanoic acid</entry><entry>0.003516</entry><entry>0.004883</entry><entry>1.4</entry><entry>0.06</entry></row><row><entry>8</entry><entry>Tebuconazole</entry><entry>2-Methyloctanoic acid</entry><entry>0.001758</entry><entry>0.001221</entry><entry>0.7</entry><entry>0.03</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0248" num="0000"><tables id="TABLE-US-00070" num="00070"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 68</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Comp</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="42pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.0075</entry><entry>0.078125</entry><entry>10</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>2-Ethylhexanoic acid</entry><entry>0.0255</entry><entry>0.078125</entry><entry>3</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>2-Ethylhexanoic acid</entry><entry>0.003516</entry><entry>0.004883</entry><entry>1</entry><entry>0.05</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0249" num="0000"><tables id="TABLE-US-00071" num="00071"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 69</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with an exemplary alkyl-substituted aliphatic acid</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="42pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Comp</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="42pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Azoxystrobin</entry><entry/><entry>0.15</entry></row><row><entry/><entry>Tebuconazole</entry><entry/><entry>0.1125</entry></row><row><entry/><entry/><entry>3-Methylhexanoic acid</entry><entry/><entry>0.125</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Methylhexanoic acid</entry><entry>0.00375</entry><entry>0.03125</entry><entry>8</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Azoxystrobin</entry><entry>3-Methylhexanoic acid</entry><entry>0.0375</entry><entry>0.0625</entry><entry>2</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Tebuconazole</entry><entry>3-Methylhexanoic acid</entry><entry>0.001758</entry><entry>0.001953</entry><entry>1</entry><entry>0.03</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0250" num="0000"><tables id="TABLE-US-00072" num="00072"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 70</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by various exemplary synthetic fungicides</entry></row><row><entry>in combination with various exemplary alkyl-substituted aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="49pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio CompB/</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>Comp A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="49pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Pyraclostrobin</entry><entry/><entry>0.015</entry><entry/><entry/><entry/></row><row><entry/><entry>Difenoconazole</entry><entry/><entry>0.051</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry>0.015625</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry>0.3125</entry></row><row><entry/><entry>Pyraclostrobin</entry><entry>2-Methyldecanoic acid</entry><entry>0.00375</entry><entry>0.0078125</entry><entry>2</entry><entry>0.75</entry></row><row><entry>1</entry><entry>Pyraclostrobin</entry><entry>3-Methylbutyric acid</entry><entry>0.00375</entry><entry>0.15625</entry><entry>42</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Difenoconazole</entry><entry>3-Methylbutyric acid</entry><entry>0.006375</entry><entry>0.078125</entry><entry>12</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0030" level="1">Example 21: Growth Inhibition of <i>Botrytis cinerea </i>by Picoxystrobin, Mancozeb, Isopyrazam, Oxathiapiprolin, Penthiopyrad, Prothioconazole and Trifloxystrobin, in Combination with Various Exemplary C4-C10 Saturated, Unsaturated, Hydroxy-, Methyl-, Ethyl-, and Diethyl-Substituted Aliphatic Acids</heading><p id="p-0251" num="0254">Working solutions of picoxystrobin, mancozeb, isopyrazam, oxathiapiprolin, penthiopyrad, prothioconazole, and trifloxystrobin, were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 71-79 below. Working solutions of 2-hydroxybutyric acid, 2-hydroxyhexanoic acid, 2-hydroxyoctanoic acid, 3-hydroxybutyric acid, 3-hydroxyhexanoic acid, 3-hydroxyoctanoic acid, 3-hydroxydecanoic acid, 8-hydroxyoctanoic acid, 10-hydroxydecanoic acid, 12-hydroxydodecanoic acid, 2,2-diethylbutanoic acid, 2-ethylhexanoic acid, 2-methyloctanoic acid, 2-methyldecanoic acid, 3-methylbutyric acid, 3-methylhexanoic acid, 3-methylnonanoic acid, 4-methylhexanoic acid, hexanoic acid, octanoic acid, nonanoic acid, decanoic acid, dodecanoic acid, 2,4-hexedienoic acid, trans-2-hexenoic acid, trans-2-octenoic acid, trans-3-octenoic acid, 7-octenoic acid, trans-2-nonenoic acid, trans-2-decenoic acid, 3-decenoic acid, 9-decenoic acid, trans-2-undecenoic acid, 2-hydroxybutyric acid, 3-hydroxybutyric acid, 3-hydroxyhexanoic acid, 3-hydroxyoctanoic acid, 3-hydroxydecanoic acid, 8-hydroxyoctanoic acid, 12-hydroxydodecanoic acid, 2-methyloctanoic acid, 2-methyldecanoic acid, and oleic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 71-79 below.</p><p id="p-0252" num="0255">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 48 hours, and the FIC Index for each combination calculated, as shown in Tables 71-79 below.</p><p id="p-0253" num="0000"><tables id="TABLE-US-00073" num="00073"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 71</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by picoxystrobin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="42pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="42pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>2-Hydroxyhexanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>2-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>3-Hydroxybutyric acid</entry><entry/><entry>10</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.0625</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>10-Hydroxydecanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>2,2-Diethylbutanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>0.0078125</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Methylhexanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>3-Methylnonanoic acid</entry><entry/><entry>0.015625</entry></row><row><entry/><entry/><entry>4-Methylhexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Picoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.015625</entry><entry>0.004883</entry><entry>0.31</entry><entry>0.31</entry></row><row><entry>2</entry><entry>Picoxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.015625</entry><entry>0.625</entry><entry>40</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Picoxystrobin</entry><entry>2-Hydroxyhexanoic acid</entry><entry>0.015625</entry><entry>0.3125</entry><entry>20</entry><entry>0.31</entry></row><row><entry>4</entry><entry>Picoxystrobin</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.015625</entry><entry>0.078125</entry><entry>5</entry><entry>0.19</entry></row><row><entry>5</entry><entry>Picoxystrobin</entry><entry>3-Hydroxybutyric acid</entry><entry>0.015625</entry><entry>1.25</entry><entry>80</entry><entry>0.19</entry></row><row><entry>6</entry><entry>Picoxystrobin</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.015625</entry><entry>0.3125</entry><entry>20</entry><entry>0.19</entry></row><row><entry>7</entry><entry>Picoxystrobin</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.03125</entry><entry>0.15625</entry><entry>5</entry><entry>0.38</entry></row><row><entry>8</entry><entry>Picoxystrobin</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.015625</entry><entry>0.015625</entry><entry>1</entry><entry>0.31</entry></row><row><entry>9</entry><entry>Picoxystrobin</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.015625</entry><entry>0.3125</entry><entry>20</entry><entry>0.31</entry></row><row><entry>10</entry><entry>Picoxystrobin</entry><entry>10-Hydroxydecanoic acid</entry><entry>0.015625</entry><entry>0.0625</entry><entry>4</entry><entry>0.31</entry></row><row><entry>11</entry><entry>Picoxystrobin</entry><entry>12-Hydroxydodecanoic</entry><entry>0.03125</entry><entry>0.025</entry><entry>0.8</entry><entry>0.38</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>12</entry><entry>Picoxystrobin</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.015625</entry><entry>0.03125</entry><entry>2</entry><entry>0.19</entry></row><row><entry>13</entry><entry>Picoxystrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.015625</entry><entry>0.019531</entry><entry>1.25</entry><entry>0.19</entry></row><row><entry>14</entry><entry>Picoxystrobin</entry><entry>2-Methyloctanoic acid</entry><entry>0.0078125</entry><entry>0.004883</entry><entry>0.6</entry><entry>0.16</entry></row><row><entry>15</entry><entry>Picoxystrobin</entry><entry>2-Methyldecanoic acid</entry><entry>0.015625</entry><entry>0.003906</entry><entry>0.25</entry><entry>0.56</entry></row><row><entry>16</entry><entry>Picoxystrobin</entry><entry>3-Methylbutyric acid</entry><entry>0.015625</entry><entry>0.078125</entry><entry>5</entry><entry>0.31</entry></row><row><entry>17</entry><entry>Picoxystrobin</entry><entry>3-Methylhexanoic acid</entry><entry>0.015625</entry><entry>0.015625</entry><entry>1</entry><entry>0.19</entry></row><row><entry>18</entry><entry>Picoxystrobin</entry><entry>3-Methylnonanoic acid</entry><entry>0.015625</entry><entry>0.001953</entry><entry>0.13</entry><entry>0.19</entry></row><row><entry>19</entry><entry>Picoxystrobin</entry><entry>4-Methylhexanoic acid</entry><entry>0.015625</entry><entry>0.019531</entry><entry>1.25</entry><entry>0.31</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0254" num="0000"><tables id="TABLE-US-00074" num="00074"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 72</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by picoxystrobin, in</entry></row><row><entry>combination with various exemplary unsaturated aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="offset" colwidth="42pt" align="left"/><colspec colname="1" colwidth="49pt" align="left"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="35pt" align="char" char="."/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="56pt" align="char" char="."/><colspec colname="6" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.015625</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry>Picoxystrobin</entry><entry>Decanoic acid</entry><entry>0.03125</entry><entry>0.0078125</entry><entry>0.25</entry><entry>0.63</entry></row><row><entry/><entry>Picoxystrobin</entry><entry>Trans-2-hexenoic</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry namest="offset" nameend="6" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0255" num="0000"><tables id="TABLE-US-00075" num="00075"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 73</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by mancozeb, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Mancozeb</entry><entry/><entry>0.03125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry>1</entry><entry>Mancozeb</entry><entry>Trans-2-octenoic acid</entry><entry>0.003906</entry><entry>0.019531</entry><entry>5</entry><entry>0.63</entry></row><row><entry>2</entry><entry>Mancozeb</entry><entry>3-Decenoic acid</entry><entry>0.003906</entry><entry>0.019531</entry><entry>5</entry><entry>0.63</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0256" num="0000"><tables id="TABLE-US-00076" num="00076"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 74</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by isopyrazam, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Isopyrazam</entry><entry/><entry>0.03125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.015625</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry/><entry/><entry>2,4-Dihexenoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Oleic acid</entry><entry/><entry>5</entry></row><row><entry>1</entry><entry>Isopyrazam</entry><entry>Hexanoic acid</entry><entry>0.0078125</entry><entry>0.03906</entry><entry>5</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Isopyrazam</entry><entry>Octanoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.31</entry></row><row><entry>3</entry><entry>Isopyrazam</entry><entry>Decanoic acid</entry><entry>0.0039062</entry><entry>0.0078125</entry><entry>2</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Isopyrazam</entry><entry>Dodecanoic acid</entry><entry>0.0078125</entry><entry>0.0125</entry><entry>1.6</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Isopyrazam</entry><entry>2,4-Dihexenoic acid</entry><entry>0.0078125</entry><entry>0.0625</entry><entry>8</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Isopyrazam</entry><entry>5-Hexenoic acid</entry><entry>0.0078125</entry><entry>0.039062</entry><entry>5</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Isopyrazam</entry><entry>7-Octenoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.31</entry></row><row><entry>8</entry><entry>Isopyrazam</entry><entry>3-Nonenoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.50</entry></row><row><entry>9</entry><entry>Isopyrazam</entry><entry>Trans-3-octenoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.75</entry></row><row><entry>10</entry><entry>Isopyrazam</entry><entry>3-Decenoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.75</entry></row><row><entry>11</entry><entry>Isopyrazam</entry><entry>9-Decenoic acid</entry><entry>0.0078125</entry><entry>0.019531</entry><entry>2.5</entry><entry>0.50</entry></row><row><entry>12</entry><entry>Isopyrazam</entry><entry>Oleic acid</entry><entry>0.03125</entry><entry>5</entry><entry>160</entry><entry>2.0</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0257" num="0000"><tables id="TABLE-US-00077" num="00077"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 75</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by oxathiapiprolin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Oxathiapiprolin</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry></row><row><entry>1</entry><entry>Oxathiapiprolin</entry><entry>12-Hydroxydodecanoic</entry><entry>0.125</entry><entry>0.025</entry><entry>0.2</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>2</entry><entry>Oxathiapiprolin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.125</entry><entry>1.25</entry><entry>10</entry><entry>0.75</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0258" num="0000"><tables id="TABLE-US-00078" num="00078"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 76</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by penthiopyrad, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="42pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="42pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Penthiopyrad</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.05</entry></row><row><entry/><entry/><entry>(2E,4E)-2,4-Hexadienoic</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-Hydroxybutyric acid</entry><entry/><entry>10</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>Oleic acid</entry><entry/><entry>5</entry></row><row><entry>1</entry><entry>Penthiopyrad</entry><entry>Hexanoic acid</entry><entry>0.0625</entry><entry>0.039062</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Penthiopyrad</entry><entry>Octanoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.31</entry></row><row><entry>3</entry><entry>Penthiopyrad</entry><entry>Nonanoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Penthiopyrad</entry><entry>Decanoic acid</entry><entry>0.03125</entry><entry>0.0078125</entry><entry>0.25</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Penthiopyrad</entry><entry>Dodecanoic acid</entry><entry>0.0625</entry><entry>0.0125</entry><entry>0.2</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Penthiopyrad</entry><entry>(2E,4E)-2,4-Hexadienoic</entry><entry>0.0625</entry><entry>0.0625</entry><entry>1</entry><entry>0.75</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>7</entry><entry>Penthiopyrad</entry><entry>Trans-2-hexenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.31</entry></row><row><entry>8</entry><entry>Penthiopyrad</entry><entry>Trans-2-octenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>9</entry><entry>Penthiopyrad</entry><entry>Trans-3-octenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Penthiopyrad</entry><entry>7-Octenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.31</entry></row><row><entry>11</entry><entry>Penthiopyrad</entry><entry>Trans-2-nonenoic acid</entry><entry>0.0625</entry><entry>0.009766</entry><entry>0.16</entry><entry>0.31</entry></row><row><entry>12</entry><entry>Penthiopyrad</entry><entry>Trans-2-decenoic acid</entry><entry>0.03125</entry><entry>0.004883</entry><entry>0.16</entry><entry>0.19</entry></row><row><entry>13</entry><entry>Penthiopyrad</entry><entry>3-Decenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>14</entry><entry>Penthiopyrad</entry><entry>9-Decenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>15</entry><entry>Penthiopyrad</entry><entry>Trans-2-undecenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.63</entry></row><row><entry>16</entry><entry>Penthiopyrad</entry><entry>2-Hydroxybutyric acid</entry><entry>0.0625</entry><entry>1.25</entry><entry>20</entry><entry>0.75</entry></row><row><entry>17</entry><entry>Penthiopyrad</entry><entry>3-Hydroxybutyric acid</entry><entry>0.0625</entry><entry>2.5</entry><entry>40</entry><entry>0.50</entry></row><row><entry>18</entry><entry>Penthiopyrad</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.0625</entry><entry>0.625</entry><entry>10</entry><entry>0.38</entry></row><row><entry>19</entry><entry>Penthiopyrad</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.0625</entry><entry>0.15625</entry><entry>2.5</entry><entry>0.50</entry></row><row><entry>20</entry><entry>Penthiopyrad</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.0625</entry><entry>0.03125</entry><entry>0.5</entry><entry>0.50</entry></row><row><entry>21</entry><entry>Penthiopyrad</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.03125</entry><entry>0.3125</entry><entry>10</entry><entry>0.25</entry></row><row><entry>22</entry><entry>Penthiopyrad</entry><entry>12-Hydroxydodecanoic</entry><entry>0.0625</entry><entry>0.025</entry><entry>0.4</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>23</entry><entry>Penthiopyrad</entry><entry>2-Methyloctanoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.31</entry></row><row><entry>24</entry><entry>Penthiopyrad</entry><entry>2-Methyldecanoic acid</entry><entry>0.03125</entry><entry>0.0039062</entry><entry>0.13</entry><entry>0.16</entry></row><row><entry>25</entry><entry>Penthiopyrad</entry><entry>Oleic acid</entry><entry>0.125</entry><entry>2.5</entry><entry>20</entry><entry>1.0</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0259" num="0000"><tables id="TABLE-US-00079" num="00079"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 77</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by prothioconazole, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="56pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry>Prothioconazole</entry><entry/><entry>0.03125</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>2-Hydroxybutyric</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>1</entry><entry>Prothioconazole</entry><entry>2-Hydroxybutyric</entry><entry>0.0078125</entry><entry>1.25</entry><entry>160</entry><entry>0.75</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0260" num="0000"><tables id="TABLE-US-00080" num="00080"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 78</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by trifloxystrobin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Trifloxystrobin</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>(2E,4E)-2,4-Hexadienoic</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Trifloxystrobin</entry><entry>Hexanoic acid</entry><entry>0.03125</entry><entry>0.039062</entry><entry>1.25</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Trifloxystrobin</entry><entry>Octanoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.16</entry></row><row><entry>3</entry><entry>Trifloxystrobin</entry><entry>Decanoic acid</entry><entry>0.03125</entry><entry>0.015625</entry><entry>0.5</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Trifloxystrobin</entry><entry>(2E,4E)-2,4-Hexadienoic</entry><entry>0.03125</entry><entry>0.0625</entry><entry>2</entry><entry>0.38</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>5</entry><entry>Trifloxystrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Trifloxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.03125</entry><entry>0.009766</entry><entry>0.3</entry><entry>0.19</entry></row><row><entry>7</entry><entry>Trifloxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.25</entry></row><row><entry>8</entry><entry>Trifloxystrobin</entry><entry>9-Decenoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.25</entry></row><row><entry>9</entry><entry>Trifloxystrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.25</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0261" num="0000"><tables id="TABLE-US-00081" num="00081"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 79</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Botrytis cinerea </i>by trifloxystrobin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Trifloxystrobin</entry><entry/><entry>0.25</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-hydroxyhexanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>2-Hydroxydecanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>3-Hydroxydecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>10-Hydroxydecanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.05</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>2,2-Diethylbutanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Methylhexanoic acid</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>4-Methylhexanoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Trifloxystrobin</entry><entry>Heptanoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Trifloxystrobin</entry><entry>Nonanoic acid</entry><entry>0.015625</entry><entry>0.009766</entry><entry>0.6</entry><entry>0.19</entry></row><row><entry>3</entry><entry>Trifloxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.03125</entry><entry>1.25</entry><entry>40</entry><entry>0.63</entry></row><row><entry>4</entry><entry>Trifloxystrobin</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.03125</entry><entry>0.625</entry><entry>20</entry><entry>0.63</entry></row><row><entry>5</entry><entry>Trifloxystrobin</entry><entry>2-Hydroxydecanoic acid</entry><entry>0.03125</entry><entry>0.15625</entry><entry>5</entry><entry>0.63</entry></row><row><entry>6</entry><entry>Trifloxystrobin</entry><entry>3-Hydroxybutyric acid</entry><entry>0.03125</entry><entry>2.5</entry><entry>80</entry><entry>0.63</entry></row><row><entry>7</entry><entry>Trifloxystrobin</entry><entry>3-Hydroxyhexanoic acid</entry><entry>0.03125</entry><entry>0.625</entry><entry>20</entry><entry>0.38</entry></row><row><entry>8</entry><entry>Trifloxystrobin</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.03125</entry><entry>0.15625</entry><entry>5</entry><entry>0.38</entry></row><row><entry>9</entry><entry>Trifloxystrobin</entry><entry>3-Hydroxydecanoic acid</entry><entry>0.03125</entry><entry>0.03125</entry><entry>1</entry><entry>0.38</entry></row><row><entry>10</entry><entry>Trifloxystrobin</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.03125</entry><entry>0.625</entry><entry>20</entry><entry>0.63</entry></row><row><entry>11</entry><entry>Trifloxystrobin</entry><entry>10-Hydroxydecanoic acid</entry><entry>0.03125</entry><entry>0.125</entry><entry>4</entry><entry>0.63</entry></row><row><entry>12</entry><entry>Trifloxystrobin</entry><entry>12-Hydroxydodecanoic</entry><entry>0.03125</entry><entry>0.025</entry><entry>0.8</entry><entry>0.63</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>13</entry><entry>Trifloxystrobin</entry><entry>2,2-Diethylbutanoic acid</entry><entry>0.03125</entry><entry>0.0625</entry><entry>2</entry><entry>0.38</entry></row><row><entry>14</entry><entry>Trifloxystrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.015625</entry><entry>0.019531</entry><entry>1.25</entry><entry>0.19</entry></row><row><entry>15</entry><entry>Trifloxystrobin</entry><entry>2-Methyloctanoic acid</entry><entry>0.015625</entry><entry>0.009766</entry><entry>0.6</entry><entry>0.19</entry></row><row><entry>16</entry><entry>Trifloxystrobin</entry><entry>2-Methyldecanoic acid</entry><entry>0.015625</entry><entry>0.0039062</entry><entry>0.25</entry><entry>0.09</entry></row><row><entry>17</entry><entry>Trifloxystrobin</entry><entry>3-Methylbutyric acid</entry><entry>0.03125</entry><entry>0.15625</entry><entry>5</entry><entry>0.63</entry></row><row><entry>18</entry><entry>Trifloxystrobin</entry><entry>3-Methylhexanoic acid</entry><entry>0.03125</entry><entry>0.03125</entry><entry>1</entry><entry>0.38</entry></row><row><entry>19</entry><entry>Trifloxystrobin</entry><entry>4-Methylhexanoic acid</entry><entry>0.015625</entry><entry>0.019531</entry><entry>1.25</entry><entry>0.31</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0031" level="1">Example 22: Growth Inhibition of <i>Alternaria Solani </i>by Picoxystrobin, Mancozeb, Penthiopyrad, and Prothioconazole, in Combination with Various Exemplary C4-C10 Saturated, Unsaturated, Hydroxy-, Methyl-, Ethyl-, and Diethyl-Substituted Aliphatic Acids</heading><p id="p-0262" num="0256">Working solutions of picoxystrobin, mancozeb, penthiopyrad, and prothioconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 80-84 below. Working solutions of 2-hydroxybutyric acid, 2-hydroxyoctanoi c acid, 2-ethylhexanoi c acid, 2-methyloctanoic acid, 2-methyldecanoic acid, 3-methylhexanoic acid, 3-methylnonanoic acid, 4-methylhexanoic acid, hexanoic acid, heptanoic, octanoic acid, nonanoic acid, decanoic acid, dodecanoic acid, 2,4-hexedienoic acid, trans-3-hexenoic acid, 5-hexenoic acid, 3-heptenoic acid, trans-2-octenoic acid, 3-octenoic acid, trans-3-octenoic acid, trans-2-nonenoic acid, 3-nonenoic acid, trans-2-decenoic acid, cis-3-hexenoic acid, 7-octenoic acid, 3-decenoic acid, 9-decenoic acid, trans-2-undecenoic acid, 2-hydroxybutyric acid, 3-hydroxybutyric acid, 3-hydroxyhexanoic acid, 3-hydroxyoctanoic acid, 3-hydroxydecanoic acid, 8-hydroxyoctanoic acid, 12-hydroxydodecanoic acid, 2-methyloctanoic acid, 2-methyldecanoic acid, and oleic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 80-84 below.</p><p id="p-0263" num="0257">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 80-84 below.</p><p id="p-0264" num="0000"><tables id="TABLE-US-00082" num="00082"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 80</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Alternaria solani </i>by picoxystrobin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Hexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Decanoic acid</entry><entry/><entry>0.03125</entry></row><row><entry/><entry/><entry>Dodecanoic acid</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>(2E,4E)-2,4-Hexadienoic</entry><entry/><entry>0.125</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>5-Hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.03906</entry></row><row><entry/><entry/><entry>Trans-2-undecenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Picoxystrobin</entry><entry>Hexanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Picoxystrobin</entry><entry>Heptanoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.25</entry></row><row><entry>3</entry><entry>Picoxystrobin</entry><entry>Octanoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.19</entry></row><row><entry>4</entry><entry>Picoxystrobin</entry><entry>Nonanoic acid</entry><entry>0.0625</entry><entry>0.009766</entry><entry>0.16</entry><entry>0.19</entry></row><row><entry>5</entry><entry>Picoxystrobin</entry><entry>Decanoic acid</entry><entry>0.0625</entry><entry>0.0078125</entry><entry>0.13</entry><entry>0.38</entry></row><row><entry>6</entry><entry>Picoxystrobin</entry><entry>Dodecanoic acid</entry><entry>0.0625</entry><entry>0.0125</entry><entry>0.2</entry><entry>0.25</entry></row><row><entry>7</entry><entry>Picoxystrobin</entry><entry>(2E,4E)-2,4-Hexadienoic</entry><entry>0.0625</entry><entry>0.03125</entry><entry>0.5</entry><entry>0.38</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>8</entry><entry>Picoxystrobin</entry><entry>Trans-3-hexenoic acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry>9</entry><entry>Picoxystrobin</entry><entry>5-Hexenoic acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Picoxystrobin</entry><entry>3-Heptenoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>11</entry><entry>Picoxystrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.50</entry></row><row><entry>12</entry><entry>Picoxystrobin</entry><entry>3-Octenoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>13</entry><entry>Picoxystrobin</entry><entry>Trans-3-octenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.25</entry></row><row><entry>14</entry><entry>Picoxystrobin</entry><entry>Trans-2-nonenoic acid</entry><entry>0.03125</entry><entry>0.019531</entry><entry>0.6</entry><entry>0.31</entry></row><row><entry>15</entry><entry>Picoxystrobin</entry><entry>3-Nonenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>16</entry><entry>Picoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.75</entry></row><row><entry>17</entry><entry>Picoxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>18</entry><entry>Picoxystrobin</entry><entry>9-Decenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.63</entry></row><row><entry>19</entry><entry>Picoxystrobin</entry><entry>Trans-2-undecenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.25</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0265" num="0000"><tables id="TABLE-US-00083" num="00083"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 81</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Alternaria solani </i>by picoxystrobin, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Cis-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>7-Octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Hydroxyoctanoic acid</entry><entry/><entry>1.25</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>10-Hydroxydecanoic acid</entry><entry/><entry>1</entry></row><row><entry/><entry/><entry>12-Hydroxydodecanoic</entry><entry/><entry>0.1</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Methylhexanoic acid</entry><entry/><entry>0.25</entry></row><row><entry/><entry/><entry>3-Methylnonanoic acid</entry><entry/><entry>0.0625</entry></row><row><entry/><entry/><entry>4-Methylhexanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>0.125</entry></row><row><entry>1</entry><entry>Picoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.63</entry></row><row><entry>2</entry><entry>Picoxystrobin</entry><entry>Cis-3-hexenoic acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Picoxystrobin</entry><entry>7-Octenoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.25</entry></row><row><entry>4</entry><entry>Picoxystrobin</entry><entry>3-Hydroxyoctanoic acid</entry><entry>0.125</entry><entry>0.15625</entry><entry>1.25</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Picoxystrobin</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Picoxystrobin</entry><entry>10-Hydroxydecanoic acid</entry><entry>0.125</entry><entry>0.125</entry><entry>1</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Picoxystrobin</entry><entry>12-Hydroxydodecanoic</entry><entry>0.125</entry><entry>0.025</entry><entry>0.2</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>8</entry><entry>Picoxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry>9</entry><entry>Picoxystrobin</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.125</entry><entry>0.15625</entry><entry>1.25</entry><entry>0.50</entry></row><row><entry>10</entry><entry>Picoxystrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>11</entry><entry>Picoxystrobin</entry><entry>2-Methyloctanoic acid</entry><entry>0.0625</entry><entry>0.019531</entry><entry>0.3</entry><entry>0.25</entry></row><row><entry>12</entry><entry>Picoxystrobin</entry><entry>3-Methylhexanoic acid</entry><entry>0.125</entry><entry>0.03125</entry><entry>0.25</entry><entry>0.38</entry></row><row><entry>13</entry><entry>Picoxystrobin</entry><entry>3-Methylnonanoic acid</entry><entry>0.125</entry><entry>0.015625</entry><entry>0.13</entry><entry>0.50</entry></row><row><entry>14</entry><entry>Picoxystrobin</entry><entry>4-Methylhexanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>15</entry><entry>Picoxystrobin</entry><entry>2-Methyldecanoic acid</entry><entry>0.125</entry><entry>0.03125</entry><entry>0.25</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0266" num="0000"><tables id="TABLE-US-00084" num="00084"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 82</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Alternaria solani </i>by penthiopyrad, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Penthiopyrad</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Octanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-3-octenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Penthiopyrad</entry><entry>Octanoic acid</entry><entry>0.0625</entry><entry>0.039062</entry><entry>0.6</entry><entry>0.25</entry></row><row><entry>2</entry><entry>Penthiopyrad</entry><entry>Trans-2-nonenoic acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.6</entry><entry>0.75</entry></row><row><entry>3</entry><entry>Penthiopyrad</entry><entry>Trans-3-octenoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0267" num="0000"><tables id="TABLE-US-00085" num="00085"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="322pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 83</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Alternaria solani </i>by prothioconazole, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Prothioconazole</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Hydroxyhexanoic</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>3-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>3-Hydroxyhexanoic</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry/><entry/><entry>8-Hydroxyoctanoic acid</entry><entry/><entry>2.5</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Methylnonanoic acid</entry><entry/><entry>0.0625</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>1</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry/><entry>0.3125</entry></row><row><entry>1</entry><entry>Prothioconazole</entry><entry>2-Hydroxybutyric acid</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Prothioconazole</entry><entry>2-Hydroxyhexanoic</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>3</entry><entry>Prothioconazole</entry><entry>3-Hydroxybutyric acid</entry><entry>0.125</entry><entry>1.25</entry><entry>10</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Prothioconazole</entry><entry>3-Hydroxyhexanoic</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry/><entry/><entry>acid</entry></row><row><entry>5</entry><entry>Prothioconazole</entry><entry>8-Hydroxyoctanoic acid</entry><entry>0.125</entry><entry>0.625</entry><entry>5</entry><entry>0.50</entry></row><row><entry>6</entry><entry>Prothioconazole</entry><entry>2-Ethylhexanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>7</entry><entry>Prothioconazole</entry><entry>3-Methylnonanoic acid</entry><entry>0.125</entry><entry>0.015625</entry><entry>0.13</entry><entry>0.50</entry></row><row><entry>8</entry><entry>Prothioconazole</entry><entry>2-Methyldecanoic acid</entry><entry>0.125</entry><entry>0.03125</entry><entry>0.25</entry><entry>0.28</entry></row><row><entry>9</entry><entry>Prothioconazole</entry><entry>3-Methylbutyric acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.6</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0268" num="0000"><tables id="TABLE-US-00086" num="00086"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 84</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Alternaria solani </i>by mancozeb, in combination with</entry></row><row><entry>various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Mancozeb</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Heptanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>2-Methyloctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>2-Methyldecanoic acid</entry><entry/><entry>1</entry></row><row><entry>1</entry><entry>Mancozeb</entry><entry>Heptanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.50</entry></row><row><entry>2</entry><entry>Mancozeb</entry><entry>2-Methyloctanoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.31</entry></row><row><entry>3</entry><entry>Mancozeb</entry><entry>2-Methyldecanoic acid</entry><entry>0.125</entry><entry>0.03125</entry><entry>0.25</entry><entry>0.28</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0032" level="1">Example 23: Growth Inhibition of <i>Sclerotinia sclerotiorum </i>by Picoxystrobin, Penthiopyrad, and Prothioconazole, in Combination with Various Exemplary C4-C10 Saturated, Unsaturated, Hydroxy-, Methyl-, and Ethyl-Substituted Aliphatic Acids</heading><p id="p-0269" num="0258">Working solutions of picoxystrobin, penthiopyrad, and prothioconazole were each prepared as described above (as Compound A) and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 85-88 below. Working solutions of 2-hydroxybutyric acid, 2-hydroxyoctanoic acid, 2-ethylhexanoic acid, 3-methylbutyric acid, nonanoic acid, trans-3-hexenoic acid, 3-heptenoic acid, trans-2-nonenoic acid, trans-2-decenoic acid, 3-decenoic acid, 9-decenoic acid, and 10-hydroxydecanoic acid (as Compound B), were each prepared as described above, and were serially diluted in PDB to the individual required concentrations for MIC testing as shown in Tables 85-88 below.</p><p id="p-0270" num="0259">Each individual compound and combination was tested over a range of 2-fold dilutions in the synergistic growth inhibition assay, observed following an incubation period of 7 days, and the FIC Index for each combination calculated, as shown in Tables 85-88 below.</p><p id="p-0271" num="0000"><tables id="TABLE-US-00087" num="00087"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 85</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by picoxystrobin, in combination</entry></row><row><entry>with various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Nonanoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>Trans-2-octenoic acid</entry><entry/><entry>0.039062</entry></row><row><entry/><entry/><entry>3-Nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry>1</entry><entry>Picoxystrobin</entry><entry>Nonanoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.75</entry></row><row><entry>2</entry><entry>Picoxystrobin</entry><entry>Trans-2-octenoic acid</entry><entry>0.125</entry><entry>0.009766</entry><entry>0.08</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Picoxystrobin</entry><entry>3-Nonenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Picoxystrobin</entry><entry>3-Decenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.38</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0272" num="0000"><tables id="TABLE-US-00088" num="00088"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 86</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by picoxystrobin, in combination</entry></row><row><entry>with various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Picoxystrobin</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-2-decenoic acid</entry><entry/><entry>0.019531</entry></row><row><entry/><entry/><entry>10-Hydroxydecanoic acid</entry><entry/><entry>0.5</entry></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry/><entry/><entry>2-Hydroxyoctanoic acid</entry><entry/><entry>0.625</entry></row><row><entry/><entry/><entry>2-Ethylhexanoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>3-Methylbutyric acid</entry><entry/><entry>0.625</entry></row><row><entry>1</entry><entry>Picoxystrobin</entry><entry>Trans-2-decenoic acid</entry><entry>0.125</entry><entry>0.004883</entry><entry>0.04</entry><entry>0.5</entry></row><row><entry>2</entry><entry>Picoxystrobin</entry><entry>10-Hydroxydecanoic acid</entry><entry>0.125</entry><entry>0.125</entry><entry>1</entry><entry>0.50</entry></row><row><entry>3</entry><entry>Picoxystrobin</entry><entry>2-Hydroxybutyric acid</entry><entry>0.125</entry><entry>1.25</entry><entry>10</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Picoxystrobin</entry><entry>2-Hydroxyoctanoic acid</entry><entry>0.125</entry><entry>0.15625</entry><entry>1.25</entry><entry>0.50</entry></row><row><entry>5</entry><entry>Picoxystrobin</entry><entry>2-Ethylhexanoic acid</entry><entry>0.125</entry><entry>0.078125</entry><entry>0.625</entry><entry>0.75</entry></row><row><entry>6</entry><entry>Picoxystrobin</entry><entry>3-Methylbutyric acid</entry><entry>0.125</entry><entry>0.15625</entry><entry>1.25</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0273" num="0000"><tables id="TABLE-US-00089" num="00089"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="308pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 87</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by penthiopyrad, in combination</entry></row><row><entry>with various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="49pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="char" char="."/><colspec colname="7" colwidth="21pt" align="char" char="."/><tbody valign="top"><row><entry/><entry>Penthiopyrad</entry><entry/><entry>0.5</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>Trans-3-hexenoic acid</entry><entry/><entry>0.3125</entry></row><row><entry/><entry/><entry>3-Heptenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>Trans-2-nonenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry/><entry/><entry>3-Decenoic acid</entry><entry/><entry>0.15625</entry></row><row><entry/><entry/><entry>9-Decenoic acid</entry><entry/><entry>0.078125</entry></row><row><entry>1</entry><entry>Penthiopyrad</entry><entry>Trans-3-hexenoic acid</entry><entry>0.125</entry><entry>0.039062</entry><entry>0.3</entry><entry>0.38</entry></row><row><entry>2</entry><entry>Penthiopyrad</entry><entry>3-Heptenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.38</entry></row><row><entry>3</entry><entry>Penthiopyrad</entry><entry>Trans-2-nonenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.50</entry></row><row><entry>4</entry><entry>Penthiopyrad</entry><entry>3-Decenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.38</entry></row><row><entry>5</entry><entry>Penthiopyrad</entry><entry>9-Decenoic acid</entry><entry>0.125</entry><entry>0.019531</entry><entry>0.16</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0274" num="0000"><tables id="TABLE-US-00090" num="00090"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="315pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 88</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Growth inhibition of <i>Sclerotinia sclerotiorum </i>by prothioconazole, in combination</entry></row><row><entry>with various exemplary saturated, unsaturated, and substituted aliphatic acids.</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="center"/><colspec colname="5" colwidth="35pt" align="center"/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry/><entry/><entry>MIC (A)</entry><entry>MIC (B)</entry><entry>Ratio Compound</entry><entry>FIC</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>(mg/mL)</entry><entry>(mg/mL)</entry><entry>B/Compound A</entry><entry>Index</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="70pt" align="left"/><colspec colname="4" colwidth="35pt" align="char" char="."/><colspec colname="5" colwidth="35pt" align="char" char="."/><colspec colname="6" colwidth="56pt" align="center"/><colspec colname="7" colwidth="21pt" align="center"/><tbody valign="top"><row><entry/><entry>Prothioconazole</entry><entry/><entry>0.0625</entry><entry/><entry/><entry/></row><row><entry/><entry/><entry>2-Hydroxybutyric acid</entry><entry/><entry>5</entry></row><row><entry>1</entry><entry>Prothioconazole</entry><entry>2-Hydroxybutyric acid</entry><entry>0.015625</entry><entry>1.25</entry><entry>80</entry><entry>0.50</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0275" num="0260">Predictive Methods</p><p id="p-0276" num="0261">In the experimental methods and results listed above, synergistic efficacy is shown for many exemplary synergistic pesticidal compositions according to some embodiments of the present disclosure, such synergistic pesticidal compositions comprising at least a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12) saturated or unsaturated aliphatic acid or salt thereof. In addition to the above listed experimental methods, it is desirable to additionally employ predictive methods for predicting synergistic efficacy of a pesticidal composition comprising at least a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12) saturated or unsaturated aliphatic acid or salt thereof. Accordingly, a synergistic composition predictive model was constructed using neural network machine learning computational techniques, to provide a synergistic compound screening system that is trained using experimentally determined in vitro results showing synergistic and non-synergistic pesticidal efficacy of pesticidal compositions comprising a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12) saturated or unsaturated aliphatic acid or salt thereof, and which determines a probability of synergistic efficacy of a specific such pesticidal composition.</p><p id="p-0277" num="0262">In one embodiment of the present disclosure, a synergistic composition predictive system was constructed using an ensemble of machine learning models, and which provides a predicted probability that a candidate pesticidal composition comprising a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12) saturated or unsaturated aliphatic acid or salt thereof will exhibit synergistic pesticidal efficacy in vitro against a target pathogen or pest. Each individual predictive model within the ensemble was initialized differently and each such model was trained using a selected portion of an in vitro synergistic pesticidal composition training dataset, leaving a remaining portion of the dataset for validation of each individual predictive model. This approach allows for a diversity between the individual predictive models in the ensemble, resulting in improved average predictive accuracy of the combined predictions of synergy across the ensemble of models, for a particular candidate pesticidal composition comprising a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12) saturated or unsaturated aliphatic acid or salt. In the present predictive method, a separate synergistic composition predictive model was constructed for predicting probability of synergy of a candidate pesticidal composition for each of three exemplary target pathogens or pests, including <i>Fusarium oxysporum, Botrytis cinerea</i>, and <i>Sclerotinia sclerotiorum</i>, and each such model was trained using an experimentally obtained dataset of in vitro synergistic efficacy results for a multiplicity of in vitro screened pesticidal compositions comprising a pesticidal active ingredient and a C4-C10 (or in alternative embodiments, alternatively C11 or C12). Each such model was validated using non-training portions of the in vitro experimental synergistic pesticidal composition dataset for the relevant pathogen, to determine and optimize its predictive performance in predicting in vitro synergy.</p><p id="p-0278" num="0263">In some embodiments, <i>Fusarium oxysporum </i>was used as a representative pest organism or pathogen to determine a predicted probability of synergy for pesticidal compositions comprising a pesticidal active ingredient agent (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent or salt thereof (compound B). In other embodiments, <i>Botrytis cinerea </i>was used as a representative pest organism or pathogen to determine a predicted probability of synergy for pesticidal compositions comprising a pesticidal active ingredient (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent or salt thereof (compound B). In further embodiments, <i>Sclerotinia sclerotiorum </i>was used as a representative pest organism or pathogen to determine a predicted probability of synergy for pesticidal compositions comprising a pesticidal active ingredient (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent or salt thereof (compound B). In some embodiments, an exemplary threshold of predicted probability of synergy greater than 55% (or 0.55) was applied to determine exemplary predictions of in vitro synergistic interaction between a pesticidal active ingredient (compound A) and one or more C4-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid agent or salt thereof (compound B) in a synergistic pesticidal composition. Results of exemplary predictions of in vitro synergistic pesticidal efficacy against an exemplary pathogen or pest made using a synergistic composition predictive system as described above are shown in the following Tables 89-91.</p><heading id="h-0033" level="1">PREDICTED EXAMPLES</heading><p id="p-0279" num="0264">Example 24: Predicted synergistic efficacy for in vitro growth inhibition of <i>Fusarium oxysporum </i>by benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, and valifenalate, in combination with various exemplary saturated and unsaturated C4-C12 aliphatic acids, according to an embodiment of the present disclosure.</p><p id="p-0280" num="0265">A prediction of probability of synergistic efficacy for each combination of benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, and valifenalate (Compound A) and a saturated or unsaturated aliphatic acid (Compound B) compound was determined using a synergistic composition predictive model trained using an experimental in vitro synergistic efficacy dataset for in vitro growth inhibition of <i>Fusarium oxysporum</i>. The resulting synergistic efficacy predictions are shown in Table 89 below.</p><p id="p-0281" num="0000"><tables id="TABLE-US-00091" num="00091"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="266pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 89</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Predicted synergistic efficacy for in vitro growth inhibition of <i>Fusarium oxysporum</i></entry></row><row><entry>by benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine,</entry></row><row><entry>florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl,</entry></row><row><entry>metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole,</entry></row><row><entry>pydiflumetofen, revysol, sedaxane, trifloxystrobin, and valifenalate, in combination</entry></row><row><entry>with various exemplary saturated and unsaturated C4-C12 aliphatic acids according</entry></row><row><entry>to an embodiment of the present disclosure</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry/><entry/><entry/><entry>Predicted</entry><entry/></row><row><entry/><entry/><entry/><entry>Probability of</entry><entry>Synergistic</entry></row><row><entry/><entry/><entry/><entry>Synergistic</entry><entry>Efficacy</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>Efficacy</entry><entry>Prediction</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="char" char="."/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry>1</entry><entry>Benzovindiflupyr</entry><entry>2-aminohexanoic acid</entry><entry>0.5767963</entry><entry>Likely</entry></row><row><entry>2</entry><entry>Benzovindiflupyr</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.55433092</entry><entry>Likely</entry></row><row><entry>3</entry><entry>Benzovindiflupyr</entry><entry>3-hydroxydecanoic acid</entry><entry>0.55428505</entry><entry>Likely</entry></row><row><entry>4</entry><entry>Benzovindiflupyr</entry><entry>2-hydroxybutyric acid</entry><entry>0.55139626</entry><entry>Likely</entry></row><row><entry>5</entry><entry>Benzovindiflupyr</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.55136665</entry><entry>Likely</entry></row><row><entry>6</entry><entry>Benzovindiflupyr</entry><entry>2-aminobutyric acid</entry><entry>0.55121322</entry><entry>Likely</entry></row><row><entry>7</entry><entry>Bixafen</entry><entry>2-aminohexanoic acid</entry><entry>0.5986134</entry><entry>Likely</entry></row><row><entry>8</entry><entry>Bixafen</entry><entry>3-hydroxydecanoic acid</entry><entry>0.59260478</entry><entry>Likely</entry></row><row><entry>9</entry><entry>Bixafen</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.59127055</entry><entry>Likely</entry></row><row><entry>10</entry><entry>Bixafen</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.58412244</entry><entry>Likely</entry></row><row><entry>11</entry><entry>Bixafen</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.58250974</entry><entry>Likely</entry></row><row><entry>12</entry><entry>Bixafen</entry><entry>2-hydroxybutyric acid</entry><entry>0.58020663</entry><entry>Likely</entry></row><row><entry>13</entry><entry>Bixafen</entry><entry>2-aminobutyric acid</entry><entry>0.57291304</entry><entry>Likely</entry></row><row><entry>14</entry><entry>Bixafen</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.55678314</entry><entry>Likely</entry></row><row><entry>15</entry><entry>Bixafen</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.55412076</entry><entry>Likely</entry></row><row><entry>16</entry><entry>Boscalid</entry><entry>2-aminohexanoic acid</entry><entry>0.56465167</entry><entry>Likely</entry></row><row><entry>17</entry><entry>Boscalid</entry><entry>2-hydroxybutyric acid</entry><entry>0.55472363</entry><entry>Likely</entry></row><row><entry>18</entry><entry>Boscalid</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.55112691</entry><entry>Likely</entry></row><row><entry>19</entry><entry>Cyproconazole</entry><entry>2-aminohexanoic acid</entry><entry>0.57628425</entry><entry>Likely</entry></row><row><entry>20</entry><entry>Fenpicoxamid</entry><entry>2-aminohexanoic acid</entry><entry>0.58695443</entry><entry>Likely</entry></row><row><entry>21</entry><entry>Fenpicoxamid</entry><entry>2-aminobutyric acid</entry><entry>0.56769621</entry><entry>Likely</entry></row><row><entry>22</entry><entry>Fenpicoxamid</entry><entry>2-hydroxybutyric acid</entry><entry>0.56525598</entry><entry>Likely</entry></row><row><entry>23</entry><entry>Fenpicoxamid</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.55343788</entry><entry>Likely</entry></row><row><entry>24</entry><entry>Fenpyrazamine</entry><entry>2-aminohexanoic acid</entry><entry>0.59352859</entry><entry>Likely</entry></row><row><entry>25</entry><entry>Fenpyrazamine</entry><entry>3-hydroxydecanoic acid</entry><entry>0.58132785</entry><entry>Likely</entry></row><row><entry>26</entry><entry>Fenpyrazamine</entry><entry>2-aminobutyric acid</entry><entry>0.5700103</entry><entry>Likely</entry></row><row><entry>27</entry><entry>Fenpyrazamine</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.55568954</entry><entry>Likely</entry></row><row><entry>28</entry><entry>Fenpyrazamine</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.55427292</entry><entry>Likely</entry></row><row><entry>29</entry><entry>Fenpyrazamine</entry><entry>3-aminobutyric acid</entry><entry>0.55375423</entry><entry>Likely</entry></row><row><entry>30</entry><entry>Fenpyrazamine</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.5508373</entry><entry>Likely</entry></row><row><entry>31</entry><entry>Florylpicoxamid</entry><entry>2-aminohexanoic acid</entry><entry>0.63476055</entry><entry>Likely</entry></row><row><entry>32</entry><entry>Florylpicoxamid</entry><entry>2-hydroxybutyric acid</entry><entry>0.61054637</entry><entry>Likely</entry></row><row><entry>33</entry><entry>Florylpicoxamid</entry><entry>2-aminobutyric acid</entry><entry>0.60774106</entry><entry>Likely</entry></row><row><entry>34</entry><entry>Florylpicoxamid</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.60711867</entry><entry>Likely</entry></row><row><entry>35</entry><entry>Florylpicoxamid</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.60666923</entry><entry>Likely</entry></row><row><entry>36</entry><entry>Florylpicoxamid</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.59813283</entry><entry>Likely</entry></row><row><entry>37</entry><entry>Florylpicoxamid</entry><entry>3-hydroxydecanoic acid</entry><entry>0.58653796</entry><entry>Likely</entry></row><row><entry>38</entry><entry>Florylpicoxamid</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.58024375</entry><entry>Likely</entry></row><row><entry>39</entry><entry>Florylpicoxamid</entry><entry>octanoic acid</entry><entry>0.57787609</entry><entry>Likely</entry></row><row><entry>40</entry><entry>Florylpicoxamid</entry><entry>heptanoic acid</entry><entry>0.57581491</entry><entry>Likely</entry></row><row><entry>41</entry><entry>Florylpicoxamid</entry><entry>hexanoic acid</entry><entry>0.57327745</entry><entry>Likely</entry></row><row><entry>42</entry><entry>Florylpicoxamid</entry><entry>decanoic acid</entry><entry>0.56412624</entry><entry>Likely</entry></row><row><entry>43</entry><entry>Florylpicoxamid</entry><entry>3-aminobutyric acid</entry><entry>0.56136031</entry><entry>Likely</entry></row><row><entry>44</entry><entry>Florylpicoxamid</entry><entry>3-hydroxybutyric acid</entry><entry>0.56075103</entry><entry>Likely</entry></row><row><entry>45</entry><entry>Florylpicoxamid</entry><entry>nonanoic acid</entry><entry>0.55557516</entry><entry>Likely</entry></row><row><entry>46</entry><entry>Florylpicoxamid</entry><entry>dodecanoic acid</entry><entry>0.55174383</entry><entry>Likely</entry></row><row><entry>47</entry><entry>Flutriafol</entry><entry>2-aminohexanoic acid</entry><entry>0.64187107</entry><entry>Likely</entry></row><row><entry>48</entry><entry>Flutriafol</entry><entry>2-aminobutyric acid</entry><entry>0.61206777</entry><entry>Likely</entry></row><row><entry>49</entry><entry>Flutriafol</entry><entry>2-hydroxybutyric acid</entry><entry>0.61086082</entry><entry>Likely</entry></row><row><entry>50</entry><entry>Flutriafol</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.60704852</entry><entry>Likely</entry></row><row><entry>51</entry><entry>Flutriafol</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.60100349</entry><entry>Likely</entry></row><row><entry>52</entry><entry>Flutriafol</entry><entry>3-hydroxydecanoic acid</entry><entry>0.59106896</entry><entry>Likely</entry></row><row><entry>53</entry><entry>Flutriafol</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.58686044</entry><entry>Likely</entry></row><row><entry>54</entry><entry>Flutriafol</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.56472518</entry><entry>Likely</entry></row><row><entry>55</entry><entry>Flutriafol</entry><entry>3-aminobutyric acid</entry><entry>0.55888988</entry><entry>Likely</entry></row><row><entry>56</entry><entry>Fluxapyroxad</entry><entry>2-aminohexanoic acid</entry><entry>0.65365264</entry><entry>Likely</entry></row><row><entry>57</entry><entry>Fluxapyroxad</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.63406985</entry><entry>Likely</entry></row><row><entry>58</entry><entry>Fluxapyroxad</entry><entry>3-hydroxydecanoic acid</entry><entry>0.63228451</entry><entry>Likely</entry></row><row><entry>59</entry><entry>Fluxapyroxad</entry><entry>2-aminobutyric acid</entry><entry>0.63064658</entry><entry>Likely</entry></row><row><entry>60</entry><entry>Fluxapyroxad</entry><entry>2-hydroxybutyric acid</entry><entry>0.62910696</entry><entry>Likely</entry></row><row><entry>61</entry><entry>Fluxapyroxad</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.62872769</entry><entry>Likely</entry></row><row><entry>62</entry><entry>Fluxapyroxad</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.62480617</entry><entry>Likely</entry></row><row><entry>63</entry><entry>Fluxapyroxad</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.59925105</entry><entry>Likely</entry></row><row><entry>64</entry><entry>Fluxapyroxad</entry><entry>3-aminobutyric acid</entry><entry>0.59057821</entry><entry>Likely</entry></row><row><entry>65</entry><entry>Fluxapyroxad</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.58737963</entry><entry>Likely</entry></row><row><entry>66</entry><entry>Fluxapyroxad</entry><entry>octanoic acid</entry><entry>0.58452264</entry><entry>Likely</entry></row><row><entry>67</entry><entry>Fluxapyroxad</entry><entry>3-hydroxybutyric acid</entry><entry>0.5824682</entry><entry>Likely</entry></row><row><entry>68</entry><entry>Fluxapyroxad</entry><entry>heptanoic acid</entry><entry>0.58077161</entry><entry>Likely</entry></row><row><entry>69</entry><entry>Fluxapyroxad</entry><entry>10-hydroxydecanoic acid</entry><entry>0.57686063</entry><entry>Likely</entry></row><row><entry>70</entry><entry>Fluxapyroxad</entry><entry>nonanoic acid</entry><entry>0.57673815</entry><entry>Likely</entry></row><row><entry>71</entry><entry>Fluxapyroxad</entry><entry>hexanoic acid</entry><entry>0.57447241</entry><entry>Likely</entry></row><row><entry>72</entry><entry>Fluxapyroxad</entry><entry>decanoic acid</entry><entry>0.5742406</entry><entry>Likely</entry></row><row><entry>73</entry><entry>Fluxapyroxad</entry><entry>dodecanoic acid</entry><entry>0.56431965</entry><entry>Likely</entry></row><row><entry>74</entry><entry>Isopyrazam</entry><entry>2-aminohexanoic acid</entry><entry>0.59632861</entry><entry>Likely</entry></row><row><entry>75</entry><entry>Isopyrazam</entry><entry>3-hydroxydecanoic acid</entry><entry>0.58139259</entry><entry>Likely</entry></row><row><entry>76</entry><entry>Isopyrazam</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.58047971</entry><entry>Likely</entry></row><row><entry>77</entry><entry>Isopyrazam</entry><entry>2-aminobutyric acid</entry><entry>0.57527404</entry><entry>Likely</entry></row><row><entry>78</entry><entry>Isopyrazam</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.57359112</entry><entry>Likely</entry></row><row><entry>79</entry><entry>Isopyrazam</entry><entry>2-hydroxybutyric acid</entry><entry>0.57283605</entry><entry>Likely</entry></row><row><entry>80</entry><entry>Isopyrazam</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.56890551</entry><entry>Likely</entry></row><row><entry>81</entry><entry>Isotianil</entry><entry>2-aminohexanoic acid</entry><entry>0.55867075</entry><entry>Likely</entry></row><row><entry>82</entry><entry>Kresoxim-methyl</entry><entry>2-aminohexanoic acid</entry><entry>0.67504148</entry><entry>Likely</entry></row><row><entry>83</entry><entry>Kresoxim-methyl</entry><entry>2-aminobutyric acid</entry><entry>0.65768701</entry><entry>Likely</entry></row><row><entry>84</entry><entry>Kresoxim-methyl</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.65029321</entry><entry>Likely</entry></row><row><entry>85</entry><entry>Kresoxim-methyl</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.64980065</entry><entry>Likely</entry></row><row><entry>86</entry><entry>Kresoxim-methyl</entry><entry>2-hydroxybutyric acid</entry><entry>0.64942813</entry><entry>Likely</entry></row><row><entry>87</entry><entry>Kresoxim-methyl</entry><entry>3-hydroxydecanoic acid</entry><entry>0.6411885</entry><entry>Likely</entry></row><row><entry>88</entry><entry>Kresoxim-methyl</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.63833933</entry><entry>Likely</entry></row><row><entry>89</entry><entry>Kresoxim-methyl</entry><entry>3-aminobutyric acid</entry><entry>0.62326319</entry><entry>Likely</entry></row><row><entry>90</entry><entry>Kresoxim-methyl</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.62174223</entry><entry>Likely</entry></row><row><entry>91</entry><entry>Kresoxim-methyl</entry><entry>octanoic acid</entry><entry>0.61937875</entry><entry>Likely</entry></row><row><entry>92</entry><entry>Kresoxim-methyl</entry><entry>heptanoic acid</entry><entry>0.6178017</entry><entry>Likely</entry></row><row><entry>93</entry><entry>Kresoxim-methyl</entry><entry>hexanoic acid</entry><entry>0.6141121</entry><entry>Likely</entry></row><row><entry>94</entry><entry>Kresoxim-methyl</entry><entry>nonanoic acid</entry><entry>0.61324196</entry><entry>Likely</entry></row><row><entry>95</entry><entry>Kresoxim-methyl</entry><entry>decanoic acid</entry><entry>0.6072263</entry><entry>Likely</entry></row><row><entry>96</entry><entry>Kresoxim-methyl</entry><entry>3-hydroxybutyric acid</entry><entry>0.60505759</entry><entry>Likely</entry></row><row><entry>97</entry><entry>Kresoxim-methyl</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.5980929</entry><entry>Likely</entry></row><row><entry>98</entry><entry>Kresoxim-methyl</entry><entry>dodecanoic acid</entry><entry>0.59499285</entry><entry>Likely</entry></row><row><entry>99</entry><entry>Kresoxim-methyl</entry><entry>10-hydroxydecanoic acid</entry><entry>0.58491864</entry><entry>Likely</entry></row><row><entry>100</entry><entry>Metrafenone</entry><entry>2-aminohexanoic acid</entry><entry>0.55733598</entry><entry>Likely</entry></row><row><entry>101</entry><entry>Oxathiapiprolin</entry><entry>2-aminohexanoic acid</entry><entry>0.60657606</entry><entry>Likely</entry></row><row><entry>102</entry><entry>Oxathiapiprolin</entry><entry>2-aminobutyric acid</entry><entry>0.57620296</entry><entry>Likely</entry></row><row><entry>103</entry><entry>Oxathiapiprolin</entry><entry>2-hydroxybutyric acid</entry><entry>0.57121888</entry><entry>Likely</entry></row><row><entry>104</entry><entry>Oxathiapiprolin</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.56699662</entry><entry>Likely</entry></row><row><entry>105</entry><entry>Oxathiapiprolin</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.56303861</entry><entry>Likely</entry></row><row><entry>106</entry><entry>Oxathiapiprolin</entry><entry>3-hydroxydecanoic acid</entry><entry>0.55268361</entry><entry>Likely</entry></row><row><entry>107</entry><entry>Penflufen</entry><entry>2-aminohexanoic acid</entry><entry>0.65852257</entry><entry>Likely</entry></row><row><entry>108</entry><entry>Penflufen</entry><entry>3-hydroxydecanoic acid</entry><entry>0.64106452</entry><entry>Likely</entry></row><row><entry>109</entry><entry>Penflufen</entry><entry>2-aminobutyric acid</entry><entry>0.63676316</entry><entry>Likely</entry></row><row><entry>110</entry><entry>Penflufen</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.63645035</entry><entry>Likely</entry></row><row><entry>111</entry><entry>Penflufen</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.63215253</entry><entry>Likely</entry></row><row><entry>112</entry><entry>Penflufen</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.62836813</entry><entry>Likely</entry></row><row><entry>113</entry><entry>Penflufen</entry><entry>2-hydroxybutyric acid</entry><entry>0.62790927</entry><entry>Likely</entry></row><row><entry>114</entry><entry>Penflufen</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.61006622</entry><entry>Likely</entry></row><row><entry>115</entry><entry>Penflufen</entry><entry>3-aminobutyric acid</entry><entry>0.60708461</entry><entry>Likely</entry></row><row><entry>116</entry><entry>Penflufen</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.60651148</entry><entry>Likely</entry></row><row><entry>117</entry><entry>Penflufen</entry><entry>octanoic acid</entry><entry>0.60432406</entry><entry>Likely</entry></row><row><entry>118</entry><entry>Penflufen</entry><entry>nonanoic acid</entry><entry>0.59918836</entry><entry>Likely</entry></row><row><entry>119</entry><entry>Penflufen</entry><entry>heptanoic acid</entry><entry>0.59838795</entry><entry>Likely</entry></row><row><entry>120</entry><entry>Penflufen</entry><entry>10-hydroxydecanoic acid</entry><entry>0.59837799</entry><entry>Likely</entry></row><row><entry>121</entry><entry>Penflufen</entry><entry>decanoic acid</entry><entry>0.59424908</entry><entry>Likely</entry></row><row><entry>122</entry><entry>Penflufen</entry><entry>3-hydroxybutyric acid</entry><entry>0.59419846</entry><entry>Likely</entry></row><row><entry>123</entry><entry>Penflufen</entry><entry>hexanoic acid</entry><entry>0.59271353</entry><entry>Likely</entry></row><row><entry>124</entry><entry>Penflufen</entry><entry>dodecanoic acid</entry><entry>0.5846236</entry><entry>Likely</entry></row><row><entry>125</entry><entry>Penthiopyrad</entry><entry>2-aminohexanoic acid</entry><entry>0.60944926</entry><entry>Likely</entry></row><row><entry>126</entry><entry>Penthiopyrad</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.59583883</entry><entry>Likely</entry></row><row><entry>127</entry><entry>Penthiopyrad</entry><entry>3-hydroxydecanoic acid</entry><entry>0.59161762</entry><entry>Likely</entry></row><row><entry>128</entry><entry>Penthiopyrad</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.58502914</entry><entry>Likely</entry></row><row><entry>129</entry><entry>Penthiopyrad</entry><entry>2-aminobutyric acid</entry><entry>0.58086249</entry><entry>Likely</entry></row><row><entry>130</entry><entry>Penthiopyrad</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.57843716</entry><entry>Likely</entry></row><row><entry>131</entry><entry>Penthiopyrad</entry><entry>2-hydroxybutyric acid</entry><entry>0.57289048</entry><entry>Likely</entry></row><row><entry>132</entry><entry>Penthiopyrad</entry><entry>octanoic acid</entry><entry>0.56894523</entry><entry>Likely</entry></row><row><entry>133</entry><entry>Penthiopyrad</entry><entry>nonanoic acid</entry><entry>0.56465257</entry><entry>Likely</entry></row><row><entry>134</entry><entry>Penthiopyrad</entry><entry>heptanoic acid</entry><entry>0.56091047</entry><entry>Likely</entry></row><row><entry>135</entry><entry>Penthiopyrad</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.55971519</entry><entry>Likely</entry></row><row><entry>136</entry><entry>Penthiopyrad</entry><entry>decanoic acid</entry><entry>0.55588841</entry><entry>Likely</entry></row><row><entry>137</entry><entry>Picoxystrobin</entry><entry>2-aminohexanoic acid</entry><entry>0.67534766</entry><entry>Likely</entry></row><row><entry>138</entry><entry>Picoxystrobin</entry><entry>2-hydroxybutyric acid</entry><entry>0.6576197</entry><entry>Likely</entry></row><row><entry>139</entry><entry>Picoxystrobin</entry><entry>2-aminobutyric acid</entry><entry>0.65465706</entry><entry>Likely</entry></row><row><entry>140</entry><entry>Picoxystrobin</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.65034573</entry><entry>Likely</entry></row><row><entry>141</entry><entry>Picoxystrobin</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.64606039</entry><entry>Likely</entry></row><row><entry>142</entry><entry>Picoxystrobin</entry><entry>3-hydroxydecanoic acid</entry><entry>0.62761118</entry><entry>Likely</entry></row><row><entry>143</entry><entry>Picoxystrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.62541364</entry><entry>Likely</entry></row><row><entry>144</entry><entry>Picoxystrobin</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.60288031</entry><entry>Likely</entry></row><row><entry>145</entry><entry>Picoxystrobin</entry><entry>3-aminobutyric acid</entry><entry>0.60074316</entry><entry>Likely</entry></row><row><entry>146</entry><entry>Picoxystrobin</entry><entry>octanoic acid</entry><entry>0.59284889</entry><entry>Likely</entry></row><row><entry>147</entry><entry>Picoxystrobin</entry><entry>heptanoic acid</entry><entry>0.59142244</entry><entry>Likely</entry></row><row><entry>148</entry><entry>Picoxystrobin</entry><entry>3-hydroxybutyric acid</entry><entry>0.5895552</entry><entry>Likely</entry></row><row><entry>149</entry><entry>Picoxystrobin</entry><entry>hexanoic acid</entry><entry>0.58764771</entry><entry>Likely</entry></row><row><entry>150</entry><entry>Picoxystrobin</entry><entry>nonanoic acid</entry><entry>0.58643743</entry><entry>Likely</entry></row><row><entry>151</entry><entry>Picoxystrobin</entry><entry>decanoic acid</entry><entry>0.58045772</entry><entry>Likely</entry></row><row><entry>152</entry><entry>Picoxystrobin</entry><entry>dodecanoic acid</entry><entry>0.56836147</entry><entry>Likely</entry></row><row><entry>153</entry><entry>Picoxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.55987424</entry><entry>Likely</entry></row><row><entry>154</entry><entry>Prothiaconazole</entry><entry>2-aminohexanoic acid</entry><entry>0.55020457</entry><entry>Likely</entry></row><row><entry>155</entry><entry>Pydiflumetofen</entry><entry>2-aminohexanoic acid</entry><entry>0.59467448</entry><entry>Likely</entry></row><row><entry/><entry>(Adepidyn)</entry></row><row><entry>156</entry><entry>Pydiflumetofen</entry><entry>2-aminobutyric acid</entry><entry>0.56779618</entry><entry>Likely</entry></row><row><entry/><entry>(Adepidyn)</entry></row><row><entry>157</entry><entry>Pydiflumetofen</entry><entry>3-hydroxydecanoic acid</entry><entry>0.55150402</entry><entry>Likely</entry></row><row><entry/><entry>(Adepidyn)</entry></row><row><entry>158</entry><entry>Pydiflumetofen</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.55106064</entry><entry>Likely</entry></row><row><entry/><entry>(Adepidyn)</entry></row><row><entry>159</entry><entry>Revysol</entry><entry>2-aminohexanoic acid</entry><entry>0.63962624</entry><entry>Likely</entry></row><row><entry>160</entry><entry>Revysol</entry><entry>2-aminobutyric acid</entry><entry>0.6040647</entry><entry>Likely</entry></row><row><entry>161</entry><entry>Revysol</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.57211448</entry><entry>Likely</entry></row><row><entry>162</entry><entry>Revysol</entry><entry>2-hydroxybutyric acid</entry><entry>0.57152455</entry><entry>Likely</entry></row><row><entry>163</entry><entry>Revysol</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.5706463</entry><entry>Likely</entry></row><row><entry>164</entry><entry>Revysol</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.5657302</entry><entry>Likely</entry></row><row><entry>165</entry><entry>Revysol</entry><entry>3-hydroxydecanoic acid</entry><entry>0.56351714</entry><entry>Likely</entry></row><row><entry>166</entry><entry>Revysol</entry><entry>3-aminobutyric acid</entry><entry>0.55580375</entry><entry>Likely</entry></row><row><entry>167</entry><entry>Revysol</entry><entry>octanoic acid</entry><entry>0.55272278</entry><entry>Likely</entry></row><row><entry>168</entry><entry>Revysol</entry><entry>decanoic acid</entry><entry>0.55074132</entry><entry>Likely</entry></row><row><entry>169</entry><entry>Sedaxane</entry><entry>2-aminohexanoic acid</entry><entry>0.61273053</entry><entry>Likely</entry></row><row><entry>170</entry><entry>Sedaxane</entry><entry>2-hydroxybutyric acid</entry><entry>0.60053037</entry><entry>Likely</entry></row><row><entry>171</entry><entry>Sedaxane</entry><entry>2-aminobutyric acid</entry><entry>0.59536255</entry><entry>Likely</entry></row><row><entry>172</entry><entry>Sedaxane</entry><entry>3-hydroxydecanoic acid</entry><entry>0.58749265</entry><entry>Likely</entry></row><row><entry>173</entry><entry>Sedaxane</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.58642283</entry><entry>Likely</entry></row><row><entry>174</entry><entry>Sedaxane</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.58351983</entry><entry>Likely</entry></row><row><entry>175</entry><entry>Sedaxane</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.58184892</entry><entry>Likely</entry></row><row><entry>176</entry><entry>Sedaxane</entry><entry>3-aminobutyric acid</entry><entry>0.57278869</entry><entry>Likely</entry></row><row><entry>177</entry><entry>Sedaxane</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.56216563</entry><entry>Likely</entry></row><row><entry>178</entry><entry>Sedaxane</entry><entry>3-hydroxybutyric acid</entry><entry>0.55541366</entry><entry>Likely</entry></row><row><entry>179</entry><entry>Trifloxystrobin</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.65884011</entry><entry>Likely</entry></row><row><entry>180</entry><entry>Trifloxystrobin</entry><entry>2-hydroxyhexanoic acid</entry><entry>0.6587482</entry><entry>Likely</entry></row><row><entry>181</entry><entry>Trifloxystrobin</entry><entry>2-aminobutyric acid</entry><entry>0.65764501</entry><entry>Likely</entry></row><row><entry>182</entry><entry>Trifloxystrobin</entry><entry>2-hydroxybutyric acid</entry><entry>0.65679943</entry><entry>Likely</entry></row><row><entry>183</entry><entry>Trifloxystrobin</entry><entry>3-hydroxydecanoic acid</entry><entry>0.64921461</entry><entry>Likely</entry></row><row><entry>184</entry><entry>Trifloxystrobin</entry><entry>3-hydroxyoctanoic acid</entry><entry>0.64454011</entry><entry>Likely</entry></row><row><entry>185</entry><entry>Trifloxystrobin</entry><entry>3-hydroxyhexanoic acid</entry><entry>0.62748345</entry><entry>Likely</entry></row><row><entry>186</entry><entry>Trifloxystrobin</entry><entry>3-aminobutyric acid</entry><entry>0.62415011</entry><entry>Likely</entry></row><row><entry>187</entry><entry>Trifloxystrobin</entry><entry>octanoic acid</entry><entry>0.6218323</entry><entry>Likely</entry></row><row><entry>188</entry><entry>Trifloxystrobin</entry><entry>heptanoic acid</entry><entry>0.62072241</entry><entry>Likely</entry></row><row><entry>189</entry><entry>Trifloxystrobin</entry><entry>hexanoic acid</entry><entry>0.61619104</entry><entry>Likely</entry></row><row><entry>190</entry><entry>Trifloxystrobin</entry><entry>nonanoic acid</entry><entry>0.61475129</entry><entry>Likely</entry></row><row><entry>191</entry><entry>Trifloxystrobin</entry><entry>3-hydroxybutyric acid</entry><entry>0.61418406</entry><entry>Likely</entry></row><row><entry>192</entry><entry>Trifloxystrobin</entry><entry>decanoic acid</entry><entry>0.60804051</entry><entry>Likely</entry></row><row><entry>193</entry><entry>Trifloxystrobin</entry><entry>dodecanoic acid</entry><entry>0.59491928</entry><entry>Likely</entry></row><row><entry>194</entry><entry>Trifloxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.59290993</entry><entry>Likely</entry></row><row><entry>195</entry><entry>Trifloxystrobin</entry><entry>10-hydroxydecanoic acid</entry><entry>0.57914078</entry><entry>Likely</entry></row><row><entry>196</entry><entry>Valifenalate</entry><entry>2-aminohexanoic acid</entry><entry>0.5944192</entry><entry>Likely</entry></row><row><entry>197</entry><entry>Valifenalate</entry><entry>2-aminobutyric acid</entry><entry>0.56510459</entry><entry>Likely</entry></row><row><entry>198</entry><entry>Valifenalate</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.55897016</entry><entry>Likely</entry></row><row><entry>199</entry><entry>Valifenalate</entry><entry>3-hydroxydecanoic acid</entry><entry>0.55603569</entry><entry>Likely</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0282" num="0266">Example 25: Predicted synergistic efficacy for in vitro growth inhibition of <i>Sclerotinia sclerotiorum </i>by bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, penflufen, penthiopyrad, picoxystrobin, pydiflumetofen, revysol, trifloxystrobin, and valifenalate, in combination with various exemplary saturated and unsaturated C4-C12 aliphatic acids, according to an embodiment of the present disclosure.</p><p id="p-0283" num="0267">A prediction of probability of synergistic efficacy for each combination of bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, penflufen, penthiopyrad, picoxystrobin, pydiflumetofen, revysol, trifloxystrobin, and valifenalate (Compound A) and saturated or unsaturated aliphatic acid (Compound B) compound was determined using a synergistic composition predictive model trained using an experimental in vitro synergistic efficacy dataset for in vitro growth inhibition of <i>Sclerotinia sclerotiorum</i>. The resulting synergistic efficacy predictions are shown in Table 90 below.</p><p id="p-0284" num="0000"><tables id="TABLE-US-00092" num="00092"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="294pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 90</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Predicted synergistic efficacy for in vitro growth inhibition of <i>Sclerotinia sclerotiorum</i></entry></row><row><entry>by bixafen, boscalid, fenpicoxamid, fenpyrazimine, florylpicoxamid, fluxapyroxad,</entry></row><row><entry>isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad,</entry></row><row><entry>picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin,</entry></row><row><entry>and valifenalate, in combination with various exemplary C4-C12 saturated and unsaturated</entry></row><row><entry>aliphatic acids according to an embodiment of the present disclosure</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="84pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry/><entry/><entry/><entry>Predicted</entry><entry/></row><row><entry/><entry/><entry/><entry>Probability of</entry><entry>Synergistic</entry></row><row><entry/><entry/><entry/><entry>Synergistic</entry><entry>Efficacy</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>Efficacy</entry><entry>Prediction</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="84pt" align="left"/><colspec colname="3" colwidth="77pt" align="left"/><colspec colname="4" colwidth="49pt" align="char" char="."/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry>1</entry><entry>Bixafen</entry><entry>trans-2-nonenoic acid</entry><entry>0.63422002</entry><entry>Likely</entry></row><row><entry>2</entry><entry>Bixafen</entry><entry>trans-2-undecenoic acid</entry><entry>0.61975961</entry><entry>Likely</entry></row><row><entry>3</entry><entry>Bixafen</entry><entry>trans-2-decenoic acid</entry><entry>0.61877499</entry><entry>Likely</entry></row><row><entry>4</entry><entry>Bixafen</entry><entry>trans-2-octenoic acid</entry><entry>0.59647564</entry><entry>Likely</entry></row><row><entry>5</entry><entry>Bixafen</entry><entry>3-decenoic acid</entry><entry>0.56026628</entry><entry>Likely</entry></row><row><entry>6</entry><entry>Boscalid</entry><entry>trans-2-undecenoic acid</entry><entry>0.64000795</entry><entry>Likely</entry></row><row><entry>7</entry><entry>Boscalid</entry><entry>trans-2-decenoic acid</entry><entry>0.63932319</entry><entry>Likely</entry></row><row><entry>8</entry><entry>Boscalid</entry><entry>trans-2-nonenoic acid</entry><entry>0.63189319</entry><entry>Likely</entry></row><row><entry>9</entry><entry>Boscalid</entry><entry>trans-2-octenoic acid</entry><entry>0.6128523</entry><entry>Likely</entry></row><row><entry>10</entry><entry>Boscalid</entry><entry>3-decenoic acid</entry><entry>0.56328052</entry><entry>Likely</entry></row><row><entry>11</entry><entry>Boscalid</entry><entry>dodecanoic acid</entry><entry>0.5582064</entry><entry>Likely</entry></row><row><entry>12</entry><entry>Boscalid</entry><entry>decanoic acid</entry><entry>0.5560983</entry><entry>Likely</entry></row><row><entry>13</entry><entry>Boscalid</entry><entry>nonanoic acid</entry><entry>0.55505839</entry><entry>Likely</entry></row><row><entry>14</entry><entry>Boscalid</entry><entry>octanoic acid</entry><entry>0.55438775</entry><entry>Likely</entry></row><row><entry>15</entry><entry>Boscalid</entry><entry>3-nonenoic acid</entry><entry>0.55383059</entry><entry>Likely</entry></row><row><entry>16</entry><entry>Fenpicoxamid</entry><entry>trans-2-undecenoic acid</entry><entry>0.64517585</entry><entry>Likely</entry></row><row><entry>17</entry><entry>Fenpicoxamid</entry><entry>trans-2-decenoic acid</entry><entry>0.64430379</entry><entry>Likely</entry></row><row><entry>18</entry><entry>Fenpicoxamid</entry><entry>trans-2-nonenoic acid</entry><entry>0.63685218</entry><entry>Likely</entry></row><row><entry>19</entry><entry>Fenpicoxamid</entry><entry>trans-2-octenoic acid</entry><entry>0.61571277</entry><entry>Likely</entry></row><row><entry>20</entry><entry>Fenpicoxamid</entry><entry>3-decenoic acid</entry><entry>0.5717719</entry><entry>Likely</entry></row><row><entry>21</entry><entry>Fenpicoxamid</entry><entry>dodecanoic acid</entry><entry>0.56812335</entry><entry>Likely</entry></row><row><entry>22</entry><entry>Fenpicoxamid</entry><entry>decanoic acid</entry><entry>0.56706998</entry><entry>Likely</entry></row><row><entry>23</entry><entry>Fenpicoxamid</entry><entry>nonanoic acid</entry><entry>0.5660589</entry><entry>Likely</entry></row><row><entry>24</entry><entry>Fenpicoxamid</entry><entry>octanoic acid</entry><entry>0.56546112</entry><entry>Likely</entry></row><row><entry>25</entry><entry>Fenpicoxamid</entry><entry>heptanoic acid</entry><entry>0.56213194</entry><entry>Likely</entry></row><row><entry>26</entry><entry>Fenpicoxamid</entry><entry>3-nonenoic acid</entry><entry>0.56106859</entry><entry>Likely</entry></row><row><entry>27</entry><entry>Fenpyrazamine</entry><entry>trans-2-undecenoic acid</entry><entry>0.64570129</entry><entry>Likely</entry></row><row><entry>28</entry><entry>Fenpyrazamine</entry><entry>trans-2-decenoic acid</entry><entry>0.64445113</entry><entry>Likely</entry></row><row><entry>29</entry><entry>Fenpyrazamine</entry><entry>trans-2-nonenoic acid</entry><entry>0.64373701</entry><entry>Likely</entry></row><row><entry>30</entry><entry>Fenpyrazamine</entry><entry>trans-2-octenoic acid</entry><entry>0.61870502</entry><entry>Likely</entry></row><row><entry>31</entry><entry>Fenpyrazamine</entry><entry>3-decenoic acid</entry><entry>0.57072864</entry><entry>Likely</entry></row><row><entry>32</entry><entry>Fenpyrazamine</entry><entry>dodecanoic acid</entry><entry>0.56926688</entry><entry>Likely</entry></row><row><entry>33</entry><entry>Fenpyrazamine</entry><entry>decanoic acid</entry><entry>0.56696534</entry><entry>Likely</entry></row><row><entry>34</entry><entry>Fenpyrazamine</entry><entry>nonanoic acid</entry><entry>0.56557274</entry><entry>Likely</entry></row><row><entry>35</entry><entry>Fenpyrazamine</entry><entry>octanoic acid</entry><entry>0.56470615</entry><entry>Likely</entry></row><row><entry>36</entry><entry>Fenpyrazamine</entry><entry>3-nonenoic acid</entry><entry>0.56308404</entry><entry>Likely</entry></row><row><entry>37</entry><entry>Fenpyrazamine</entry><entry>heptanoic acid</entry><entry>0.56026874</entry><entry>Likely</entry></row><row><entry>38</entry><entry>Fenpyrazamine</entry><entry>trans-2-hexenoic acid</entry><entry>0.55896424</entry><entry>Likely</entry></row><row><entry>39</entry><entry>Fenpyrazamine</entry><entry>9-decenoic acid</entry><entry>0.55287297</entry><entry>Likely</entry></row><row><entry>40</entry><entry>Florylpicoxamid</entry><entry>trans-2-undecenoic acid</entry><entry>0.66003401</entry><entry>Likely</entry></row><row><entry>41</entry><entry>Florylpicoxamid</entry><entry>trans-2-decenoic acid</entry><entry>0.65861813</entry><entry>Likely</entry></row><row><entry>42</entry><entry>Florylpicoxamid</entry><entry>trans-2-nonenoic acid</entry><entry>0.65382792</entry><entry>Likely</entry></row><row><entry>43</entry><entry>Florylpicoxamid</entry><entry>trans-2-octenoic acid</entry><entry>0.63490106</entry><entry>Likely</entry></row><row><entry>44</entry><entry>Florylpicoxamid</entry><entry>3-decenoic acid</entry><entry>0.58621619</entry><entry>Likely</entry></row><row><entry>45</entry><entry>Florylpicoxamid</entry><entry>dodecanoic acid</entry><entry>0.5781119</entry><entry>Likely</entry></row><row><entry>46</entry><entry>Florylpicoxamid</entry><entry>3-nonenoic acid</entry><entry>0.57620949</entry><entry>Likely</entry></row><row><entry>47</entry><entry>Florylpicoxamid</entry><entry>trans-2-hexenoic acid</entry><entry>0.57501872</entry><entry>Likely</entry></row><row><entry>48</entry><entry>Florylpicoxamid</entry><entry>nonanoic acid</entry><entry>0.57407232</entry><entry>Likely</entry></row><row><entry>49</entry><entry>Florylpicoxamid</entry><entry>decanoic acid</entry><entry>0.5728504</entry><entry>Likely</entry></row><row><entry>50</entry><entry>Florylpicoxamid</entry><entry>octanoic acid</entry><entry>0.5696201</entry><entry>Likely</entry></row><row><entry>51</entry><entry>Florylpicoxamid</entry><entry>heptanoic acid</entry><entry>0.56792373</entry><entry>Likely</entry></row><row><entry>52</entry><entry>Florylpicoxamid</entry><entry>3-octenoic acid</entry><entry>0.55302533</entry><entry>Likely</entry></row><row><entry>53</entry><entry>Florylpicoxamid</entry><entry>hexanoic acid</entry><entry>0.55097026</entry><entry>Likely</entry></row><row><entry>54</entry><entry>Fluxapyroxad</entry><entry>trans-2-undecenoic acid</entry><entry>0.66353832</entry><entry>Likely</entry></row><row><entry>55</entry><entry>Fluxapyroxad</entry><entry>trans-2-decenoic acid</entry><entry>0.66228828</entry><entry>Likely</entry></row><row><entry>56</entry><entry>Fluxapyroxad</entry><entry>trans-2-nonenoic acid</entry><entry>0.65719566</entry><entry>Likely</entry></row><row><entry>57</entry><entry>Fluxapyroxad</entry><entry>trans-2-octenoic acid</entry><entry>0.63807777</entry><entry>Likely</entry></row><row><entry>58</entry><entry>Fluxapyroxad</entry><entry>3-decenoic acid</entry><entry>0.58704056</entry><entry>Likely</entry></row><row><entry>59</entry><entry>Fluxapyroxad</entry><entry>3-nonenoic acid</entry><entry>0.57704323</entry><entry>Likely</entry></row><row><entry>60</entry><entry>Fluxapyroxad</entry><entry>trans-2-hexenoic acid</entry><entry>0.56795649</entry><entry>Likely</entry></row><row><entry>61</entry><entry>Fluxapyroxad</entry><entry>dodecanoic acid</entry><entry>0.56294662</entry><entry>Likely</entry></row><row><entry>62</entry><entry>Fluxapyroxad</entry><entry>decanoic acid</entry><entry>0.56026234</entry><entry>Likely</entry></row><row><entry>63</entry><entry>Fluxapyroxad</entry><entry>nonanoic acid</entry><entry>0.55851251</entry><entry>Likely</entry></row><row><entry>64</entry><entry>Fluxapyroxad</entry><entry>octanoic acid</entry><entry>0.55714217</entry><entry>Likely</entry></row><row><entry>65</entry><entry>Fluxapyroxad</entry><entry>3-octenoic acid</entry><entry>0.55502918</entry><entry>Likely</entry></row><row><entry>66</entry><entry>Fluxapyroxad</entry><entry>trans-3-octenoic acid</entry><entry>0.55502918</entry><entry>Likely</entry></row><row><entry>67</entry><entry>Fluxapyroxad</entry><entry>heptanoic acid</entry><entry>0.5533742</entry><entry>Likely</entry></row><row><entry>68</entry><entry>Isotianil</entry><entry>trans-2-undecenoic acid</entry><entry>0.58734897</entry><entry>Likely</entry></row><row><entry>69</entry><entry>Isotianil</entry><entry>trans-2-decenoic acid</entry><entry>0.5861208</entry><entry>Likely</entry></row><row><entry>70</entry><entry>Isotianil</entry><entry>trans-2-nonenoic acid</entry><entry>0.57581536</entry><entry>Likely</entry></row><row><entry>71</entry><entry>Isotianil</entry><entry>trans-2-octenoic acid</entry><entry>0.55436011</entry><entry>Likely</entry></row><row><entry>72</entry><entry>Kresoxim-methyl</entry><entry>trans-2-undecenoic acid</entry><entry>0.69437059</entry><entry>Likely</entry></row><row><entry>73</entry><entry>Kresoxim-methyl</entry><entry>trans-2-nonenoic acid</entry><entry>0.68996981</entry><entry>Likely</entry></row><row><entry>74</entry><entry>Kresoxim-methyl</entry><entry>trans-2-decenoic acid</entry><entry>0.68445944</entry><entry>Likely</entry></row><row><entry>75</entry><entry>Kresoxim-methyl</entry><entry>trans-2-octenoic acid</entry><entry>0.67452894</entry><entry>Likely</entry></row><row><entry>76</entry><entry>Kresoxim-methyl</entry><entry>dodecanoic acid</entry><entry>0.63170701</entry><entry>Likely</entry></row><row><entry>77</entry><entry>Kresoxim-methyl</entry><entry>3-decenoic acid</entry><entry>0.62730097</entry><entry>Likely</entry></row><row><entry>78</entry><entry>Kresoxim-methyl</entry><entry>nonanoic acid</entry><entry>0.62720372</entry><entry>Likely</entry></row><row><entry>79</entry><entry>Kresoxim-methyl</entry><entry>decanoic acid</entry><entry>0.62517832</entry><entry>Likely</entry></row><row><entry>80</entry><entry>Kresoxim-methyl</entry><entry>octanoic acid</entry><entry>0.62229298</entry><entry>Likely</entry></row><row><entry>81</entry><entry>Kresoxim-methyl</entry><entry>heptanoic acid</entry><entry>0.61779979</entry><entry>Likely</entry></row><row><entry>82</entry><entry>Kresoxim-methyl</entry><entry>3-nonenoic acid</entry><entry>0.61715368</entry><entry>Likely</entry></row><row><entry>83</entry><entry>Kresoxim-methyl</entry><entry>trans-2-hexenoic acid</entry><entry>0.616918</entry><entry>Likely</entry></row><row><entry>84</entry><entry>Kresoxim-methyl</entry><entry>hexanoic acid</entry><entry>0.59974539</entry><entry>Likely</entry></row><row><entry>85</entry><entry>Kresoxim-methyl</entry><entry>3-octenoic acid</entry><entry>0.59338092</entry><entry>Likely</entry></row><row><entry>86</entry><entry>Kresoxim-methyl</entry><entry>9-decenoic acid</entry><entry>0.58882145</entry><entry>Likely</entry></row><row><entry>87</entry><entry>Kresoxim-methyl</entry><entry>3-heptenoic acid</entry><entry>0.5842284</entry><entry>Likely</entry></row><row><entry>88</entry><entry>Kresoxim-methyl</entry><entry>trans-3-octenoic acid</entry><entry>0.58338154</entry><entry>Likely</entry></row><row><entry>89</entry><entry>Kresoxim-methyl</entry><entry>2-ethylhexanoic acid</entry><entry>0.58021401</entry><entry>Likely</entry></row><row><entry>90</entry><entry>Kresoxim-methyl</entry><entry>3-methylnonanoic acid</entry><entry>0.57904676</entry><entry>Likely</entry></row><row><entry>91</entry><entry>Kresoxim-methyl</entry><entry>2-methyloctanoic acid</entry><entry>0.57545126</entry><entry>Likely</entry></row><row><entry>92</entry><entry>Kresoxim-methyl</entry><entry>2-methyldecanoic acid</entry><entry>0.57396175</entry><entry>Likely</entry></row><row><entry>93</entry><entry>Kresoxim-methyl</entry><entry>7-octenoic acid</entry><entry>0.56941623</entry><entry>Likely</entry></row><row><entry>94</entry><entry>Kresoxim-methyl</entry><entry>2-hydroxyoctanoic acid</entry><entry>0.56689941</entry><entry>Likely</entry></row><row><entry>95</entry><entry>Kresoxim-methyl</entry><entry>2-aminohexanoic acid</entry><entry>0.56447951</entry><entry>Likely</entry></row><row><entry>96</entry><entry>Metrafenone</entry><entry>trans-2-undecenoic acid</entry><entry>0.64443278</entry><entry>Likely</entry></row><row><entry>97</entry><entry>Metrafenone</entry><entry>trans-2-decenoic acid</entry><entry>0.64366354</entry><entry>Likely</entry></row><row><entry>98</entry><entry>Metrafenone</entry><entry>trans-2-nonenoic acid</entry><entry>0.63731814</entry><entry>Likely</entry></row><row><entry>99</entry><entry>Metrafenone</entry><entry>trans-2-octenoic acid</entry><entry>0.61913326</entry><entry>Likely</entry></row><row><entry>100</entry><entry>Metrafenone</entry><entry>3-decenoic acid</entry><entry>0.56409456</entry><entry>Likely</entry></row><row><entry>101</entry><entry>Metrafenone</entry><entry>dodecanoic acid</entry><entry>0.55737829</entry><entry>Likely</entry></row><row><entry>102</entry><entry>Metrafenone</entry><entry>trans-2-hexenoic acid</entry><entry>0.55535108</entry><entry>Likely</entry></row><row><entry>103</entry><entry>Metrafenone</entry><entry>3-nonenoic acid</entry><entry>0.55484796</entry><entry>Likely</entry></row><row><entry>104</entry><entry>Metrafenone</entry><entry>decanoic acid</entry><entry>0.55289211</entry><entry>Likely</entry></row><row><entry>105</entry><entry>Metrafenone</entry><entry>nonanoic acid</entry><entry>0.55017602</entry><entry>Likely</entry></row><row><entry>106</entry><entry>Penflufen</entry><entry>trans-2-undecenoic acid</entry><entry>0.64399335</entry><entry>Likely</entry></row><row><entry>107</entry><entry>Penflufen</entry><entry>trans-2-decenoic acid</entry><entry>0.64252008</entry><entry>Likely</entry></row><row><entry>108</entry><entry>Penflufen</entry><entry>trans-2-nonenoic acid</entry><entry>0.62746654</entry><entry>Likely</entry></row><row><entry>109</entry><entry>Penflufen</entry><entry>trans-2-octenoic acid</entry><entry>0.61407125</entry><entry>Likely</entry></row><row><entry>110</entry><entry>Penflufen</entry><entry>dodecanoic acid</entry><entry>0.57058068</entry><entry>Likely</entry></row><row><entry>111</entry><entry>Penflufen</entry><entry>decanoic acid</entry><entry>0.56765798</entry><entry>Likely</entry></row><row><entry>112</entry><entry>Penflufen</entry><entry>nonanoic acid</entry><entry>0.56592093</entry><entry>Likely</entry></row><row><entry>113</entry><entry>Penflufen</entry><entry>octanoic acid</entry><entry>0.56437438</entry><entry>Likely</entry></row><row><entry>114</entry><entry>Penflufen</entry><entry>3-decenoic acid</entry><entry>0.56411505</entry><entry>Likely</entry></row><row><entry>115</entry><entry>Penflufen</entry><entry>3-nonenoic acid</entry><entry>0.56120105</entry><entry>Likely</entry></row><row><entry>116</entry><entry>Penflufen</entry><entry>heptanoic acid</entry><entry>0.55998814</entry><entry>Likely</entry></row><row><entry>117</entry><entry>Penthiopyrad</entry><entry>trans-2-decenoic acid</entry><entry>0.60351946</entry><entry>Likely</entry></row><row><entry>118</entry><entry>Penthiopyrad</entry><entry>trans-2-octenoic acid</entry><entry>0.57867577</entry><entry>Likely</entry></row><row><entry>119</entry><entry>Picoxystrobin</entry><entry>trans-2-decenoic acid</entry><entry>0.6041138</entry><entry>Likely</entry></row><row><entry>120</entry><entry>Picoxystrobin</entry><entry>trans-2-undecenoic acid</entry><entry>0.60380391</entry><entry>Likely</entry></row><row><entry>121</entry><entry>Picoxystrobin</entry><entry>trans-2-nonenoic acid</entry><entry>0.60102845</entry><entry>Likely</entry></row><row><entry>122</entry><entry>Picoxystrobin</entry><entry>trans-2-octenoic acid</entry><entry>0.58557471</entry><entry>Likely</entry></row><row><entry>123</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>trans-2-undecenoic acid</entry><entry>0.62980278</entry><entry>Likely</entry></row><row><entry>124</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>trans-2-decenoic acid</entry><entry>0.62913683</entry><entry>Likely</entry></row><row><entry>125</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>trans-2-nonenoic acid</entry><entry>0.6215863</entry><entry>Likely</entry></row><row><entry>126</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>trans-2-octenoic acid</entry><entry>0.59947248</entry><entry>Likely</entry></row><row><entry>127</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>dodecanoic acid</entry><entry>0.55658742</entry><entry>Likely</entry></row><row><entry>128</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>decanoic acid</entry><entry>0.55425756</entry><entry>Likely</entry></row><row><entry>129</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>nonanoic acid</entry><entry>0.55224037</entry><entry>Likely</entry></row><row><entry>130</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>octanoic acid</entry><entry>0.55034847</entry><entry>Likely</entry></row><row><entry>131</entry><entry>Revysol</entry><entry>trans-2-undecenoic acid</entry><entry>0.57872331</entry><entry>Likely</entry></row><row><entry>132</entry><entry>Revysol</entry><entry>trans-2-decenoic acid</entry><entry>0.57789835</entry><entry>Likely</entry></row><row><entry>133</entry><entry>Revysol</entry><entry>trans-2-nonenoic acid</entry><entry>0.57143113</entry><entry>Likely</entry></row><row><entry>134</entry><entry>Revysol</entry><entry>trans-2-octenoic acid</entry><entry>0.55187153</entry><entry>Likely</entry></row><row><entry>135</entry><entry>Trifloxystrobin</entry><entry>trans-2-octenoic acid</entry><entry>0.65344118</entry><entry>Likely</entry></row><row><entry>136</entry><entry>Trifloxystrobin</entry><entry>dodecanoic acid</entry><entry>0.60296979</entry><entry>Likely</entry></row><row><entry>137</entry><entry>Trifloxystrobin</entry><entry>3-decenoic acid</entry><entry>0.60065202</entry><entry>Likely</entry></row><row><entry>138</entry><entry>Trifloxystrobin</entry><entry>decanoic acid</entry><entry>0.59917673</entry><entry>Likely</entry></row><row><entry>139</entry><entry>Trifloxystrobin</entry><entry>nonanoic acid</entry><entry>0.59665176</entry><entry>Likely</entry></row><row><entry>140</entry><entry>Trifloxystrobin</entry><entry>octanoic acid</entry><entry>0.59411821</entry><entry>Likely</entry></row><row><entry>141</entry><entry>Trifloxystrobin</entry><entry>trans-2-hexenoic acid</entry><entry>0.58938381</entry><entry>Likely</entry></row><row><entry>142</entry><entry>Trifloxystrobin</entry><entry>3-nonenoic acid</entry><entry>0.58652177</entry><entry>Likely</entry></row><row><entry>143</entry><entry>Trifloxystrobin</entry><entry>heptanoic acid</entry><entry>0.58451477</entry><entry>Likely</entry></row><row><entry>144</entry><entry>Trifloxystrobin</entry><entry>3-octenoic acid</entry><entry>0.56976633</entry><entry>Likely</entry></row><row><entry>145</entry><entry>Trifloxystrobin</entry><entry>9-decenoic acid</entry><entry>0.56827708</entry><entry>Likely</entry></row><row><entry>146</entry><entry>Trifloxystrobin</entry><entry>trans-3-octenoic acid</entry><entry>0.56589124</entry><entry>Likely</entry></row><row><entry>147</entry><entry>Trifloxystrobin</entry><entry>hexanoic acid</entry><entry>0.56398016</entry><entry>Likely</entry></row><row><entry>148</entry><entry>Trifloxystrobin</entry><entry>3-heptenoic acid</entry><entry>0.56110153</entry><entry>Likely</entry></row><row><entry>149</entry><entry>Trifloxystrobin</entry><entry>3-methylnonanoic acid</entry><entry>0.55144026</entry><entry>Likely</entry></row><row><entry>150</entry><entry>Valifenalate</entry><entry>trans-2-octenoic acid</entry><entry>0.62518207</entry><entry>Likely</entry></row><row><entry>151</entry><entry>Valifenalate</entry><entry>3-decenoic acid</entry><entry>0.57403389</entry><entry>Likely</entry></row><row><entry>152</entry><entry>Valifenalate</entry><entry>trans-2-hexenoic acid</entry><entry>0.57030915</entry><entry>Likely</entry></row><row><entry>153</entry><entry>Valifenalate</entry><entry>nonanoic acid</entry><entry>0.5635556</entry><entry>Likely</entry></row><row><entry>154</entry><entry>Valifenalate</entry><entry>dodecanoic acid</entry><entry>0.56304971</entry><entry>Likely</entry></row><row><entry>155</entry><entry>Valifenalate</entry><entry>decanoic acid</entry><entry>0.55918886</entry><entry>Likely</entry></row><row><entry>156</entry><entry>Valifenalate</entry><entry>octanoic acid</entry><entry>0.55868943</entry><entry>Likely</entry></row><row><entry>157</entry><entry>Valifenalate</entry><entry>heptanoic acid</entry><entry>0.55620831</entry><entry>Likely</entry></row><row><entry>158</entry><entry>Valifenalate</entry><entry>3-nonenoic acid</entry><entry>0.55386801</entry><entry>Likely</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0285" num="0268">Example 26: Predicted synergistic efficacy for in vitro growth inhibition of <i>Botritis cinerea </i>by bixafen, fenpicoxamid, florylpicoxamid, fluxapyroxad, kresoxim-methyl, picoxystrobin, pydiflumetofen, revysol, trifloxystrobin, and valifenalate, in combination with various exemplary saturated and unsaturated C4-C12 aliphatic acids, according to an embodiment of the present disclosure.</p><p id="p-0286" num="0269">A prediction of probability of synergistic efficacy for each combination of bixafen, fenpicoxamid, florylpicoxamid, fluxapyroxad, kresoxim-methyl, picoxystrobin, pydiflumetofen, revysol, trifloxystrobin, and valifenalate (Compound A) and a saturated or unsaturated C4-C12 aliphatic acid (Compound B) compound was determined using a synergistic composition predictive model trained using an experimental in vitro synergistic efficacy dataset for in vitro growth inhibition ofBotritis <i>cinerea</i>. The resulting synergistic efficacy predictions are shown in Table 91 below.</p><p id="p-0287" num="0000"><tables id="TABLE-US-00093" num="00093"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="301pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 91</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Predicted synergistic efficacy for in vitro growth inhibition of <i>Botritis cinerea</i></entry></row><row><entry>by bixafen, fenpicoxamid, florylpicoxamid, fluxapyroxad, kresoxim-methyl, picoxystrobin,</entry></row><row><entry>pydiflumetofen, revysol, trifloxystrobin, and valifenalate, in combination with</entry></row><row><entry>various exemplary saturated and unsaturated C4-C12 aliphatic acids</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="center"/><colspec colname="2" colwidth="84pt" align="left"/><colspec colname="3" colwidth="84pt" align="left"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry/><entry/><entry/><entry>Predicted</entry><entry/></row><row><entry/><entry/><entry/><entry>Probability of</entry><entry>Synergistic</entry></row><row><entry/><entry/><entry/><entry>Synergistic</entry><entry>Efficacy</entry></row><row><entry>Combination</entry><entry>Compound A</entry><entry>Compound B</entry><entry>Efficacy</entry><entry>Prediction</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="5"><colspec colname="1" colwidth="42pt" align="char" char="."/><colspec colname="2" colwidth="84pt" align="left"/><colspec colname="3" colwidth="84pt" align="left"/><colspec colname="4" colwidth="49pt" align="char" char="."/><colspec colname="5" colwidth="42pt" align="left"/><tbody valign="top"><row><entry>1</entry><entry>Bixafen</entry><entry>9-decenoic acid</entry><entry>0.55622956</entry><entry>Likely</entry></row><row><entry>2</entry><entry>Bixafen</entry><entry>decanoic acid</entry><entry>0.55589771</entry><entry>Likely</entry></row><row><entry>3</entry><entry>Bixafen</entry><entry>octanoic acid</entry><entry>0.55586089</entry><entry>Likely</entry></row><row><entry>4</entry><entry>Bixafen</entry><entry>nonanoic acid</entry><entry>0.55584134</entry><entry>Likely</entry></row><row><entry>5</entry><entry>Bixafen</entry><entry>dodecanoic acid</entry><entry>0.55552297</entry><entry>Likely</entry></row><row><entry>6</entry><entry>Fenpicoxamid</entry><entry>nonanoic acid</entry><entry>0.62459222</entry><entry>Likely</entry></row><row><entry>7</entry><entry>Fenpicoxamid</entry><entry>octanoic acid</entry><entry>0.61360456</entry><entry>Likely</entry></row><row><entry>8</entry><entry>Fenpicoxamid</entry><entry>decanoic acid</entry><entry>0.61240222</entry><entry>Likely</entry></row><row><entry>9</entry><entry>Fenpicoxamid</entry><entry>dodecanoic acid</entry><entry>0.61135991</entry><entry>Likely</entry></row><row><entry>10</entry><entry>Fenpicoxamid</entry><entry>heptanoic acid</entry><entry>0.61086404</entry><entry>Likely</entry></row><row><entry>11</entry><entry>Fenpicoxamid</entry><entry>9-decenoic acid</entry><entry>0.60419807</entry><entry>Likely</entry></row><row><entry>12</entry><entry>Fenpicoxamid</entry><entry>7-octenoic acid</entry><entry>0.58622763</entry><entry>Likely</entry></row><row><entry>13</entry><entry>Fenpicoxamid</entry><entry>hexanoic acid</entry><entry>0.58429749</entry><entry>Likely</entry></row><row><entry>14</entry><entry>Fenpicoxamid</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.57570006</entry><entry>Likely</entry></row><row><entry>15</entry><entry>Fenpicoxamid</entry><entry>10-hydroxydecanoic acid</entry><entry>0.57503872</entry><entry>Likely</entry></row><row><entry>16</entry><entry>Fenpicoxamid</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.57498789</entry><entry>Likely</entry></row><row><entry>17</entry><entry>Fenpicoxamid</entry><entry>3-methylnonanoic acid</entry><entry>0.55528876</entry><entry>Likely</entry></row><row><entry>18</entry><entry>Fenpicoxamid</entry><entry>5-hexenoic acid</entry><entry>0.55508957</entry><entry>Likely</entry></row><row><entry>19</entry><entry>Florylpicoxamid</entry><entry>decanoic acid</entry><entry>0.71071466</entry><entry>Likely</entry></row><row><entry>20</entry><entry>Florylpicoxamid</entry><entry>nonanoic acid</entry><entry>0.71019579</entry><entry>Likely</entry></row><row><entry>21</entry><entry>Florylpicoxamid</entry><entry>dodecanoic acid</entry><entry>0.70658516</entry><entry>Likely</entry></row><row><entry>22</entry><entry>Florylpicoxamid</entry><entry>octanoic acid</entry><entry>0.70647826</entry><entry>Likely</entry></row><row><entry>23</entry><entry>Florylpicoxamid</entry><entry>heptanoic acid</entry><entry>0.6966848</entry><entry>Likely</entry></row><row><entry>24</entry><entry>Florylpicoxamid</entry><entry>9-decenoic acid</entry><entry>0.69075607</entry><entry>Likely</entry></row><row><entry>25</entry><entry>Florylpicoxamid</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.68890783</entry><entry>Likely</entry></row><row><entry>26</entry><entry>Florylpicoxamid</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.68347669</entry><entry>Likely</entry></row><row><entry>27</entry><entry>Florylpicoxamid</entry><entry>10-hydroxydecanoic acid</entry><entry>0.6833026</entry><entry>Likely</entry></row><row><entry>28</entry><entry>Florylpicoxamid</entry><entry>7-octenoic acid</entry><entry>0.68061823</entry><entry>Likely</entry></row><row><entry>29</entry><entry>Florylpicoxamid</entry><entry>hexanoic acid</entry><entry>0.68034807</entry><entry>Likely</entry></row><row><entry>30</entry><entry>Florylpicoxamid</entry><entry>5-hexenoic acid</entry><entry>0.63863994</entry><entry>Likely</entry></row><row><entry>31</entry><entry>Florylpicoxamid</entry><entry>3-methylnonanoic acid</entry><entry>0.63745326</entry><entry>Likely</entry></row><row><entry>32</entry><entry>Florylpicoxamid</entry><entry>trans-2-undecenoic acid</entry><entry>0.63357106</entry><entry>Likely</entry></row><row><entry>33</entry><entry>Florylpicoxamid</entry><entry>trans-2-decenoic acid</entry><entry>0.62787411</entry><entry>Likely</entry></row><row><entry>34</entry><entry>Florylpicoxamid</entry><entry>3-decenoic acid</entry><entry>0.61742779</entry><entry>Likely</entry></row><row><entry>35</entry><entry>Florylpicoxamid</entry><entry>trans-2-nonenoic acid</entry><entry>0.61304636</entry><entry>Likely</entry></row><row><entry>36</entry><entry>Florylpicoxamid</entry><entry>3-nonenoic acid</entry><entry>0.6103797</entry><entry>Likely</entry></row><row><entry>37</entry><entry>Florylpicoxamid</entry><entry>3-methylhexanoic acid</entry><entry>0.60093858</entry><entry>Likely</entry></row><row><entry>38</entry><entry>Florylpicoxamid</entry><entry>3-heptenoic acid</entry><entry>0.5967274</entry><entry>Likely</entry></row><row><entry>39</entry><entry>Florylpicoxamid</entry><entry>trans-2-octenoic acid</entry><entry>0.59637633</entry><entry>Likely</entry></row><row><entry>40</entry><entry>Florylpicoxamid</entry><entry>3-octenoic acid</entry><entry>0.59633581</entry><entry>Likely</entry></row><row><entry>41</entry><entry>Florylpicoxamid</entry><entry>trans-3-octenoic acid</entry><entry>0.59633581</entry><entry>Likely</entry></row><row><entry>42</entry><entry>Florylpicoxamid</entry><entry>trans-2-hexenoic acid</entry><entry>0.57528369</entry><entry>Likely</entry></row><row><entry>43</entry><entry>Florylpicoxamid</entry><entry>trans-3-hexenoic acid</entry><entry>0.56214715</entry><entry>Likely</entry></row><row><entry>44</entry><entry>Florylpicoxamid</entry><entry>cis-3-hexenoic acid</entry><entry>0.56185557</entry><entry>Likely</entry></row><row><entry>45</entry><entry>Florylpicoxamid</entry><entry>4-hexenoic acid</entry><entry>0.55965197</entry><entry>Likely</entry></row><row><entry>46</entry><entry>Florylpicoxamid</entry><entry>2-methyloctanoic acid</entry><entry>0.55344194</entry><entry>Likely</entry></row><row><entry>47</entry><entry>Florylpicoxamid</entry><entry>2-methyldecanoic acid</entry><entry>0.55045301</entry><entry>Likely</entry></row><row><entry>48</entry><entry>Florylpicoxamid</entry><entry>3-methylbutyric acid</entry><entry>0.55003294</entry><entry>Likely</entry></row><row><entry>49</entry><entry>Fluxapyroxad</entry><entry>9-decenoic acid</entry><entry>0.57082343</entry><entry>Likely</entry></row><row><entry>50</entry><entry>Fluxapyroxad</entry><entry>decanoic acid</entry><entry>0.5582246</entry><entry>Likely</entry></row><row><entry>51</entry><entry>Fluxapyroxad</entry><entry>dodecanoic acid</entry><entry>0.55812293</entry><entry>Likely</entry></row><row><entry>52</entry><entry>Fluxapyroxad</entry><entry>octanoic acid</entry><entry>0.55790607</entry><entry>Likely</entry></row><row><entry>53</entry><entry>Kresoxim-methyl</entry><entry>9-decenoic acid</entry><entry>0.65007721</entry><entry>Likely</entry></row><row><entry>54</entry><entry>Kresoxim-methyl</entry><entry>dodecanoic acid</entry><entry>0.64561872</entry><entry>Likely</entry></row><row><entry>55</entry><entry>Kresoxim-methyl</entry><entry>decanoic acid</entry><entry>0.64533766</entry><entry>Likely</entry></row><row><entry>56</entry><entry>Kresoxim-methyl</entry><entry>octanoic acid</entry><entry>0.64519368</entry><entry>Likely</entry></row><row><entry>57</entry><entry>Kresoxim-methyl</entry><entry>nonanoic acid</entry><entry>0.64517309</entry><entry>Likely</entry></row><row><entry>58</entry><entry>Kresoxim-methyl</entry><entry>heptanoic acid</entry><entry>0.63135262</entry><entry>Likely</entry></row><row><entry>59</entry><entry>Kresoxim-methyl</entry><entry>7-octenoic acid</entry><entry>0.63015161</entry><entry>Likely</entry></row><row><entry>60</entry><entry>Kresoxim-methyl</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.62234793</entry><entry>Likely</entry></row><row><entry>61</entry><entry>Kresoxim-methyl</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.62204227</entry><entry>Likely</entry></row><row><entry>62</entry><entry>Kresoxim-methyl</entry><entry>10-hydroxydecanoic acid</entry><entry>0.62185931</entry><entry>Likely</entry></row><row><entry>63</entry><entry>Kresoxim-methyl</entry><entry>hexanoic acid</entry><entry>0.61156485</entry><entry>Likely</entry></row><row><entry>64</entry><entry>Kresoxim-methyl</entry><entry>5-hexenoic acid</entry><entry>0.58608413</entry><entry>Likely</entry></row><row><entry>65</entry><entry>Kresoxim-methyl</entry><entry>3-methylnonanoic acid</entry><entry>0.58495826</entry><entry>Likely</entry></row><row><entry>66</entry><entry>Kresoxim-methyl</entry><entry>trans-2-decenoic acid</entry><entry>0.5617413</entry><entry>Likely</entry></row><row><entry>67</entry><entry>Kresoxim-methyl</entry><entry>trans-2-undecenoic acid</entry><entry>0.5611554</entry><entry>Likely</entry></row><row><entry>68</entry><entry>Kresoxim-methyl</entry><entry>3-decenoic acid</entry><entry>0.55813311</entry><entry>Likely</entry></row><row><entry>69</entry><entry>Picoxystrobin</entry><entry>9-decenoic acid</entry><entry>0.64360938</entry><entry>Likely</entry></row><row><entry>70</entry><entry>Picoxystrobin</entry><entry>decanoic acid</entry><entry>0.63400232</entry><entry>Likely</entry></row><row><entry>71</entry><entry>Picoxystrobin</entry><entry>nonanoic acid</entry><entry>0.6337739</entry><entry>Likely</entry></row><row><entry>72</entry><entry>Picoxystrobin</entry><entry>octanoic acid</entry><entry>0.63365494</entry><entry>Likely</entry></row><row><entry>73</entry><entry>Picoxystrobin</entry><entry>dodecanoic acid</entry><entry>0.63256371</entry><entry>Likely</entry></row><row><entry>74</entry><entry>Picoxystrobin</entry><entry>7-octenoic acid</entry><entry>0.62759129</entry><entry>Likely</entry></row><row><entry>75</entry><entry>Picoxystrobin</entry><entry>heptanoic acid</entry><entry>0.62253746</entry><entry>Likely</entry></row><row><entry>76</entry><entry>Picoxystrobin</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.61545208</entry><entry>Likely</entry></row><row><entry>77</entry><entry>Picoxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.61335731</entry><entry>Likely</entry></row><row><entry>78</entry><entry>Picoxystrobin</entry><entry>10-hydroxydecanoic acid</entry><entry>0.60911996</entry><entry>Likely</entry></row><row><entry>79</entry><entry>Picoxystrobin</entry><entry>hexanoic acid</entry><entry>0.60391683</entry><entry>Likely</entry></row><row><entry>80</entry><entry>Picoxystrobin</entry><entry>5-hexenoic acid</entry><entry>0.58423756</entry><entry>Likely</entry></row><row><entry>81</entry><entry>Picoxystrobin</entry><entry>trans-2-decenoic acid</entry><entry>0.57715665</entry><entry>Likely</entry></row><row><entry>82</entry><entry>Picoxystrobin</entry><entry>trans-2-undecenoic acid</entry><entry>0.57706139</entry><entry>Likely</entry></row><row><entry>83</entry><entry>Picoxystrobin</entry><entry>3-decenoic acid</entry><entry>0.56894624</entry><entry>Likely</entry></row><row><entry>84</entry><entry>Picoxystrobin</entry><entry>trans-2-nonenoic acid</entry><entry>0.56590575</entry><entry>Likely</entry></row><row><entry>85</entry><entry>Picoxystrobin</entry><entry>3-nonenoic acid</entry><entry>0.56021643</entry><entry>Likely</entry></row><row><entry>86</entry><entry>Picoxystrobin</entry><entry>3-methylnonanoic acid</entry><entry>0.55981524</entry><entry>Likely</entry></row><row><entry>87</entry><entry>Picoxystrobin</entry><entry>trans-2-octenoic acid</entry><entry>0.55049884</entry><entry>Likely</entry></row><row><entry>88</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>octanoic acid</entry><entry>0.58507421</entry><entry>Likely</entry></row><row><entry>89</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>nonanoic acid</entry><entry>0.58455386</entry><entry>Likely</entry></row><row><entry>90</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>decanoic acid</entry><entry>0.58388714</entry><entry>Likely</entry></row><row><entry>91</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>dodecanoic acid</entry><entry>0.58166713</entry><entry>Likely</entry></row><row><entry>92</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>heptanoic acid</entry><entry>0.57342989</entry><entry>Likely</entry></row><row><entry>93</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>9-decenoic acid</entry><entry>0.57237365</entry><entry>Likely</entry></row><row><entry>94</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>hexanoic acid</entry><entry>0.55570532</entry><entry>Likely</entry></row><row><entry>95</entry><entry>Pydiflumetofen (Adepidyn)</entry><entry>7-octenoic acid</entry><entry>0.55530685</entry><entry>Likely</entry></row><row><entry>96</entry><entry>Revysol</entry><entry>dodecanoic acid</entry><entry>0.6001254</entry><entry>Likely</entry></row><row><entry>97</entry><entry>Revysol</entry><entry>decanoic acid</entry><entry>0.59978312</entry><entry>Likely</entry></row><row><entry>98</entry><entry>Revysol</entry><entry>nonanoic acid</entry><entry>0.59915221</entry><entry>Likely</entry></row><row><entry>99</entry><entry>Revysol</entry><entry>octanoic acid</entry><entry>0.59870726</entry><entry>Likely</entry></row><row><entry>100</entry><entry>Revysol</entry><entry>heptanoic acid</entry><entry>0.5884472</entry><entry>Likely</entry></row><row><entry>101</entry><entry>Revysol</entry><entry>9-decenoic acid</entry><entry>0.58379308</entry><entry>Likely</entry></row><row><entry>102</entry><entry>Revysol</entry><entry>hexanoic acid</entry><entry>0.56996538</entry><entry>Likely</entry></row><row><entry>103</entry><entry>Revysol</entry><entry>7-octenoic acid</entry><entry>0.56562299</entry><entry>Likely</entry></row><row><entry>104</entry><entry>Revysol</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.56383193</entry><entry>Likely</entry></row><row><entry>105</entry><entry>Revysol</entry><entry>10-hydroxydecanoic acid</entry><entry>0.56139958</entry><entry>Likely</entry></row><row><entry>106</entry><entry>Revysol</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.55953437</entry><entry>Likely</entry></row><row><entry>107</entry><entry>Revysol</entry><entry>3-methylnonanoic acid</entry><entry>0.5520322</entry><entry>Likely</entry></row><row><entry>108</entry><entry>Trifloxystrobin</entry><entry>9-decenoic acid</entry><entry>0.6725654</entry><entry>Likely</entry></row><row><entry>109</entry><entry>Trifloxystrobin</entry><entry>dodecanoic acid</entry><entry>0.66157781</entry><entry>Likely</entry></row><row><entry>110</entry><entry>Trifloxystrobin</entry><entry>decanoic acid</entry><entry>0.66133578</entry><entry>Likely</entry></row><row><entry>111</entry><entry>Trifloxystrobin</entry><entry>nonanoic acid</entry><entry>0.66097871</entry><entry>Likely</entry></row><row><entry>112</entry><entry>Trifloxystrobin</entry><entry>octanoic acid</entry><entry>0.66093915</entry><entry>Likely</entry></row><row><entry>113</entry><entry>Trifloxystrobin</entry><entry>7-octenoic acid</entry><entry>0.65512001</entry><entry>Likely</entry></row><row><entry>114</entry><entry>Trifloxystrobin</entry><entry>heptanoic acid</entry><entry>0.65001921</entry><entry>Likely</entry></row><row><entry>115</entry><entry>Trifloxystrobin</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.64941725</entry><entry>Likely</entry></row><row><entry>116</entry><entry>Trifloxystrobin</entry><entry>10-hydroxydecanoic acid</entry><entry>0.64885914</entry><entry>Likely</entry></row><row><entry>117</entry><entry>Trifloxystrobin</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.64848276</entry><entry>Likely</entry></row><row><entry>118</entry><entry>Trifloxystrobin</entry><entry>hexanoic acid</entry><entry>0.63310591</entry><entry>Likely</entry></row><row><entry>119</entry><entry>Trifloxystrobin</entry><entry>3-methylnonanoic acid</entry><entry>0.61211242</entry><entry>Likely</entry></row><row><entry>120</entry><entry>Trifloxystrobin</entry><entry>5-hexenoic acid</entry><entry>0.60404247</entry><entry>Likely</entry></row><row><entry>121</entry><entry>Trifloxystrobin</entry><entry>trans-2-decenoic acid</entry><entry>0.59111476</entry><entry>Likely</entry></row><row><entry>122</entry><entry>Trifloxystrobin</entry><entry>trans-2-undecenoic acid</entry><entry>0.59108112</entry><entry>Likely</entry></row><row><entry>123</entry><entry>Trifloxystrobin</entry><entry>3-decenoic acid</entry><entry>0.58504908</entry><entry>Likely</entry></row><row><entry>124</entry><entry>Trifloxystrobin</entry><entry>trans-2-nonenoic acid</entry><entry>0.57766945</entry><entry>Likely</entry></row><row><entry>125</entry><entry>Trifloxystrobin</entry><entry>3-nonenoic acid</entry><entry>0.57481307</entry><entry>Likely</entry></row><row><entry>126</entry><entry>Trifloxystrobin</entry><entry>3-methylhexanoic acid</entry><entry>0.57295034</entry><entry>Likely</entry></row><row><entry>127</entry><entry>Trifloxystrobin</entry><entry>trans-2-octenoic acid</entry><entry>0.56120624</entry><entry>Likely</entry></row><row><entry>128</entry><entry>Trifloxystrobin</entry><entry>3-octenoic acid</entry><entry>0.56061667</entry><entry>Likely</entry></row><row><entry>129</entry><entry>Trifloxystrobin</entry><entry>3-heptenoic acid</entry><entry>0.5584203</entry><entry>Likely</entry></row><row><entry>130</entry><entry>Valifenalate</entry><entry>dodecanoic acid</entry><entry>0.59915539</entry><entry>Likely</entry></row><row><entry>131</entry><entry>Valifenalate</entry><entry>decanoic acid</entry><entry>0.5985593</entry><entry>Likely</entry></row><row><entry>132</entry><entry>Valifenalate</entry><entry>nonanoic acid</entry><entry>0.59810962</entry><entry>Likely</entry></row><row><entry>133</entry><entry>Valifenalate</entry><entry>octanoic acid</entry><entry>0.59787693</entry><entry>Likely</entry></row><row><entry>134</entry><entry>Valifenalate</entry><entry>heptanoic acid</entry><entry>0.58391599</entry><entry>Likely</entry></row><row><entry>135</entry><entry>Valifenalate</entry><entry>9-decenoic acid</entry><entry>0.58095987</entry><entry>Likely</entry></row><row><entry>136</entry><entry>Valifenalate</entry><entry>hexanoic acid</entry><entry>0.56507724</entry><entry>Likely</entry></row><row><entry>137</entry><entry>Valifenalate</entry><entry>12-hydroxydodecanoic acid</entry><entry>0.5648372</entry><entry>Likely</entry></row><row><entry>138</entry><entry>Valifenalate</entry><entry>10-hydroxydecanoic acid</entry><entry>0.56308371</entry><entry>Likely</entry></row><row><entry>139</entry><entry>Valifenalate</entry><entry>8-hydroxyoctanoic acid</entry><entry>0.56188978</entry><entry>Likely</entry></row><row><entry>140</entry><entry>Valifenalate</entry><entry>7-octenoic acid</entry><entry>0.56071382</entry><entry>Likely</entry></row><row><entry namest="1" nameend="5" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0288" num="0270">In some embodiments according to the present disclosure, and as illustrated in some exemplary embodiments in the above-described experimental examples, the combination of a C4-C10 unsaturated aliphatic acid (and agriculturally acceptable salts thereof in some particular embodiments) and a pesticidal active ingredient produces a synergistic pesticidal composition demonstrating or reasonably predicted to demonstrate a synergistic effect. That is, when used in combination, the C4-C10 unsaturated aliphatic acid and the pesticidal active ingredient have or are reasonably predicted to have an efficacy that is greater than would be expected by simply adding the efficacy of the pesticidal active ingredient and the C4-C10 unsaturated aliphatic acid when used alone. In some alternative embodiments, the unsaturated aliphatic acid or agriculturally acceptable salt thereof may comprise a C11 unsaturated aliphatic acid or agriculturally acceptable salt thereof. In some further alternative embodiments, the unsaturated aliphatic acid or agriculturally acceptable salt thereof may comprise a C12 unsaturated aliphatic acid or agriculturally acceptable salt thereof.</p><p id="p-0289" num="0271">In some embodiments according to the present disclosure, and as illustrated in some exemplary embodiments in the above-described experimental examples, the combination of a C4-C10 saturated aliphatic acid (and agriculturally acceptable salts thereof in some particular embodiments) and a pesticidal active ingredient produces a synergistic pesticidal composition demonstrating a synergistic effect or reasonably predicted to demonstrate a synergistic effect. That is, when used in combination, the C4-C10 saturated aliphatic acid and the pesticidal active ingredient have or are predicted to have an efficacy that is greater than would be expected by simply adding the efficacy of the pesticidal active ingredient and the C4-C10 saturated aliphatic acid when used alone. In some particular embodiments, the combination of a C4-C10 saturated aliphatic acid and a neem seed, kernel, oil, extract or derivative pesticidal active ingredient produces a synergistic pesticidal composition demonstrating a synergistic pesticidal effect. In some further embodiments, the combination of a C11 or C12 saturated aliphatic acid and a neem seed, kernel, oil, extract or derivative pesticidal active ingredient produces a synergistic pesticidal composition demonstrating or reasonably predicted to demonstrate a synergistic pesticidal effect. In some alternative embodiments according to the present disclosure, the combination of a C11 or C12 saturated aliphatic acid (and agriculturally acceptable salts thereof in some particular embodiments) and a pesticidal active ingredient produces a synergistic pesticidal composition demonstrating a synergistic effect.</p><p id="p-0290" num="0272">While a number of exemplary aspects and embodiments have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are to be given the broadest interpretation consistent with the disclosure as a whole.</p><?detailed-description description="Detailed Description" end="tail"?></description><claims id="claims"><claim id="CLM-00001" num="00001"><claim-text><b>1</b>. A synergistic pesticidal composition comprising<claim-text>a pesticidal active ingredient selected from the list comprising: benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxiconazole, propiconazole, difenoconazole, fludioxonil, mancozeb, tebuconazole, valifenalate, and combinations thereof; and</claim-text><claim-text>a C4-C10 saturated or unsaturated aliphatic acid or an agriculturally compatible salt thereof;</claim-text><claim-text>wherein a ratio of the concentrations of said pesticidal active ingredient and said C4-C10 saturated or unsaturated aliphatic acid or an agriculturally compatible salt thereof is between about 1:15000 and 15000:1.</claim-text></claim-text></claim><claim id="CLM-00002" num="00002"><claim-text><b>2</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said C4-C10 saturated or unsaturated aliphatic acid comprises a C4-C10 unsaturated aliphatic acid;<claim-text>wherein the C4-C10 unsaturated aliphatic acid comprises at least one unsaturated C&#x2014;C bond; and</claim-text><claim-text>wherein a ratio of the concentrations of said pesticidal active ingredient and said C4-C10 unsaturated aliphatic acid is between about 1:15,000 and 15,000:1.</claim-text></claim-text></claim><claim id="CLM-00003" num="00003"><claim-text><b>3</b>. (canceled)</claim-text></claim><claim id="CLM-00004" num="00004"><claim-text><b>4</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the C4-C10 saturated or unsaturated aliphatic acid or salt thereof comprises a methyl-, ethyl-, hydroxy-, or amino-substituent.</claim-text></claim><claim id="CLM-00005" num="00005"><claim-text><b>5</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the C4-C10 unsaturated aliphatic acid comprises at least one of:<claim-text>a trans-butanoic acid, a cis-butanoic acid, a butynoic acid, a buta-dienoic acid, a trans-hexenoic acid, a cis-hexenoic acid, a hexa-dienoic acid, a hexynoic acid, a trans-heptenoic acid, a cis-heptenoic acid, a hepta-dienoic acid, a heptynoic acid, a trans-octenoic acid, a cis-octenoic acid, an octa-dienoic acid, an octynoic acid, a trans-nonenoic acid, a cis-nonenoic acid, a nona-dienoic acid, a nonynoic acid, a trans-decenoic acid, a cis-decenoic acid, a deca-dienoic acid, and a decynoic acid.</claim-text></claim-text></claim><claim id="CLM-00006" num="00006"><claim-text><b>6</b>. (canceled)</claim-text></claim><claim id="CLM-00007" num="00007"><claim-text><b>7</b>. (canceled)</claim-text></claim><claim id="CLM-00008" num="00008"><claim-text><b>8</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the synergistic pesticidal composition has a predicted probability of synergy of greater than 0.55.</claim-text></claim><claim id="CLM-09-11" num="09-11"><claim-text><b>9</b>.-<b>11</b>. (canceled)</claim-text></claim><claim id="CLM-00012" num="00012"><claim-text><b>12</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said pesticidal active ingredient comprises at least one pesticidal active ingredient selected from the list comprising:<claim-text>A) Respiration inhibitors selected from:<claim-text>inhibitors of complex III at Q<sub>o </sub>site: azoxystrobin (II-1), coumethoxy-strobin, coumoxystrobin, dimoxystrobin (II-2), enestroburin, fenamin-strobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin (II-3), kresoxim-methyl (II-4), metominostrobin, orysastrobin (II-5), picoxystrobin (II-6), pyraclostrobin (II-7), pyrametostrobin, pyraoxystrobin, trifloxystrobin (II-8), 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneamino-oxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;</claim-text><claim-text>Inhibitors of complex III at Q<sub>i </sub>site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)-amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbony-loxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol5-ylmethoxy)-4-methoxy-pyridine-2-carbon-yl]amino]-6-methyl-4,9-dioxol,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenyl-methyl)-1,5-dioxonan-7-yl 2-methylpropanoate;</claim-text><claim-text>Inhibitors of complex II: benodanil, benzovindiflupyr (II-9), bixafen (II-10), boscalid (II-11), carboxin, fenfuram, fluopyram (II-12), flutolanil, fluxapyroxad (II-13), furametpyr, isofetamid, isopyrazam (II-14), mepronil, oxycarboxin, penflufen (II-15), penthiopyrad (II-16), sedaxane (II-17), tecloftalam, thifluzamide, N-(4&#x2032;-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluorome-thyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trime-thyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide;</claim-text><claim-text>Other respiration inhibitors: diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluorometh-ylpyridin-2-yloxy)-phenyl]-ethyl}-amine; binapacryl, dinobuton, dinocap, fluazinam (II-18); ferimzone; fentin salts such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin (II-19); and silthiofam; B) Sterol biosynthesis inhibitors (SBI fungicides) selected from:</claim-text><claim-text>C14 demethylase inhibitors (DMI fungicides): azaconazole, bitertanol, bromuconazole, cyproconazole (II-20), difenoconazole (II-21), diniconazole, diniconazole-M, epoxiconazole (II-22), fenbuconazole, fluquinconazole (II-23), flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole (II-24), myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole (II-25), prothioconazole (II-26), simeconazole, tebuconazole (II-27), tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole; imazalil, pefurazoate, prochloraz, triflumizol; fenarimol, nuarimol, pyrifenox, triforine, [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;</claim-text><claim-text>Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorphacetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;</claim-text><claim-text>Inhibitors of 3-keto reductase: fenhexamid;</claim-text></claim-text><claim-text>C) Nucleic acid synthesis inhibitors selected from:<claim-text>phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam) (II-38), ofurace, oxadixyl;</claim-text><claim-text>others nucleic acid inhibitors: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;</claim-text></claim-text><claim-text>D) Inhibitors of cell division and cytoskeleton selected from:<claim-text>tubulin inhibitors: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl (II-39); 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine</claim-text><claim-text>other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone (II-40), pyriofenone;</claim-text></claim-text><claim-text>E) Inhibitors of amino acid and protein synthesis selected from:<claim-text>methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim, Pyrimethanil (II-41);</claim-text><claim-text>protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;</claim-text></claim-text><claim-text>F) Signal transduction inhibitors selected from:<claim-text>MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;</claim-text><claim-text>G protein inhibitors: quinoxyfen;</claim-text></claim-text><claim-text>G) Lipid and membrane synthesis inhibitors selected from:<claim-text>Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; propamocarb, propamocarb-hydrochloride;</claim-text><claim-text>lipid peroxidation inhibitors: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;</claim-text><claim-text>phospholipid biosynthesis and cell wall deposition: dimethomorph (II-42), flumorph, mandipropamid (II-43), pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;</claim-text><claim-text>acid amide hydrolase inhibitors: oxathiapiprolin;</claim-text></claim-text><claim-text>H) Inhibitors with Multi Site Action selected from:</claim-text><claim-text>&#x2003;inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride (II-44), basic copper sulfate, sulfur;<claim-text>thio- and dithiocarbamates: ferbam, mancozeb (II-45), maneb, metam, metiram (II-46), propineb, thiram, zineb, ziram;</claim-text><claim-text>organochlorine compounds: anilazine, Chlorothalonil (II-47), captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorophenole and its salts, phthalide, tolylfluanid, N-(4-chlo-ro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;</claim-text><claim-text>guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoc-tadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1H,5H-[1,4]dithii-no[2,3-c:5,6-c&#x2032;]dipyrrole-1,3,5,7(2H,6H)-tetraone (II-48);</claim-text></claim-text><claim-text>I) Cell wall synthesis inhibitors selected from:<claim-text>inhibitors of glucan synthesis: validamycin, polyoxin B;</claim-text><claim-text>melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;</claim-text></claim-text><claim-text>J) Plant defence inducers selected from:<claim-text>acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; fosetyl, fosetyl-aluminum, phosphorous acid and its salts (II-49);</claim-text></claim-text><claim-text>K) Unknown mode of action selected from: bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, tolprocarb, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yl-oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]-ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclo-propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N&#x2032;-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxyacetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-meth-ylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phe-nyl)-isoxazol-5-yl]-2-prop2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, tertbutyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]-amino]oxymethyl]-2-pyridyl]carbamate, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-dif-luoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-qui-nolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroiso-quinolin-1-yl)quinoline;</claim-text><claim-text>L) Antifungal biopesticides selected from: <i>Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pumilus </i>(II-50), <i>Bacillus subtilis </i>(II-51), <i>Bacillus subtilis </i>var. <i>amyloliquefaciens </i>(II-52), <i>Candida oleophila </i>I-82, <i>Candida saitoana, Clonostachys rosea </i>f. <i>catenulata</i>, also named <i>Gliocladium catenulatum, Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Metschnikowia fructicola, Microdochium dimerum, Phlebiopsis gigantea, Pseudozyma flocculosa, Pythium oligandrum </i>DV74, <i>Reynoutria sachlinensis, Talaromyces flavus </i>V117b, <i>Trichoderma asperellum </i>SKT-1<i>, T. atroviride </i>LC52, <i>T. harzianum </i>T-22, <i>T. harzianum </i>TH 35, <i>T. harzianum </i>T-39; <i>T. harzianum </i>and <i>T. viride, T. harzianum </i>ICCO12 and <i>T. viride </i>ICC080<i>; T. polysporum </i>and <i>T. harzianum; T. stromaticum, T. virens </i>GL-21, <i>T. viride, T. viride </i>TV1<i>, Ulocladium oudemansii </i>HRU3;</claim-text><claim-text>M) Growth regulators selected from: abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassino-lide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride) (II-54), naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium, II-55), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid, trinex-apac-ethyl and uniconazole;</claim-text><claim-text>N) Herbicides selected from:<claim-text>acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, flufenacet, mefenacet, me-tolachlor, metazachlor, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;</claim-text><claim-text>amino acid derivatives: bilanafos, glyphosate, glufosinate, sulfosate;</claim-text><claim-text>aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuryl;</claim-text><claim-text>Bipyridyls: diquat, paraquat;</claim-text><claim-text>(thio)carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;</claim-text><claim-text>cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;</claim-text><claim-text>dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin;</claim-text><claim-text>diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen; &#x2014;hydroxybenzonitriles: bomoxynil, dichlobenil, ioxynil;</claim-text><claim-text>imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;</claim-text><claim-text>phenoxy acetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;</claim-text><claim-text>pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazon, pyridate;</claim-text><claim-text>pyridines: aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, picolinafen, thiazopyr;</claim-text><claim-text>sulfonyl ureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuronethyl, chlorsulfuron, cinosul-furon, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metazosulfuron, metsulfuron-methyl, nico-sulfuron, oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosul-furon, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;</claim-text><claim-text>triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazinone, metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;</claim-text><claim-text>ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, methabenzthiazuron, tebuthiuron;</claim-text><claim-text>other acetolactate synthase inhibitors: bispyribac-sodium, cloransulammethyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribam-benz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, py-roxsulam;</claim-text><claim-text>other herbicides: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl, chlorthal, cinmethylin, clomazone, cumyluron, cyprosulfa-mide, dicamba, difenzoquat, diflufenzopyr, <i>Drechslera monoceras</i>, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac, mesotrione, methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyri-din-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester;</claim-text></claim-text><claim-text>O) Insecticides selected from:<claim-text>organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phos-phamidon, phorate, phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;</claim-text><claim-text>carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenox-ycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;</claim-text><claim-text>pyrethroids: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zetacypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fen-valerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin;</claim-text><claim-text>insect growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyramazin, dif-lubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;</claim-text><claim-text>nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran, flupyradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-2-chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinane;</claim-text><claim-text>nicotinic acetylcholine receptor disruptors or allosteric modulators (IRAC Goup 5):</claim-text></claim-text><claim-text>spinosyn (including but not limited to spinosyns A, D, B, C, E, F, G, H, J, and other spinosyn isolates from <i>Saccharopolyspora spinosa </i>culture), spinosad (comprising primarily spinsyns A and D), and derivatives or substituents thereof (including but not limited to tetracyclic and pentacyclic spinosyn derivatives, aziridine spinosyn derivatives, C-5,6 and/or C-13,14 substituted spinosyn derivatives); spinetoram (including but not limited to XDE-175-J, XDE-175-L or other O-ethyl substituted spinosyn derivatives); butenyl-spinosyn and derivatives or substituents thereof (such as isolates from <i>Saccharopolyspora pogona </i>culture);<claim-text>bioinsecticides including but not limited to <i>Bacillus </i>thuriengiensis, <i>Burkholderia </i>spp, <i>Beauveria bassiana, Metarhizium anisoptiae, Paecilomyces </i>fumosoroseus, and baculoviruses (including but not limited to granuloviruses and nucleopolyhedroviruses);</claim-text><claim-text>GABA antagonist compounds: endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1-(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1H-pyrazole-3-carbothioic acid amide;</claim-text><claim-text>mitochondrial electron transport inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;</claim-text><claim-text>METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon;</claim-text><claim-text>Uncouplers: chlorfenapyr;</claim-text><claim-text>oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;</claim-text><claim-text>moulting disruptor compounds: cryomazine;</claim-text><claim-text>mixed function oxidase inhibitors: piperonyl butoxide;</claim-text><claim-text>sodium channel blockers: indoxacarb, metaflumizone;</claim-text><claim-text>ryanodine receptor inhibitors: chlorantraniliprole, cyantraniliprole, fluben-diamide, N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyra-zole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-car-boxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanyli-dene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide; N-[4,6-di-bromo-2-[(di-2-propyl-lambda-4-sulfanyl-idene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluor-omethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;</claim-text><claim-text>others: benclothiaz, bifenazate, cartap, flonicamid, pyridalyl, pymetrozine, sulfur, thiocyclam, cy-enopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron, pyrifluquinazon, 1,1&#x2032;-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]-methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl] cyclopropaneacetic acid ester; fluensulfone, fluoroalkenyl thioethers; and</claim-text></claim-text><claim-text>P) ribonucleic acid (RNA) and associated compounds including double-stranded RNA (dsRNA), microRNA (miRNA) and small interfering RNA (siRNA); bacteriophages.</claim-text></claim-text></claim><claim id="CLM-00013" num="00013"><claim-text><b>13</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein a ratio of the concentrations of said pesticidal active ingredient and said C4-C10 saturated or unsaturated aliphatic acid or an agriculturally compatible salt thereof is between about at least one of: 1:15,000 and 15,000:1; 1:10,000 and 10,000:1, 1:5000 and 5000:1, 1:2500 and 2500:1, 1:1500 and 1500:1, 1:1000 and 1000, 1:750 and 750:1, 1:500 and 500:1, 1:400 and 400:1, 1:300 and 300:1, 1:250 and 250:1, 1:200 and 200:1, 1:150 and 150:1, 1:100 and 100:1, 1:90 and 90:1, 1:80 and 80:1, 1:70 and 70:1, 1:60 and 60:1, 1:50 and 50:1, 1:40 and 40:1, 1:30 and 30:1, 1:25 and 25:1, 1:20 and 20:1, 1:15 and 15:1, 1:10 and 10:1, 1:9 and 9:1. 1:8 and 8:1, 1:7 and 7:1, 1:6 and 6:1, 1:5 and 5:1, 1: and 4:1, 1:3 and 3:1, 1:2 and 2:1, 1:1.5 and 1.5:1, and 1.25 and 1.25:1.</claim-text></claim><claim id="CLM-00014" num="00014"><claim-text><b>14</b>. A method of synergistically enhancing the pesticidal activity of at least one pesticidal active ingredient adapted to control at least one target pest organism comprising:<claim-text>providing at least one pesticidal active ingredient active for said at least one target pest organism, wherein said pesticidal active ingredient is selected from the list comprising: benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxiconazole, propiconazole, difenoconazole, fludioxonil, mancozeb, tebuconazole, valifenalate, and combinations thereof;</claim-text><claim-text>adding a synergistically effective concentration of at least one C4-C10 saturated or unsaturated aliphatic acid, or an agriculturally acceptable salt thereof, to said pesticidal active ingredient to provide a synergistic pesticidal composition; and</claim-text><claim-text>applying said synergistic pesticidal composition in a pesticidally effective concentration to control said at least one target pest organism.</claim-text></claim-text></claim><claim id="CLM-15-17" num="15-17"><claim-text><b>15</b>.-<b>17</b>. (canceled)</claim-text></claim><claim id="CLM-00018" num="00018"><claim-text><b>18</b>. The method according to <claim-ref idref="CLM-00014">claim 14</claim-ref>, wherein a ratio of said synergistically effective concentration of said C4-C10 saturated or unsaturated aliphatic acid or an agriculturally compatible salt thereof and said pesticidal active ingredient is between about at least one of: 1:15,000 and 15,000:1; 1:10,000 and 10,000:1, 1:5000 and 5000:1, 1:2500 and 2500:1, 1:1500 and 1500:1, 1:1000 and 1000, 1:750 and 750:1, 1:500 and 500:1, 1:400 and 400:1, 1:300 and 300:1, 1:250 and 250:1, 1:200 and 200:1, 1:150 and 150:1, 1:100 and 100:1, 1:90 and 90:1, 1:80 and 80:1, 1:70 and 70:1, 1:60 and 60:1, 1:50 and 50:1, 1:40 and 40:1, 1:30 and 30:1, 1:25 and 25:1, 1:20 and 20:1, 1:15 and 15:1, 1:10 and 10:1, 1:9 and 9:1. 1:8 and 8:1, 1:7 and 7:1, 1:6 and 6:1, 1:5 and 5:1, 1: and 4:1, 1:3 and 3:1, 1:2 and 2:1, 1:1.5 and 1.5:1, and 1.25 and 1.25:1.</claim-text></claim><claim id="CLM-00019" num="00019"><claim-text><b>19</b>. The method according to <claim-ref idref="CLM-00014">claim 14</claim-ref>, wherein the synergistic pesticidal composition has an FIC Index value of less than 1; or preferably less than 0.75, or more preferably less than 0.5.</claim-text></claim><claim id="CLM-00020" num="00020"><claim-text><b>20</b>. The method according to <claim-ref idref="CLM-00014">claim 14</claim-ref>, wherein the synergistic pesticidal composition has a predicted probability of synergy of greater than 0.55.</claim-text></claim><claim id="CLM-00021" num="00021"><claim-text><b>21</b>. A pesticidal composition comprising:<claim-text>one or more pesticidal agents selected from the list comprising: benzovindiflupyr, bixafen, boscalid, cyproconazole, fenpicoxamid, fenpyrazimine, florylpicoxamid, flutriafol, fluxapyroxad, isopyrazam, isotianil, kresoxim-methyl, metrafenone, oxathiapiprolin, penflufen, penthiopyrad, picoxystrobin, prothioconazole, pydiflumetofen, revysol, sedaxane, trifloxystrobin, pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxiconazole, propiconazole, difenoconazole, fludioxonil, mancozeb, tebuconazole, valifenalate, and combinations thereof; and</claim-text><claim-text>one or more saturated or unsaturated C4-C10 aliphatic acids or agriculturally compatible salts thereof,</claim-text><claim-text>wherein said one or more saturated or unsaturated C4-C10 aliphatic acids produce a synergistic effect on the pesticidal activity of the pesticidal composition in comparison to the pesticidal activity of the pesticidal agent alone and are present in a respective synergistically active concentration ratio between about 1:15000 and 15000:1.</claim-text></claim-text></claim><claim id="CLM-00022" num="00022"><claim-text><b>22</b>. (canceled)</claim-text></claim><claim id="CLM-00023" num="00023"><claim-text><b>23</b>. The pesticidal composition according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein the C4-C10 saturated or unsaturated aliphatic acid comprises a C4-C10 unsaturated aliphatic acid, and wherein the unsaturated C4-C10 aliphatic acid comprises at least one of: a trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, and trans-9, cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, and cis-9 unsaturated bond.</claim-text></claim><claim id="CLM-00024" num="00024"><claim-text><b>24</b>. (canceled)</claim-text></claim><claim id="CLM-00025" num="00025"><claim-text><b>25</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein the synergistic pesticidal composition has an FIC Index value of less than 1; or preferably less than 0.75, or more preferably less than 0.5.</claim-text></claim><claim id="CLM-00026" num="00026"><claim-text><b>26</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein the synergistic pesticidal composition has a predicted probability of synergy of greater than 0.55.</claim-text></claim><claim id="CLM-00027" num="00027"><claim-text><b>27</b>. The pesticidal composition according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein said pesticidal agent comprises at least one pesticidal active ingredient selected from the list comprising:<claim-text>A) Respiration inhibitors selected from:<claim-text>inhibitors of complex III at Q<sub>o </sub>site: azoxystrobin (II-1), coumethoxy-strobin, coumoxystrobin, dimoxystrobin (II-2), enestroburin, fenamin-strobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin (II-3), kresoxim-methyl (II-4), metominostrobin, orysastrobin (II-5), picoxystrobin (II-6), pyraclostrobin (II-7), pyrametostrobin, pyraoxystrobin, trifloxystrobin (II-8), 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneamino-oxymethyl)-phe-nyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;</claim-text><claim-text>Inhibitors of complex III at Q<sub>i </sub>site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)-amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbony-loxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol5-ylmethoxy)-4-methoxy-pyridine-2-carbon-yl]amino]-6-methyl-4,9-dioxol,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenyl-methyl)-1,5-dioxonan-7-yl 2-methylpropanoate;</claim-text></claim-text><claim-text>Inhibitors of complex II: benodanil, benzovindiflupyr (II-9), bixafen (II-10), boscalid (II-11), carboxin, fenfuram, fluopyram (II-12), flutolanil, fluxapyroxad (II-13), furametpyr, isofetamid, isopyrazam (II-14), mepronil, oxycarboxin, penflufen (II-15), penthiopyrad (II-16), sedaxane (II-17), tecloftalam, thifluzamide, N-(4&#x2032;-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluorome-thyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trime-thyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide;</claim-text><claim-text>Other respiration inhibitors: diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluorometh-ylpyridin-2-yloxy)-phenyl]-ethyl}-amine; binapacryl, dinobuton, dinocap, fluazinam (II-18); ferimzone; fentin salts such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin (II-19); and silthiofam;</claim-text><claim-text>B) Sterol biosynthesis inhibitors (SBI fungicides) selected from:<claim-text>C14 demethylase inhibitors (DMI fungicides): azaconazole, bitertanol, bromuconazole, cyproconazole (II-20), difenoconazole (II-21), diniconazole, diniconazole-M, epoxiconazole (II-22), fenbuconazole, fluquinconazole (II-23), flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole (II-24), myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole (II-25), prothioconazole (II-26), simeconazole, tebuconazole (II-27), tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole; imazalil, pefurazoate, prochloraz, triflumizol; fenarimol, nuarimol, pyrifenox, triforine, [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;</claim-text><claim-text>Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorphacetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;</claim-text><claim-text>Inhibitors of 3-keto reductase: fenhexamid;</claim-text></claim-text><claim-text>C) Nucleic acid synthesis inhibitors selected from:<claim-text>phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam) (II-38), ofurace, oxadixyl;</claim-text><claim-text>others nucleic acid inhibitors: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;</claim-text></claim-text><claim-text>D) Inhibitors of cell division and cytoskeleton selected from:<claim-text>tubulin inhibitors: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl (II-39); 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine</claim-text><claim-text>other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone (II-40), pyriofenone;</claim-text></claim-text><claim-text>E) Inhibitors of amino acid and protein synthesis selected from:<claim-text>methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim, Pyrimethanil (II-41);</claim-text><claim-text>protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;</claim-text></claim-text><claim-text>F) Signal transduction inhibitors selected from:<claim-text>MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;</claim-text><claim-text>G protein inhibitors: quinoxyfen;</claim-text></claim-text><claim-text>G) Lipid and membrane synthesis inhibitors selected from:<claim-text>Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; propamocarb, propamocarb-hydrochloride;</claim-text><claim-text>lipid peroxidation inhibitors: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;</claim-text><claim-text>phospholipid biosynthesis and cell wall deposition: dimethomorph (II-42), flumorph, mandipropamid (II-43), pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;</claim-text><claim-text>acid amide hydrolase inhibitors: oxathiapiprolin;</claim-text></claim-text><claim-text>H) Inhibitors with Multi Site Action selected from:<claim-text>inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride (II-44), basic copper sulfate, sulfur;</claim-text><claim-text>thio- and dithiocarbamates: ferbam, mancozeb (II-45), maneb, metam, metiram (II-46), propineb, thiram, zineb, ziram;</claim-text><claim-text>organochlorine compounds: anilazine, Chlorothalonil (II-47), captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorophenole and its salts, phthalide, tolylfluanid, N-(4-chlo-ro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;</claim-text><claim-text>guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoc-tadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1H,5H-[1,4]dithii-no[2,3-c:5,6-c&#x2032;]dipyrrole-1,3,5,7(2H,6H)-tetraone (II-48);</claim-text></claim-text><claim-text>I) Cell wall synthesis inhibitors selected from:<claim-text>inhibitors of glucan synthesis: validamycin, polyoxin B;</claim-text><claim-text>melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;</claim-text></claim-text><claim-text>J) Plant defence inducers selected from:<claim-text>acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; fosetyl, fosetyl-aluminum, phosphorous acid and its salts (II-49);</claim-text></claim-text><claim-text>K) Unknown mode of action selected from: bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, tolprocarb, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl1-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yl-oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]-ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-15-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclo-propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N&#x2032;-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N&#x2032;-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxyacetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-meth-ylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phe-nyl)-isoxazol-5-yl]-2-prop2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, tertbutyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]-amino]oxymethyl]-2-pyridyl]carbamate, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-dif-luoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-qui-nolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroiso-quinolin-1-yl)quinoline;</claim-text><claim-text>Fenpicoxamid, florylpicoxamid;</claim-text><claim-text>L) Antifungal biopesticides selected from: <i>Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pumilus </i>(II-50), <i>Bacillus subtilis </i>(II-51), <i>Bacillus subtilis </i>var. <i>amyloliquefaciens </i>(II-52), <i>Candida oleophila </i>I-82, <i>Candida saitoana, Clonostachys rosea </i>f. <i>catenulata</i>, also named <i>Gliocladium catenulatum, Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Metschnikowia fructicola, Microdochium dimerum, Phlebiopsis gigantea, Pseudozyma flocculosa, Pythium oligandrum </i>DV74, <i>Reynoutria sachlinensis, Talaromyces flavus </i>V117b, <i>Trichoderma asperellum </i>SKT-1<i>, T. atroviride </i>LC52, <i>T. harzianum </i>T-22, <i>T. harzianum </i>TH 35, <i>T. harzianum </i>T-39; <i>T. harzianum </i>and <i>T. viride, T. harzianum </i>ICCO12 and <i>T. viride </i>ICC080<i>; T. polysporum </i>and <i>T. harzianum; T. stromaticum, T. virens </i>GL-21, <i>T. viride, T. viride </i>TV1<i>, Ulocladium oudemansii </i>HRU3;</claim-text><claim-text>M) Growth regulators selected from: abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassino-lide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride) (II-54), naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium, II-55), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid, trinex-apac-ethyl and uniconazole;</claim-text><claim-text>N) Herbicides selected from:<claim-text>acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, flufenacet, mefenacet, me-tolachlor, metazachlor, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;</claim-text><claim-text>amino acid derivatives: bilanafos, glyphosate, glufosinate, sulfosate;</claim-text><claim-text>aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuryl;</claim-text><claim-text>Bipyridyls: diquat, paraquat;</claim-text><claim-text>(thio)carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;</claim-text><claim-text>cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;</claim-text><claim-text>dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin;</claim-text><claim-text>diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen; &#x2014;hydroxybenzonitriles: bomoxynil, dichlobenil, ioxynil;</claim-text><claim-text>imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;</claim-text><claim-text>phenoxy acetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;</claim-text><claim-text>pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazon, pyridate;</claim-text><claim-text>pyridines: aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, picolinafen, thiazopyr;</claim-text><claim-text>sulfonyl ureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuronethyl, chlorsulfuron, cinosul-furon, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metazosulfuron, metsulfuron-methyl, nico-sulfuron, oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosul-furon, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;</claim-text><claim-text>triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazinone, metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;</claim-text><claim-text>ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, methabenzthiazuron, tebuthiuron;</claim-text><claim-text>other acetolactate synthase inhibitors: bispyribac-sodium, cloransulammethyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribam-benz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, py-roxsulam;</claim-text><claim-text>other herbicides: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl, chlorthal, cinmethylin, clomazone, cumyluron, cyprosulfa-mide, dicamba, difenzoquat, diflufenzopyr, <i>Drechslera monoceras</i>, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac, mesotrione, methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyri-din-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester;</claim-text></claim-text><claim-text>O) Insecticides selected from:<claim-text>organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phos-phamidon, phorate, phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;</claim-text><claim-text>carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenox-ycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;</claim-text><claim-text>pyrethroids: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zetacypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fen-valerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin;</claim-text><claim-text>insect growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyramazin, dif-lubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;</claim-text><claim-text>nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran, flupyradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-2-chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinane;</claim-text><claim-text>nicotinic acetylcholine receptor disruptors or allosteric modulators (IRAC Goup 5): spinosyn (including but not limited to spinosyns A, D, B, C, E, F, G, H, J, and other spinosyn isolates from <i>Saccharopolyspora spinosa </i>culture), spinosad (comprising primarily spinsyns A and D), and derivatives or substituents thereof (including but not limited to tetracyclic and pentacyclic spinosyn derivatives, aziridine spinosyn derivatives, C-5,6 and/or C-13,14 substituted spinosyn derivatives); spinetoram (including but not limited to XDE-175-J, XDE-175-L or other O-ethyl substituted spinosyn derivatives); butenyl-spinosyn and derivatives or substituents thereof (such as isolates from <i>Saccharopolyspora pogona </i>culture);</claim-text><claim-text>bioinsecticides including but not limited to <i>Bacillus thuriengiensis, Burkholderia </i>spp, <i>Beauveria bassiana, Metarhizium anisoptiae, Paecilomyces fumosoroseus</i>, and baculoviruses (including but not limited to granuloviruses and nucleopolyhedroviruses);</claim-text><claim-text>GABA antagonist compounds: endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1-(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1H-pyrazole-3-carbothioic acid amide;</claim-text><claim-text>mitochondrial electron transport inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;</claim-text><claim-text>METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon;</claim-text><claim-text>Uncouplers: chlorfenapyr;</claim-text><claim-text>oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;</claim-text><claim-text>moulting disruptor compounds: cryomazine;</claim-text><claim-text>mixed function oxidase inhibitors: piperonyl butoxide;</claim-text><claim-text>sodium channel blockers: indoxacarb, metaflumizone;</claim-text><claim-text>ryanodine receptor inhibitors: chlorantraniliprole, cyantraniliprole, fluben-diamide, N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyra-zole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-car-boxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanyli-dene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide; N-[4,6-di-bromo-2-[(di-2-propyl-lambda-4-sulfanyl-idene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluor-omethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;</claim-text><claim-text>others: benclothiaz, bifenazate, cartap, flonicamid, pyridalyl, pymetrozine, sulfur, thiocyclam, cyenopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron, pyrifluquinazon, 1,1&#x2032;-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]-methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl] cyclopropaneacetic acid ester; fluensulfone, fluoroalkenyl thioethers; and</claim-text></claim-text><claim-text>P) ribonucleic acid (RNA) and associated compounds including double-stranded RNA (dsRNA), microRNA (miRNA) and small interfering RNA (siRNA); bacteriophages.</claim-text></claim-text></claim><claim id="CLM-00028" num="00028"><claim-text><b>28</b>. The pesticidal composition according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein said pesticidal agent comprises at least one of: a fungicide, nematicide, insecticide, acaricide, herbicide, molluscicide, and a bactericide.</claim-text></claim><claim id="CLM-29-33" num="29-33"><claim-text><b>29</b>.-<b>33</b>. (canceled)</claim-text></claim><claim id="CLM-00034" num="00034"><claim-text><b>34</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said C4-C10 saturated or unsaturated aliphatic acid comprises at least one substituent selected from the list comprising: hydroxy-alkyl- and amino-substituents.</claim-text></claim><claim id="CLM-00035" num="00035"><claim-text><b>35</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the pesticidal active ingredient is selected from at least one of: a fungicide having a fungicidal mode of action inhibiting a cellular membrane cytochrome bc1 complex, and a fungicide having a fungicidal mode of action inhibiting a cellular membrane cytochrome p450 complex.</claim-text></claim><claim id="CLM-00036" num="00036"><claim-text><b>36</b>. The synergistic pesticidal composition according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the pesticidal active ingredient comprises at least one of a strobilurin fungicide, and a triazole fungicide.</claim-text></claim></claims></us-patent-application>